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Diff erent non-invasive imaging modalities are used for to assess cardiac anatomy and 
function. Echocardiography and MRI allow assessment of cardiac structures and function 
of the cardiac chambers and valves as well as perfusion of the left ventricular wall while 
CT-angiography in addition provides unique information on the structure of the coronary 
arteries1. Nuclear cardiology off ers measurement of global, and to some extend regional left 
ventricular function and perfusion of the left ventricular wall. While these diff erent modalities 
continue to evolve, assessment of their accuracy, inter- and intraobserver reproducibility are 
crucial to assess their clinical value. In this thesis we present a series of studies of new applica-
tions of echocardiography.
Echocardiography is a very versatile tool for diagnosis of valvular disease, congenital heart 
disease and cardiomyopathy. Yet, assessment of left ventricular function is hampered by 
uncertainty to determine the precise endocardial borders. The latter may be improved by 
administration of echo contrast (chapter 2) or by harmonic imaging. In the studies presented 
in chapter 3, 4 and 5 we assessed image quality and inter- and intraobserver variability of 
harmonic imaging and contrast enhanced echocardiography in comparison to standard 
echocardiography. The value of echo contrast is further illustrated in a case report of non-
compaction cardiomyopathy (chapter 6).
Besides improved delineation of the endocardium of the cardiac chambers, contrast echo-
cardiography provides information of perfusion2 of the left ventricular wall. In chapter 7 we 
analysed perfusion assessed by contrast echocardiography in comparison with single photon 
emission computed tomography (SPECT) as the golden standard. Furthermore we assessed 
the value of echo perfusion imaging and myocardial wall thickness to predict recovery of left 
ventricular function after primary PCI for acute myocardial infarction (chapter 8).
Doppler tissue imaging (DTI) provides additional information of regional and global left 
ventricular function which may be abnormal in patients with apparently global normal left 
ventricular function as measured by the ejection fraction3-5. We assessed the clinical value 
of such abnormal DTI in patients with severe aortic stenosis and a normal left ventricular 
ejection fraction. Measurements of DTI parameters were compared with an independent 
measure of cardiac function, NT-pro BNP (chapter 9). Furthermore we assessed whether 
abnormal DTI parameters improved after surgery for aortic stenosis (chapter 10).
Chest pain can be related to many cardiac and non-cardiac causes including coronary artery 
disease, pericarditis, cardiomyopathy, valvular heart disease but also pulmonary embolism, 
pleuritis and esophagitis6,7. Echocardiography may be helpful in the diagnosis of several of 
these abnormalities. We assessed the clinical value of the systematic use of echocardiography 
in patients with chronic chest pain at the outpatient clinic (chapter 11).
In patients with chronic chest pain it is crucial to establish the presence of, or to rule out 
signifi cant coronary artery disease. The presence and amount of calcium in the coronary ar-
teries has been established as a powerful predictor of future coronary events8-11. We assessed 
the diagnostic value of coronary calcium detected by computer tomography in patients with 
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chest pain in comparison with CT angiography and exercise testing (chapter 12). Finally 
the diagnostic value of the latter two methods was assessed in comparison with invasive 
angiography (chapter 13).
Although cardiologists are often impressed by new imaging modalities such as contrast 
echocardiography, Doppler tissue imaging, myocardial perfusion echocardiography and CT-
angiography with or without PET, the clinical value needs to be carefully assessed. The results 
of diff erent studies evaluating these imaging techniques are presented in this thesis.
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ABSTRACT
Although other imaging techniques, such as magnetic resonance imaging and computer 
tomography, are becoming more and more important in cardiology, two-dimensional echo-
cardiography is still the most used technique in clinical cardiology. Quantifi cation of left ven-
tricular function and dimensions is important because therapeutic strategies, for example 
implanting an ICD after myocardial infarction, are based on ejection fraction measurements. 
Because of the sometimes-low quality of echocardiographic images we started to use an 
ultrasound contrast agent and in this article we describe our experiences with SonoVue, a 
second-generation contrast agent, over a three-year period in the Thoraxcenter.
Keywords: echocardiography, SonoVue, clinical practice.
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INTRODUCTION
Two-dimensional echocardiography is the main diagnostic technique for most cardiac 
diagnoses. Although considerable technical improvements have been achieved during the 
last decades, poor acoustic windows are still an important limiting factor of transthoracic 
echocardiography. Ultrasound contrast agents that traverse the pulmonary circulation and 
opacify the left cardiac chambers may overcome this limitation and have proven to be impor-
tant for the assessment of left ventricular (LV) border detection and function.1,2 An overview 
of the use of ultrasound contrast agents was published in this journal in 1998.3,4 SonoVue, a 
commercially available contrast agent, has been used in the Netherlands since 2001. In this 
article we report our SonoVue experience during a three-year period from 2002 to 2004.
Contrast agent
SonoVue (Bracco, Milan, Italy) is based on stabilized sulphur hexafl uoride microbubbles 
surrounded by a phospholipid shell with a mean size of 2.5 μm.5 After mixing with saline, 
a manual process that takes less than one minute (fi gure 1), a suspension is obtained with 
SonoVue microbubbles in a concentration of 1 to 5 x 108 per ml. This suspension should be in-
jected intravenously in a straight access through a three-way stopcock (to avoid destruction 
of the microbubbles) as a bolus (0.5 ml with additional 0.25 ml injections when necessary) 
followed by saline injection or as a continuous infusion by a dedicated pump delivered by 
the Bracco Company. In our institute we only use bolus injections. It should be emphasized 
that it is important to constantly shake the suspension to keep the microbubbles soluble. For 
virtually all indications 5 ml of SonoVue is suffi  cient; simple questions (LV ejection fraction) 
can often be answered with only half this volume in 15 minutes.
Figure 1: SonoVue fi le including syringe and needle
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Echocardiography
Transthoracic echocardiography was performed with the Philips Sonos 5500 (Philips, Best, 
the Netherlands) system with a S3 transducer in the second harmonic contrast-imaging 
mode. Transmit/receive frequency was 1.6/3.2 MHz and the mechanical index was 0.4 for 
endocardial border detection and 0.1 for myocardial perfusion imaging. Mechanical index 
refl ects the normalized energy to which a target (such as a microbubble) is exposed in an 
ultrasound fi eld. Normally this index ranges from 0.1 to 2.0. For myocardial perfusion studies 
power modulation imaging was used. With this technique, diff erences in acoustic properties 
of microbubbles and tissue result in selective enhancement of microbubble-generated re-
fl ections but suppression of refl ections from cardiac tissues. To visualize myocardial contrast 
bubble replenishment with real-time power modulation imaging, at peak contrast intensity 
the microbubbles in the myocardium were fi rst destroyed with fl ash imaging with high a 
mechanical index (1.6).
The basic assumption underlying power modulation imaging is that the refl ective properties 
of cardiac structures, unlike those of microbubbles, are mostly linear.6 Power modulation uses 
this assumption by transmitting repeated pulses of diff erent intensities in the same direc-
tion (fi gure 2). Two consecutive pulses of identical shape but twofold diff erence in amplitude 
would result in identical refl ections from the heart, other than the expected twofold diff er-
ence in amplitude. The smaller pulse is then multiplied by 2 and subtracted from the larger 
one, resulting in a zero signal. When refl ected by the nonlinear microbubbles, the same two 
Figure 2: Upper panel shows myocardial refl ection and lower panel microbubble refl ection in power modulation mode (also see text for 
explanation).
Mor-Avi V, et al. Circulation 2001;104:352-357
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pulses would diff er from each other not only in amplitude but also in their shape. Amplifying 
the smaller pulse and subtracting it from the larger one would result in a nonzero signal. The 
amplitude of this signal is colour-coded and displayed in an overlay over the grey-scale image.
Real-time power modulation imaging was started after fl ash imaging with a high mechani-
cal index (1.6) to destroy the microbubbles in the myocardium at peak contrast intensity in 
order to explore artifacts and to visualize myocardial contrast bubble replenishment.
Contrast applications
During the three-year period, 289 contrast studies were performed in 241 patients (48 
patients underwent two studies because of a research protocol).7 As indicated in the next 
sections and in table 1, SonoVue was used for many diff erent indications.
LV ejection fraction
As seen in fi gure 3, echo contrast improves endocardial border detection and therefore 
makes LV wall motion analysis8 and LV ejection fraction assessment more reliable.9,10 This 
improvement is refl ected by an increase in intra- and inter-observer agreement of LV ejection 
fraction and volumes.9,10 In a recently completed study in our centre, LV ejection fraction 
inter-observer variability decreased from 16.9% with second harmonic imaging to 7.0% with 
contrast imaging (unpublished data). Currently, we are using contrast for LV ejection frac-
tion in several research protocols and in routine patients in whom accurate assessment of 
LV ejection fraction is necessary because of potential changes in clinical decision-making. 
Well known examples of this latter include initiation of chemotherapy and implantation of 
an internal cardiac defi brillator.11
Table 1. Overview of SonoVue contrast echocardiography applications.
Application Patients Reference
Research – completed
- Myocardial perfusion after acute myocardial infarction 96 5
- Right ventricular visualisation in congenital heart disease 20 16
Research – ongoing
- LV ejection fraction interobserver variability* 96
- LV ejection fraction versus nuclear imaging 29
- 3D stress echocardiography 14
- Noncompaction cardiomyopathy 34
- Arrhythmogenic right ventricular cardiomyopathy 8
- Percutaneous transluminal septal myocardial ablation 43
Routine use
- Left ventricular ejection fraction 50
- Dobutamine stress echocardiography 25
- Differentiation of extra- and intra-cardiac structures 12
*The same patients as in reference 5.
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Myocardial perfusion
Contrast myocardial perfusion refl ects total myocardial capillary blood volume. One of the 
most promising applications of this new modality is in patients with acute myocardial infarc-
tion. We and others have shown that intact myocardial perfusion of infarcted myocardium 
assessed by contrast echocardiography can predict functional recovery in time.12,13 In ad-
dition, contrast echocardiography contributes to a better measurement of interventricular 
septal thickness and the combination of wall thickness >11 mm in the infarct region and 
intact perfusion is an excellent predictor of functional improvement.7 Another application 
of myocardial perfusion is in patients with hyperthrophic cardiomyopathy undergoing 
percutaneous transluminal septal myocardial ablation. During this procedure a localised 
chemical septal myocardial infarction is induced by injection of ethanol into one or more 
septal branches. By infusion of echo contrast the specifi c septal branch that supplies that part 
of the hypertrophied septum believed to produce LV outfl ow tract obstruction can be easily 
identifi ed. In at least 10% of the procedures the echo contrast images change the selection 
of the septal branch.14,15
Figure 3: Visualisation of endocardial border in four- and three-chamber images without (upper images) and with (lower images) contrast.
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Noncompaction cardiomyopathy
Noncompaction cardiomyopathy is a relatively rare congenital, unclassifi ed cardiomyopathy 
that is characterised by excessively prominent trabecular meshwork and deep intertrabecu-
lar recesses, best evidenced by colour Doppler fl ow.16 Currently, we are studying the value 
of contrast echocardiography in these noncompaction patients. As seen in fi gure 4, we have 
described one patient in the literature in whom fl ow in the intertrabecular recesses could 
only be detected with the use of SonoVue contrast.17
Right ventricular function and morphology
Echocardiographic visualization of the right ventricle remains a true challenge for the cli-
nician. More reliable may be particularly useful in patients with congenital heart disease. 
In one study we demonstrated that in particular in the near-fi eld images right ventricular 
contrast imaging gives a signifi cantly better visibility of the endocardial border (fi gure 5).18 In 
addition, better identifi cation of right ventricular trabeculation was possible, which may be 
important in the diff erentiation of right ventricular hypertrophy from marked trabeculation.
More recently, we started a research protocol in patients with a suspicion of arrhythmo-
genic right ventricular cardiomyopathy. According to existing guidelines echocardiography 
should be part of the diagnostic work-up. For the diagnosis of arrhythmogenic right ven-
Figure 4: Intertrabecular recesses fi lling with contrast (*) and apical mobile thrombus in a patient with noncompaction cardiomyopathy.
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tricular cardiomyopathy visualization of the right ventricle is important, but often diffi  cult in 
routine echocardiography. We are currently examining whether contrast echocardiography 
can help in the visualization of right ventricular aneurysms, (segmental) right ventricular 
dilatation and (regional) right ventricular hypokinesia, all criteria for the diagnosis of this 
cardiac disease.19
Stress echocardiography
The use of echo contrast improves interobserver agreement and diagnostic accuracy of 
dobutamine stress echocardiography, in particular in patients with suboptimal image qual-
ity.8,20,21 The limited use of contrast in stress echocardiography in our centre is mainly due to 
the confi dence of the observer during the described time period in its interpretation quality 
and to a lesser extent SonoVue costs. Because 3D real-time stress echocardiography suff ers 
from a signifi cant decrease in image quality compared with conventional 2D imaging we are 
convinced that contrast may play an even more important role in this new stress modality. At 
the moment the role of contrast in 3D real-time stress echocardiography is one of our main 
research interests.
Diff erentiation of extra- and intracardiac structures
Contrast echocardiography may also be helpful in the identifi cation of cavities of unknown 
origin. Since newer contrast agents such as SonoVue pass the pulmonary circulation, the 
microbubbles can reach all intracardiac cavities. If opacifi cation with SonoVue is limited to 
the cardiac chambers, the cavity of interest has no luminal connection to a cardiac chamber 
and is thus diagnosed as located extracardiacally (fi gure 6).
Figure 5: Endocardial border detection of right ventricle without (left) and with contrast (right).
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Left ventricular thrombus detection
LV thrombus detection may have important implications with regard to the use of antico-
agulant therapy. With conventional echocardiography it is sometimes diffi  cult to image 
well-defi ned apical details. As seen in fi gure 4, besides the noncompaction cardiomyopathy, 
contrast echocardiography may also be of great help in the correct interpretation of the pres-
ence or absence of an apical LV thrombus.
Safety
During the described three-year study period, two of the 241 patients (1%) experienced mild 
hypotension, sinus tachycardia and skin fl ushing most likely caused by an allergic reaction 
to SonoVue. Both patients had received SonoVue for the second time and were successfully 
treated with intravenous clemastine and hydrocortisone. Before this study period we used 
SonoVue in a role-in phase in a patient to enhance endocardial border detection with dobu-
tamine-stress echocardiography. He developed extensive skin erythema and anaphylactic 
shock with a decrease in blood pressure from 150/70 to 70/30 mmHg. After intravenously 
administered clemastine, hydrocortisone and volume, the patient rapidly recovered and was 
discharged the next day. This adverse event was reported to the EMEA. In 2004 several serious 
side eff ects with SonoVue were also reported by others22 and in a postmarketing analysis of 
157,838 SonoVue studies 19 cases of severe (0.0012%) and three cases of fatal adverse events 
(0.002%) were described (http://www.emea.eu.int/humandocs/Humans/EPAR/sonovue/
sonovue.htm). All three patients with a fatal outcome had severe coronary artery disease and 
Figure 6: Patient with echinococcus cyst; contrast image shows no connection with left ventricle.
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their clinical situation was far from stable. The allergic reactions may have been caused by the 
sulphur hexafl uoride gas or the shell component polyethylene glycol (macrogel 4000).23,24 
Subsequently, in May 2004 the European Medicines Agency (EMA) recommended not to use 
SonoVue as an ultrasound agent in cardiology. After a review of the cases by the Committee 
for Human Medicinal Products in November 2004 the recommendations changed and the 
use of SonoVue was again allowed in cardiac ultrasound. However, SonoVue is still contra-
indicated in patients with recent unstable cardiac symptoms, a recent (<7 days) coronary 
intervention, class III and IV heart failure or serious arrhythmias. An allergic reaction should 
always be anticipated and antiallergic drugs should be available in addition to standard 
resuscitation equipment. It is also recommended to keep the patient under medical supervi-
sion during and for at least 30 minutes following the infusion of SonoVue.
Limitations of SonoVue contrast
As described before, SonoVue may have important side eff ects, which makes the attendance 
of a physician mandatory. Contrast echocardiography needs a diff erent pre-setting of the 
echo machine (mechanical index, second harmonic imaging). Another limitation for the 
widespread use of SonoVue is costs because there is only a small reimbursement for contrast 
echocardiography.
CONCLUSION
When detailed morphological and/or quantitative information of the heart is needed echo 
contrast agents such as SonoVue may provide better and more reliable results. Imaging 
of myocardial perfusion will be a main area for future applications, but in our opinion it is 
not applicable for routine practice at this moment. Costs and safety issues will most likely 
determine the clinical future of SonoVue.
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ABSTRACT
Harmonic imaging (HI) has been developed to improve the potential of contrast echocar-
diography.1,2 It exploits the fact that microbubbles can resonate when hit by ultrasound 
producing harmonics as multiples of transmitted frequency.3, 4, 5 If the ultrasound machine is 
tuned to receive a second harmonic frequency selectively, it can diff erentiate contrast from 
tissue.6 However, baseline imaging is not deleted completely, because of nonlinear backscat-
ter properties of tissue.7, 8 This allows one to use harmonic imaging without contrast agents; 
this modality has been called tissue HI or native HI. Recent transthoracic echo studies have 
shown the ability of tissue HI to improve endocardial border delineation.9, 10, 11 No previous 
study has been performed to assess the role of tissue HI during transesophageal echocar-
diography (TEE). Usually, TEE shows high-quality images, but at several occasions, as during 
cardiac surgery when the heart is dislocated from its normal position, image quality can be 
suboptimal. We developed a prototype transesophageal transducer that is able to obtain HI, 
and compared it with TEE image quality of harmonic and fundamental (conventional) imag-
ing. The study was performed in the operating room during coronary artery bypass surgery 
(CABG).
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INTRODUCTION
Fourteen consecutive patients (mean age 60 ± 8 years) referred for CABG were enrolled in the 
study. Transesophageal echocardiograms in both harmonic and fundamental modes were 
performed before and immediately after CABG in the operating room. The second acquisition 
was performed just after termination of cardiopulmonary bypass pump to evaluate possible 
new wall motion abnormalities before its removal. A prototype transesophageal mono-
plane transducer interfaced with a Vingmed System Five ultrasound machine (Vingmed, 
Oslo, Norway) was used for all studies. Transgastric short-axis and esophageal 4-chamber 
views were obtained in all patients. Fundamental images were obtained using a 4.4-MHz 
transmitted frequency, whereas for the harmonic mode the transducer transmitted at 2.9 
MHz and received at 5.8 MHz. The 64-element broad-band transducer received wide band 
in fundamental and small band in the second harmonic mode. Mechanical index was set 
at 1.0. Imaging was optimized by increasing dynamic range or by adjusting overall gain. 
Dynamic range was set at >60 dB in all cases. In 5 patients an additional second transducer 
with a higher fundamental frequency (5.7 MHz) was tested after CABG to compare HI with 
fundamental imaging obtained by a commercial probe (Vingmed). Two experienced observ-
ers, blinded for the acquisition method used, scored each echocardiogram for visualization 
of endocardial borders. Visibility of endocardium was defi ned segment by segment using 
the following score: 0 = not visible; 1 = incomplete visualization during the all cardiac cycle; 
2 = incomplete visualization during part of the cardiac cycle; and 3 = complete visualization. 
Wall motion was scored in a 4-grade model: 1 indicating normal wall motion, 2 hypokinesia, 
3 akinesia and 4 dyskinesia.
Inter- and intraobserver variability for visibility of endocardial borders was scored by 2 
independent observers and 30 days later by the fi rst observer. Both observers were blinded 
for the acquisition method used. Kappa coeffi  cients were calculated using a SAS system (SAS 
Institute, Cary, North Carolina) A κ coeffi  cient of >0.4, >0.6, and >0.8 indicated fair, good, 
and excellent agreement, respectively. Data are presented as mean ± 1 SD. Diff erences be-
tween fundamental and harmonic score were evaluated by analysis of variance for repeated 
measures or by paired Student’s t test when appropriate. A p value <0.05 was considered 
signifi cant. In all, 168 segments (12 segments × 14 patients) were scored at both harmonic 
and fundamental imaging. Inter- and intraobserver variability for visibility of endocardium 
were both excellent (κ 0.81 and 0.88, respectively). Mean visibility score for endocardial 
border delineation was signifi cantly higher for harmonic than for fundamental imaging (2.58 
± 0.72 vs 2.24 ± 0.98; p <0.001). Endocardial border delineation improved with HI in 26% of 
segments (44 of 168) compared with fundamental imaging, and worsened in only 2% (4 of 
168) (p <0.001) Figures 1 and 2.
Visualization of 37% of segments (31 of 84) improved in the transgastric short-axis view 
with HI; no decrease in endocardial visibility was seen using HI. Visualization of 18% of seg-
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ments (15 of 84) improved in the 4-chamber view with HI and 5% (4 of 84) worsened. The 
number of segments improving endocardial visualization with HI was signifi cantly higher in 
the transgastric view than in the transesophageal view (37% [31 of 168] vs 18% [15 of 84]; p = 
0.01). Scoring of wall motion was altered in 7% of segments (12 of 168) when viewed with HI 
compared with fundamental imaging. In the 5 patients in whom we also used a commercial 
fundamental TEE transducer at 5.7 MHz, a total number of 60 segments (12 segments × 5 
patients) were compared. HI (2.9 to 5.8 MHz) improved endocardial border delineation in 
23% of segments (14 of 60) and worsened in 3% (2 of 60); (p = 0.003).
Figure 2: Transgastric short-axis view in a patient with a suboptimal acoustic window. Harmonic imaging (2.9 to 5.8 MHz) compared with 
fundamental imaging (4.4 MHz).
Figure 1: Transesophageal echocardiography. Fundamental imaging (5.7 MHz) compared with harmonic imaging (2.9 to 5.8 MHz) in the same 
patient.
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Tissue HI has been shown to improve image quality when compared with fundamental 
imaging during transthoracic echocardiography. A recent transthoracic study showed that HI 
improved endocardial border delineation in 64% of analyzed segments and worsened in only 
3%.9 The results of this study showed that also during TEE, HI improves endocardial border 
visualization compared with fundamental imaging. The improvement was seen in 26% of 
analyzed segments. Worsening of endocardial visibility was seen in 2% of segments. How-
ever, with use of HI, a change in wall motion score was determined in only 7% of segments. 
Transesophageal image quality is much better than transthoracic image quality, and this can 
explain the lower degree of improvement shown with HI. During this study TEE image quality 
improvement was higher in the transgastric view than in the transesophageal view (37% 
vs 18%; p = 0.01), probably because of lower quality of transgastric fundamental images. 
However, overall TEE quality improvement with HI was highly signifi cant (p <0.001). To be 
sure that the improvement was due to the harmonics and not to the tuning of the transducer, 
we used both the prototype transducer in fundamental (4.4 MHz) and harmonic mode (2.9 to 
5.8 MHz), and a commercially available transducer with a higher fundamental frequency (5.7 
MHz) in 5 patients. The results confi rmed the previous fi ndings, with a signifi cant improve-
ment in endocardial visualization with HI (p = 0.003). Physical properties of the harmonic 
mode are described in the following formula that relates the power of the second harmonic 
backscatter to several variables8: P2=(B/A+2)×(∏f/2ρc
3)×l×p2ac, where P = power (decibel); P2 
= power with second harmonic mode; B/A = nonlinear parameter of the medium; f = fre-
quency; ρ = density of the medium; c = acoustic velocity; pac = applied acoustic pressure; and 
l = distance travelled from the source.
Harmonic signal intensity is related to the distance between the acoustic transducer and 
the tissue. The farther the tissue is from the transducer, the higher the refl ected harmonic 
signal will be.12 This produces 2 results: (1) It reduces the near-fi eld clutter that is the acoustic 
noise near the transducer usually present with a phased-array system. (2) It increases the 
image quality in the far fi eld, because the signal refl ected from the far fi eld, which usually is 
weak, with the harmonic mode is higher.
B/A is the acoustic parameter of nonlinear properties of biological media. Experimental 
studies showed that the myocardium has a higher B/A (between 6.8 and 7.4) than the blood 
(≈5.7).8, 13 This means that the myocardium has a higher tendency to refl ect ultrasound with 
diff erent frequencies from the transmitted one. For this reason the myocardium produces a 
higher signal in the second harmonic mode than does the blood, and this can improve the 
endocardial border delineation, increasing the contrast between myocardium and blood.
The refl ected beam generated by normal diagnostic equipment is narrower using the 
harmonic versus the fundamental mode. According to Ward et al, the refl ected beam width 
decrease is: Wn/Wl=l/n 
0.78, where n is the harmonic number.14 It means that with the second 
harmonic mode (n = 2) the refl ected beam is 42% narrower. A narrow refl ected beam in-
creases the lateral resolution of the image (Figure 3).
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Side lobes are extraneous beams of ultrasound not in the direction of the main ultrasonic 
beam, and they can produce artifactual information. The harmonic beam has a lower level of 
side lobes than the fundamental beam (Figure 3). This is mainly due to the lower transmitting 
frequency. If the side lobes are reduced, it increases the signal-to-noise ratio, improving the 
image quality.15
CONCLUSION
In conclusion, although conventional TEE shows good quality images, tissue HI further im-
proves delineation of endocardial borders. This allows a better assessment of left ventricular 
function during cardiac surgery. Feasibility and the high-image quality of TEE HI suggest a 
future role of this modality for contrast echo studies of myocardial perfusion.
Figure 3: Comparison of beams generated by normal diagnostic equipment in harmonic and fundamental modes. The refl ected beam 
generated in the second harmonic mode is narrower. This increases the lateral resolution of the image. White arrows indicate the side lobes level 
in the near fi eld. A diminished side lobe level increases the signal-to-noise ratio in the harmonic imaging.
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ABSTRACT
Aims: Despite its relatively high intra- and inter-observer variability for left ventricular ejec-
tion fraction (LV-EF) echocardiography is clinically still the most used modality to assess 
LV-EF. We studied whether adding a second-generation microbubble contrast agent could 
decrease this variability.
Methods and results: Forty-eight patients underwent transthoracic echocardiography in 
second-harmonic mode (SHI) with and without contrast within 5 days after an acute myo-
cardial infarction. LV-EF was determined using the Simpson’s biplane method. With contrast 
intra-observer variability decreased from 12.5 ± 11.5% to 7.0 ± 7.0% (p<0.001) and inter-ob-
server variability decreased from 16.9 ± 9.9% to 7.0 ± 6.2% (p<0.001). Bland-Altman analysis 
confi rmed these fi ndings by demonstrating smaller 95% limits of agreement for both the 
intra- and inter-observer variability when contrast was used. This improvement in intra- and 
inter-observer variability was seen to a comparable extent in patients with moderate-to-poor 
and good quality SHI echocardiograms.
Conclusion: Echo contrast signifi cantly improves intra- and inter-observer variability for LV-
EF, both in patients with moderate-to-poor and good quality SHI echocardiograms.
Keywords: Echocardiography, contrast, ejection fraction, myocardial infarction
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INTRODUCTION
Left ventricular ejection fraction (LV-EF) after acute myocardial infarction (AMI) is an impor-
tant marker for mortality.1,2 LV-EF may be assessed by nuclear imaging, magnetic resonance 
imaging, and echocardiography.3,4,5 Nuclear imaging and magnetic resonance imaging 
provide relatively reliable information and with acceptable intra- and inter-observer variabil-
ity.6,7 However, the use of these imaging modalities is limited by radiation exposure during 
nuclear imaging, high costs and non-availability in the coronary care unit and catheterization 
laboratory. Echocardiography is currently the most frequently used imaging modality for the 
assessment of LV-EF. However, echocardiographic images are sometimes of poor quality 
and in a recent review article high intra- and inter-observer variabilities were reported for 
echocardiographic LV-EF assessment.5
Left ventricular opacifi cation (LVO) with echo contrast has been shown to improve image 
quality and in particular endocardial border delineation and this may improve intra- and 
inter-observer variability.8,9 Therefore, we conducted a post-AMI trial in which LV-EF was as-
sessed with second harmonic imaging (SHI) and LVO.
METHODS
Both SHI and LVO echocardiography were performed in 48 consecutive (regardless of image 
quality) patients within 5 days after primary angioplasty for AMI by one single experienced 
sonographer (WBV). Imaging was performed using the Sonos 5500 system (Philips, Best, 
The Netherlands). SHI images were acquired with a transmitted frequency of 1.6 MHz and a 
received frequency of 3.2 MHz, mechanical index was 1.6 and frame rate 50 Hz. For LVO imag-
ing mechanical index was 0.3 and frame rate 25 Hz. Contrast agent SonoVue (Bracco, Milan, 
Italy) was used. This contrast agent consists of stabilized sulfur hexafl uoride micro bubbles 
surrounded by a phospholipid shell with a mean size of 2.5μm.10 The contrast agent was 
given as a bolus of 0.5 ml with additional boluses of 0.25 ml when needed. Care was taken to 
record the images at a phase when contrast fl ow was relatively stable with absent or minimal 
swirling of contrast in the apex.
Non-foreshortened apical 2 and 4 chamber views were used for assessment of LV-EF 
(Figure 1). Manual tracing of LV end-systolic and end-diastolic frames was performed off -line 
according to Simpson’s method, recommended by the American Society of Echocardiogra-
phy,11 using commercially available Enconcert software (Philips, Best, The Netherlands) by 
two experienced cardiologists (TWG, EB). Papillary muscles were considered as part of the LV 
cavity, and thus included in LV volume. To determine the inter-observer variability for both 
SHI and LVO images, all measurements were repeated by a second observer (EB) blinded 
to the values obtained by the fi rst observer (TWG). To assess intra-observer variability, all 
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measurements were repeated one month later by an observer (TWG) blinded to the results 
of the previous measurements. Endocardial border visualization was scored for 12 segments 
derived from the 2- and 4 chamber apical views in SHI mode to investigate if intra- and inter-
observer variability was infl uenced by quality of SHI. Endocardial border visualization was 
scored according to a 3-level scoring system where 0 = border invisible, 1 = border visual-
ized only partially throughout the cardiac cycle and/or incomplete segment length, and 2 = 
complete visualization of the border.9 An endocardial visualization score was calculated by 
adding the score of all 12 segments in every patient. On basis of the quality score two image 
quality groups were defi ned: good (score 19-24), and moderate-to-poor (score <19) quality 
echo. The local ethics committee approved the study protocol and all patients gave written 
informed consent.
Statistical analysis
Continues variables are expressed as mean ± standard deviation (SD). Intra- and inter-
observer variabilities were calculated as the absolute diff erence between two measurements 
in percent of their mean. To test diff erences in intra- and interobserver variability between 
techniques a paired t test was used. A two-tailed p-value<0.05 was considered statistically 
signifi cant. In addition, Bland-Altman analysis was used to determine the 95% limits of agree-
ment (1.96SD) between measurements.12
Figure 1: Four-and two-chamber image SHI (upper panel) and LVO (lower panel). In the SHI image the endocardiumis only partially visible (arrow).
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RESULTS
Patients: Baseline characteristics of all patients are summarized in Table 1. Mean age of the 
patients was 52 ± 13 years. The AMI-related coronary artery was the LAD in 54%, the RCA 
in 31%, and the LCX in 15%. Multivessel disease was present in 48% of patients. Two of the 
48 patients (4%) experienced mild hypotension, sinus tachycardia and skin fl ushing most 
likely caused by an allergic reaction of SonoVue. Both patients were successfully treated with 
intravenous clemastine and hydrocortisone.
Ejection fraction: Mean LV-EF for observer 1 was 47.1% ± 9.1% with SHI and 47.5% ± 8.3% 
with LVO. Intra-observer variability (expressed as absolute diff erence in percent of their 
mean) decreased from 12.5 ± 11.5% to 7.0 ± 7.0% (P <0.001) with LVO. Inter-observer vari-
ability decreased from 16.9 ± 9.9% to 7.0 ± 6.2% (P <0.001) with LVO (Table 2).
In addition, Bland-Altman analysis confi rmed these results by demonstrating smaller limits 
of agreement for LV-EF when contrast was used for both intra- and inter-observer variability 
(Figures 2,3). Good and moderate-to-poor image qualities were present in 15 (31%) and 33 
(69%) patients, respectively. As seen in Table 2 signifi cant improvements in intra- and inter-
observer variability were found for both image quality groups. Again this was confi rmed by 
Bland-Altman analysis showing smaller limits of agreements when contrast was used regard-
less of image quality (Figures not shown).
Table 1 Baseline clinical characteristics
Clinical feature
Age (years) 53+13
Male 41 (85%)
Current smoker 29 (60%)
Diabetes 4 (8%)
Hypertension 14 (29%)
Hypercholesterolemia 30 (63%)
Prior myocardial infarction 6 (13%)
Prior PCI/CABG 1 (2%)
Infarct related vessel
LAD 26 (54%)
LCX 7 (15%)
RCA 15 (31%)
Multivessel disease 23 (48%)
PCI, percutaneous coronary intervention; CABG, coronary artery bypass
grafting; LAD, left anterior descending; LCX, left circumflex artery; RCA,
right coronary artery.
Table 2 Intra- and inter-observer variabilities for ejection fraction measurements without and with contrast for the total population and
as a function of image quality
Intra-observer variability (%) Inter-observer variability (%)
SHI LVO P-value SHI LVO P-value
Total (n ¼ 48) 12.5+11.5 7.0+7.0 ,0.001 16.9+9.9 7.0+6.2 ,0.001
Good (n ¼ 15) 10.4+7.1 5.8+5.2 0.06 16.0+6.7 7.5+7.3 0.001
Moderate/poor (n ¼ 33) 13.4+13.0 7.5+7.7 0.002 17.3+11.1 6.8+5.7 ,0.001
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DISCUSSION
LV-EF after AMI is an important marker for mortality and is becoming increasingly important 
because the selection of patients who benefi t from an internal cardiac defi brillator is based 
on LV-EF.1,2,13 Currently, echocardiography is the imaging modality most often used to assess 
LV-EF. However, echocardiography is limited by high intra- and inter-observer variability.5 
Reliable contour detection of the LV is only possible if the endocardial border is visible 
during end-systole and end-diastole. Although SHI improves endocardial border detection 
compared to fundamental imaging, even in good quality echocardiograms it is sometimes 
diffi  cult to delineate the endocardium in the still frames whereas with LVO this may be more 
reliable.9 So, in our study, SonoVue echo contrast further improved endocardial border detec-
tion in post-AMI patients resulting in a signifi cant decrease in intra- and inter-observer vari-
ability for LV-EF. Our fi ndings confi rm the results published recently by others.14,15 In Figure 
4, the intra- and inter-observer variabilities for LV-EF reported in studies using SHI and LVO 
imaging are summarized.14,16,17 Due to the consecutive character of patient inclusion in our 
study (no patient was excluded because of image quality) our SHI result seem worse than 
those reported by others. Although some authors showed an improvement in LV endocardial 
Figure 2: Intra-observer variability by Bland–Altman analysis for LV-EF. Left panel: SHI, right panel: LVO.
Figure 3: Inter-observer variability by Bland–Altman analysis for LV-EF. Left panel: SHI, right panel: LVO.
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border detection with SHI compared to FI9, optimal intra- and inter-observer variability in 
LV-EF can only be achieved when echo contrast agent is added to SHI imaging. In a study by 
Hoff mann et al. inter-observer variability between three readers from diff erent institutions 
was best (even compared to MRI images and cineventriculography) with contrast-enhanced 
echocardiography and worst with unenhanced echocardiography.18 In patients with 
moderate-to-poor image quality higher intra- and inter-observer variabilities were found 
for SHI imaging. However, the improvement with LVO imaging in intra- and inter-observer 
variabilities was almost similar in patients with moderate-to-poor and good image quality. 
These fi ndings are in agreement with studies published by Malm et al., and Nayyar et al., 
although Hundley et al. noticed improvement in LV-EF variability particularly in subjects with 
two or more adjacent endocardial segments not seen at baseline.14,19,20 Unfortunately, we 
did not compare SHI and LVO LV-EF with a gold standard technique. However, several studies 
have shown an excellent correlation between LVO and magnetic resonance imaging.15,20,21 
Furthermore, observers could not be blinded to the use of contrast or not.
CONCLUSION
Assessment of LV-EF is more reliable with LVO imaging, evidenced by better intra- and inter-
observer variability. Our study supports the concept that when LV-EF may infl uence clinical 
decision-making, LVO imaging should not be limited to patients with moderate-to-poor 
echocardiographic windows. This is in disagreement with the ASE Task Force Guidelines 
which recommend to use LVO only when at least 2 of 6 contiguous segments in a standard 
apical view are not visualized.22
Figure 4: Intra- and inter-observer variabilities for LV-EF reported in studies using SHI and LVO imaging.
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ABSTRACT
Background: The wall motion score index (WMSI) is a surrogate marker for left ventricular 
ejection fraction (LV-EF). Unfortunately, there are only few data on the relation between these 
parameters and poor echo windows can make the WMSI unreliable. The value of contrast-
enhanced imaging for WMSI assessment was not investigated before.
Aim of the study: To compare interobserver agreement for segmental wall motion and WMSI 
in patients who underwent both two-dimensional second harmonic (SH) and contrast LVO 
echocardiography and to study the correlation between the LVO-imaged WMSI and LV-EF.
Methods: The study comprised 100 consecutive patients (mean age 57 ± 13 years, 85% 
males). Two independent physicians assessed LV segmental quality and wall motion for both 
the SH and LVO studies according to a 17-segment model. Systolic wall motion was defi ned 
as (1) normokinesia, (2) hypokinesia (systolic inward endocardial motion <7mm), (3) akinesia, 
and (4) dyskinesia. LV-EF was assessed from the LVO images according to the biplane modi-
fi ed Simpson’s method.
Results: Of the 1,700 analyzed segments, 453 (26.6%) were poorly visualized with SH imag-
ing, and 173 (10,2%) with LVO imaging (P <0.0001). The two observers agreed on segmental 
wall motion score in 1,299 segments (agreement 76%, Kappa 0.60) with SH imaging and in 
1,491 segments (agreement 88%, Kappa 0.78) with LVO imaging. Interobserver correlation 
(r2) was 0.86 for the SH-imaged WMSI and 0.93 for the LVO-imaged WMSI. The limit of agree-
ment for interobserver LVO-imaged WMSI (mean relative diff erence -1.0% ± 6.8%, agreement 
-14.6%, 12.6%) was lower than that for SH-imaged WMSI (mean relative diff erence -2.3% ± 
10.1%, agreement -22.5, 17.9). The LVO-imaged WMSI correlated well with LV-EF (r2 = 0.71). 
LV-EF could be estimated according to the formula 1.01 - 0.32 x WMSI.
Conclusion: Echo contrast improves interobserver agreement for wall motion scoring and 
the WMSI. The LVO-imaged WMSI correlates well with LV-EF.
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INTRODUCTION
Left ventricular ejection fraction (LV-EF) is a strong predictor of mortality in cardiac patients1 
and is a crucial variable in clinical decision-making for valvular surgical interventions,2 im-
plantation of an internal cardiac defi brillator,3 and the initiation of chemotherapy.4 However, 
for routine applications LV-EF measurements are time-consuming and often a wall motion 
score index (WMSI) is provided as a surrogate marker for LV-EF. Despite its common clinical 
use, there are only few studies in which the relation between the WMSI and LV-EF was inves-
tigated.5,6 Surprisingly, in none of these studies defi nitions for hypokinesis were provided. In 
addition, poor echo windows make the WMSI (and LV-EF) unreliable in an important number 
of patients.7 In several studies it has been shown that LV opacifying (LVO) contrast improves 
endocardial border detection 7-10 and interobserver agreement for classifying segmental wall 
motion.11,12 The purpose of the present study was to compare interobserver agreement for 
segmental wall motion and the WMSI for two-dimensional second harmonic (SH) and contrast 
LVO echocardiography and to study the correlation between the LVO-imaged WMSI and LV-EF.
METHODS
Patient population: The study comprised 100 consecutive patients who underwent both SH 
and LVO echocardiography for clinical evaluation of LV function. Mean age of the patients was 
57 ± 13 years and 85 were males (85%). Ten patients (10%) were not known with cardiovascular 
disease, 84 patients (84%) had a history of fi rst acute myocardial infarction treated with coro-
nary angioplasty and 6 patients (6%) were referred for LV-EF assessment for internal cardiac 
defi brillator screening. None of the patients had a dilated cardiomyopathy, defi ned as a LV 
end-diastolic diameter >60mm.
Echocardiographic imaging: Echocardiography was performed with a Sonos 5500 or 
7500 system (Philips, Best, The Netherlands). SH images were acquired with a transmitted 
frequency of 1.6 MHz and a received frequency of 3.2 MHz, mechanical index was 1.6, for 
LVO imaging mechanical index was 0.3. LVO imaging was done with SonoVue (Bracco, Milan, 
Italy),13 administered as a bolus of 0.5 ml intravenously with repeated boluses of 0.25 ml 
when necessary. Care was taken to record the images at a phase when contrast fl ow was 
relatively stable. All acquired SH and LVO images were digitally stored.
Echocardiographic analysis: The LV was analyzed according to the recommended 17-seg-
ment model.14 Two independent physicians (MLG, AvdV) assessed segmental quality and 
wall motion for both the SH and LVO studies. Quality was scored on a binary scale as poorly 
visualized (absent or no clear endocardial delineation) or adequately visualized. Segments 
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were considered poorly visualized when at least one physician noticed this score. Systolic 
wall motion was defi ned as (1) normokinesia (systolic inward endocardial motion ≥7mm), (2) 
hypokinesia (systolic inward endocardial motion <7mm), (3) akinesia (absence of systolic en-
docardial motion), and (4) dyskinesia (systolic outward endocardial motion). After the initial 
independent segmental wall motion scoring by the two observers, a segmental consensus 
score was reached between the two observers. To resolve consensus issues, electronic 
calipers were used when necessary. The WMSI was defi ned as the summed segmental wall 
motion scores divided by the number of analyzed segments. LV-EF was assessed from the 
LVO images according to the biplane (apical 2- and 4-chamber views) modifi ed Simpson’s 
method by two other blinded physicians (TWG, OIIS) using EnConcert software.15
Statistical analysis
The limits of agreement between readings of the two independent observers were estimated 
as the relative mean diff erence ± 2 SD of this diff erence, as described by Bland and Altman.16 
The kappa (κ) coeffi  cient was calculated to determine interobserver agreement. A kappa 
value <0.4 was considered poor, 0.4 to 0.7 moderate, and >0.7 good.
RESULTS
Segment visualization: Of the 1,700 analyzed segments, 455 (26.7%) were poorly visualized 
with SH imaging, and 173 (10,2%) with LVO imaging (P <0.0001). The distribution of poorly 
Figure 1: Diagram showing the distribution of poorly visualized segments with second harmonic (SHI, top) and left ventricular opacifying (LVO, 
bottom) imaging.
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Tjebbe BW 19-5b.indd   52 20-05-10   10:47
53
Contrast Echocardiography improves Interobserver Agreement for WMSI and Correlation with EF
Ch
ap
te
r 5
visualized segments with SH and LVO imaging is depicted in Figure 1. For both SH and LVO 
imaging anterior segments were most problematic (110 and 80 anterior segments were 
poorly visualized, respectively). With LVO imaging segment visibility increased towards the 
apex (poor visualization was present in 14.2% of basal segments, 9.2% of mid segments, and 
6.6% of apical segments, respectively).
Segmental interobserver agreement: As seen in Figure 2, the two observers agreed on 
segmental wall motion score in 1,299 of the 1,700 segments (agreement 76%, Kappa 0.59) 
with SH imaging and in 1,491 of the 1,700 segments (agreement 88%, Kappa 0.78) with LVO 
imaging. The segmental distribution of agreement with SH and LVO imaging is depicted in 
Figure 3a and 3b.
Figure 3a: Segmental distribution of agreement with second harmonic imaging.
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Figure 2: Segmental wall motion score by the two observers with second harmonic (left) and left ventricular opacifying (right) imaging.
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Interbserver agreement according to segment visualization: Interobserver agreement 
and the Kappa value for SH imaging in the 455 poorly visualized segments vs. the 1,245 ad-
equately visualized segments was 72% and 0.52 vs. 78% and 0.62. Interobserver agreement 
and the Kappa value for LVO imaging in the 173 poorly visualized segments vs. the 1,527 
adequately visualized segments was 78% and 0.62 vs. 89% and 0.80.
Improvement with LVO according to segment visualization: In the 455 poorly visualized 
SHI-segments, LVO imaging improved interobserver agreement from 72% to 84% and the 
Kappa value from 0.52 to 0.72. In the 1,245 adequately visualized SHI-segments, LVO imaging 
improved interobserver agreement from 78% to 89% and the Kappa value from 0.62 to 0.80.
Figure 3b: Segmental distribution of agreement with second harmonic (top) and left ventricular opacifying (bottom) imaging.
92 92 92
LVO Agreement
93 92 84 90 83 90
84 84 90 85 84 84
89 95 84 89 87 79
74 73 83 75 73 74
.88 .88 .88LVO Kappa
.87 .83 .71 .81 .63 .83
. . . . . .
.85 .73 .74 .65 .64.80
Figure 4: Interobserver correlation (r2) for second harmonic (left) and left ventricular opacifying (right) imaging.
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WMSI interobserver agreement: As seen in Figure 4, interobserver correlation (r2) was 0.86 
for the SH-imaged WMSI and 0.93 for the LVO-imaged WMSI. As seen in Figure 5, interobserver 
limits of agreement for LVO-imaged WMSI (mean relative diff erence -1.0% ± 6.8%, agreement 
-14.6%, 12.6%) was better than that for SH-imaged WMSI (mean relative diff erence -2.3% ± 
10.1%, agreement -22.5, 17.9).
Correlation of WMSI with LV-EF: Mean consensus WMSI was 1.62 ± 0.37 for SH and 1.55 ± 
0.37 for LVO imaging and mean LV-EF was 52 ± 14% (range 18 to 84%). As seen in Figure 6, 
the 17 segments based on SH and LVO imaging WMSI correlated well with LV-EF (r2 = 0.69 and 
0.71, respectively).
Figure 5: Interobserver limits of agreement for second harmonic (left) and left ventricular opacifying (right) imaging.
Relative Difference [%] Mean Difference = -2.3 ± 10.1
20
30
40
0
10
+2 SD
-20
-10
Mean
-40
-30
-2 SD
0.00 0.50 1.00 1.50 2.00 2.50 3.00
Mean WMSI (second harmonic imaging)  
Relative Difference [%] Mean Difference = -1.0 ± 6.8
20
30
40
0
10
+2 SD
Mean
-20
-10
-2 SD
-40
-30
0.00 0.50 1.00 1.50 2.00 2.50 3.00
Mean WMSI (contrast imaging)
Figure 6: Correlation of ejection fraction with the wall motion score index based on harmonic (left) and left ventricular opacifying (right) imaging.
80
90
100
n
r2 = 0.69
y = 102 - 31.3x
50
60
70
Ej
ec
tio
n 
Fr
ac
tio
n
30
40
E
0
10
20
0.00 0.50 1.00 1.50 2.00 2.50 3.00
Consensus WMSI (second harmonic imaging)  
100
80
90
r2 = 0.71
y = 101 - 32x
je
ct
io
n 
Fr
ac
tio
n
50
60
70
Ej
30
40
0
10
20
Consensus WMSI (contrast imaging)
0.00 0.50 1.00 1.50 2.00 2.50 3.00
Tjebbe BW 19-5b.indd   55 20-05-10   10:47
Chapter 5
56
DISCUSSION
Calculation of LV-EF by manual tracing of endocardial borders at end-diastole and end-systole 
in at least two views remains a tedious and time-consuming task. In many cases, identifi ca-
tion of the endocardial border requires analysis of the moving and still standing images using 
both the cine-loop and frame-by-frame features of the system. The semi-quantitative WMSI 
forms an alternative global estimate of systolic LV function. In this index, endocardial motion 
for each defi ned myocardial segment is described as normal, hypokinetic, akinetic, or dyski-
netic, with a score ranging from 1 to 4 corresponding to these descriptive terms.15 An overall 
WMSI can be derived by dividing the sum of scores for each myocardial segment by the num-
ber of segments evaluated. In our study 17 LV segments were evaluated, in accordance to the 
latest recommendations.14 It is surprising that in only a few studies the WMSI was validated 
and that in these studies the extent of endocardial excursion that defi ned hypokinesis was 
not mentioned at all.5,6,17 In our study we defi ned hypokinesis as segmental motion <7mm, a 
value derived from normal values for end-diastolic and end-systolic LV dimensions described 
in standard references.18
Accurate identifi cation of the LV endocardial border is crucial in the echocardiographic 
evaluation of LV systolic function. Unfortunately, endocardial border defi nition is sometimes 
negatively infl uenced by anatomic and technical (poor lateral resolution, skill of the sonogra-
pher) factors.7 Therefore, we used LVO contrast to optimize LV endocardial border defi nition 
and for the fi rst time determined the value of the contrast-enhanced WMSI. Compared to SH 
imaging, LVO-imaged myocardial segments were visualised better and interobserver agree-
ment for segmental wall motion and the WMSI improved. Surprisingly, this was not only true for 
poor visualized segments with SH imaging but also for moderate-to-good visualized segments.
The clinical importance of the WMSI was recently confi rmed in a study from the Mayo 
clinic.5 The WMSI is not only a more readily available estimate of systolic LV function but 
had also greater predictive power than LV-EF in patients after acute myocardial infarction.5 
As seen in the Table, the results of all published 5,6 and our formulas to estimate LV-EF from 
the WMSI are quite similar, regardless of the golden standard for LV-EF (standard or contrast 
echocardiography, or nuclear). In most patients the following rule of thumb can be applied 
for 16 or 17-segment LV models: LV-EF = 70% - 2% for each wall motion abnormality (akinesis 
equals 2 x 2% penalty points) or LV-EF = 1 - (0.3 x WMSI). In patients with mild to moder-
ate impaired LV function (WMSI <2.50) this rule of thumb has an error margin less than 5% 
when compared to all the formulas shown in the Table. In patients with severely impaired 
LV function (WMSI ≥2.50), LV-EF is somewhat underestimated by this rule of thumb, as it is 
with eyeballing. In these patients the following common sense rules can be used in addition: 
a LV-EF below 10% is very rare and when some LV motion is seen the LV-EF is usually in the 
range of 15 to 20%.
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CONCLUSION
Echo contrast improves interobserver agreement for wall motion scoring and the WMSI. The 
LVO-imaged WMSI correlates well with LV-EF and may serve as an accurate surrogate marker 
for LV-EF.
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INTRODUCTION
Non-compaction cardiomyopathy (NCC) is a rare disorder characterized by excessive and 
prominent trabeculation of the left ventricle (LV). Prominent trabeculae are seen in the right 
ventricle (RV) but this is very unusual after birth in the left ventricle. We describe a patient 
with obvious non-compaction cardiomyopathy diagnosed with contrast echocardiography.
CASE REPORT
A 35-year-old man consulted our hospital for gradual onset of dyspnea, orthopnea, palpita-
tions and nausea since 2 months. Physical examination showed signs of heart failure: elevated 
jugular venous pressure, enlargement of the liver and edema of both lower legs. His pulse rate 
was 120 bpm and blood pressure 110/85 mm Hg. Electrocardiography demonstrated sinus 
rhythm, right axis deviation and left bundle branch block. Chest X-ray showed bilateral stasis.
Admission transthoracic echocardiography revealed a dilated left atrium and LV with 
severely impaired systolic function (Figure 1). An echo-dense mobile mass was visible at 
the apex. Multiple prominent muscular trabeculations were present in the LV most evident 
Figure 1: Two-dimensional echocardiography apical four-chamber view with (right) and without (left) contrast. Excessive and prominent 
trabeculation of the left ventricle is visible. The contrast shows the communication between the recesses and ventricular cavity. A thrombus is 
visible at the apex.
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at the apical and the infero-lateral wall. Deep intertrabecular spaces were evident on the 
two-dimensional echo with contrast. These fi ndings are pathognomonic for ventricular non-
compaction. Both the RV and right atrium (RA) were enlarged with decreased RV function.
Treatment with enoximon, dopamin, nitroglycerin and heparin was started. After 5 days had 
the patient a clinical recovery and he is now treated with an ACE-inhibitor, anticoagulants and 
diuretics. Three days after admission, magnetic resonance imaging (MRI) confi rmed trabecula-
tions of both the LV and RV and the mass in the apex seen a few days earlier was disappeared 
(Figure 2). This was confi rmed by repeated echocardiography with and without contrast.
DISCUSSION
During normal embryogenesis, the loosely interwoven meshwork of myocardial fi bers be-
comes more compact towards the epicardial surface and condenses to a compact wall. NCC is 
thought to be related to an arrest in this process resulting in a thickened left ventricular wall 
with deep intertrabecular recesses.1
Many diagnostic modalities have been evaluated for diagnosis of NCC. CT and MRI can pro-
vide high-resolution imaging of non-compacted myocardium and may indicate a disturbed 
microcirculation due to fi brosis and thrombus formation.2
Characteristics on echocardiography have been defi ned as absent coexisting cardiac 
abnormalities, non-compacted trabecular endocardium with deep endomyocardial spaces, 
predominant localisation of the trabeculation to mid-lateral, apical and mid-inferior seg-
ments, and a colour Doppler evidence of deep perfused intertrabecular recesses.3
As bloodfl ow is low in the spaces between the trabeculations, the communication between 
the recesses and the ventricular cavity can be missed using conventional colour Doppler. For 
Figure 2: MRI two-chamber (left) and short-axis view (right). Multiple prominent trabeculations are present in the LV at the apical and 
the infero-lateral wall with an end-systolic ratio of non-compacted to compacted layer of 3. More than 2 is diagnostic for non-compaction 
cardiomyopathy.
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that reason, we used intravenous contrast (Sonovue®, Bracco, Italy). Only one previous case 
report described the use of contrast to diagnose NCC.4 The echo-dense mass was assumed to 
be a ventricular thrombus and was treated with heparin.
CONCLUSION
In echocardiography, the use of echo contrast can be very helpful to confi rm the connection 
of the intertrabecular spaces and the LV cavity. It can also be helpful to improve visualisation 
of trabeculations in patients with poor baseline echo images. Together with greater under-
standing and awareness, it is likely that an increased number of patients will be diagnosed 
with NCC in an earlier disease stage.
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ABSTRACT
Microvascular integrity, as seen by myocardial contrast echocardiography (MCE), assesses 
whether myocardium has been successfully reperfused after an acute myocardial infarction. 
Until now this has been demonstrated only with intracoronary injection of an ultrasound 
contrast agent. Power Doppler imaging is a recently developed myocardial contrast echo-
cardiographic method that counts the contrast microbubbles destroyed by ultrasounds and 
displays this number in colour. This study sought to evaluate whether power Doppler MCE is 
able to visualize myocardial reperfusion during intravenous contrast injection. Thirty patients 
were evaluated 2 days after their fi rst myocardial infarction during intravenous infusion of 
perfl uorocarbon-exposed sonicated dextrose albumin (PESDA). Coronary artery angiog-
raphy and single-photon emission computed tomography (SPECT) were used as reference 
techniques. A 16-segment left ventricular model was used to relate perfusion to coronary 
artery territories. Sensitivity and specifi city of power Doppler MCE for segments supplied 
by infarct related arteries were 82% and 95%, respectively. Accuracy of power Doppler MCE 
and SPECT were similar (90% vs. 92% on segmental basis and 98% vs. 98% on coronary artery 
territory basis). Two-dimensional echocardiography was repeated after 6 weeks. Segments 
recovering wall motion after 6 weeks were defi ned as stunning myocardium. Dysfunctional 
but perfused myocardium at day 2 after the infarction showed a better late recovery of wall 
motion compared with dysfunctional but nonperfused myocardium (p<0.001). In conclusion, 
harmonic power Doppler imaging is a sensitive and specifi c method for the identifi cation of 
myocardial reperfusion early after myocardial infarction. It yields prognostic information for 
late recovery of ventricular function diff erentiating stunning (dysfunctional but perfused) 
from necrotic myocardium (dysfunctional and nonperfused).
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INTRODUCTION
The best approach to determine whether myocardium has been successfully reperfused after 
an acute myocardial infarction is to assess microvascular integrity.1,2 Despite the presence 
of an open artery, myocardial perfusion may not be achieved because of microvascular 
disruption (“no refl ow phenomenon”). 3,4 Moreover, it has been shown that microvascular 
integrity predicts the outcome in patients with a fi rst acute myocardial infarction.5–10 Of 
currently available techniques, intracoronary myocardial contrast echocardiography (MCE) 
is a recognized method to assess microvascular integrity.3–10 It uses microbubbles that are 
pure intravascular tracers that allow unique information about capillary fl ow to be obtained. 
Recently, it has been shown that myocardial perfusion could be studied using a peripheral 
intravenous injection of echocontrast agents.11–13 Particularly, the newer ultrasound contrast 
agents that contain a high molecular weight gas show great promise for the detection of 
myocardial ischemia.14–17 Current studies have either used gray-scale harmonic imaging 
or colour-coded imaging obtained from subtracted gray-scale images.11,12 Power Doppler 
imaging is a recently developed myocardial contrast echocardiographic method that counts 
the contrast microbubbles destroyed by ultrasounds and displays this number in colour. 
Therefore, it can selectively evaluate the signal coming from an ultrasound contrast agent. 
We hypothesized that this new imaging modality could provide an assessment of myocardial 
reperfusion after a recent myocardial infarction.
METHODS
Patients: Thirty consecutive patients with a fi rst acute myocardial infarction were enrolled 
in the study. The diagnosis of acute myocardial infarction was made on the basis of chest 
pain lasting >30 minutes, ST elevation of ≥2 mm in 2 contiguous electrocardiographic leads, 
and an increase in serum creatine kinase to more than twice the upper limit of normal. All 
patients were in stable clinical condition at day 2 after the infarction. No patient underwent 
coronary artery angioplasty (primary or rescue). Ten patients (33%) did not receive thrombo-
lytic therapy because of delayed arrival to the hospital. Patient characteristics are described 
in Table 1. The institutional review board of the hospital approved the study protocol, and the 
patients gave oral informed consent for participation in the study.
Control group: Fifteen healthy volunteers with normal wall motion were enrolled in the 
study to check for accuracy of power Doppler MCE imaging in normal patients. Images were 
analyzed by technicians who were blinded to wall motion score, in a random order with the 
MCE images of the 30 patients with acute myocardial infarction.
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Study protocol: Each patient underwent intravenous MCE on the second day after admis-
sion. Coronary angiography was performed as close as possible to MCE and was considered 
the primary gold standard technique. Technetium-99m-sestamibi single-photon emission 
computed tomography (SPECT) at rest was performed in 18 patients, also before hospital 
discharge. Follow-up 2-dimensional echocardiography was performed after 6 weeks to 
evaluate possible wall motion recovery.
Myocardial contrast echocardiography: MCE was performed with a Hewlett-Packard Sonos 
5500 (Andover, Massachusetts) during continuous intravenous infusion of perfl uorocarbon-
exposed sonicated dextrose albumin (PESDA) using second harmonic mode (1.8 to 3.6 MHz) 
and power Doppler imaging. Images were acquired at end-systolic triggering every fi fth 
cardiac cycle. Standard apical 4-, 2-, and 3-chamber views were acquired.
Contrast medium: PESDA was prepared as previously described.15 Briefl y, 8 ml of perfl uoro-
butane was hand agitated with a 3:1 mixture of 5% dextrose and 5% human albumin. This 
mixture then underwent electromechanical sonication for 80 seconds. The mean micro-
bubble size of PESDA is 4.7 ± 0.2 μm with a mean concentration of 1.3 x 109 microbubbles 
per milliliter.15 The total amount of infused PESDA was 0.04 ml/kg. This dose was diluted in 
40 ml of saline 0.9% and was administered intravenously using an infusion pump. The rate 
of infusion was adjusted accordingly to the operator’s opinion of image quality. Mean rate of 
infusion was 1.8 ± 0.4 ml/min.
Power Doppler setting: Before starting the contrast injection, the pulse repetition frequency 
was set to 2.5 kHz and power Doppler gain was adjusted from its maximal setting downward 
until colour (wall motion artifact) disappeared and the myocardium was gray. In case of 
colour persistence at low gain (<50%), the power Doppler pulse repetition frequency was 
increased until the myocardium was gray (maximum pulse repetition frequency 3.0 kHz). This 
setting was fi xed before contrast injection and held constant throughout all of the acquisi-
tion. When premature ventricular contraction or deep breath occurred, the relative frames 
were ignored because of possible wall motion artifact. The mechanical index was set at 1.5 
MPa. Because the displayed mechanical index refl ects only the value around the focal point, 
the focus was moved at the level of potential perfusion defects to eliminate false-positive 
perfusion defects.
Analysis of myocardial contrast echocardiographic perfusion: A 16-segment left ven-
tricular model was used for myocardial perfusion analysis. Myocardial perfusion was scored 
as 0 = contrast defi cit, 0.5 = partial perfusion, and 1 = complete perfusion. Perfusion pattern 
was scored separately by 2 observers who were blinded to wall motion data. Analysis was 
performed on 5 consecutive single stop-frames acquired during end-systolic triggering. Ob-
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servers were unaware of clinical, angiographic, and wall motion data. Grade 1 was considered 
normal and grades 0 and 0.5 abnormal. Each of the 16 segments was assigned a priori to 1 
of the 3 coronary arteries (left anterior descending, left circumfl ex, or right coronary artery). 
Both apical segments of the lateral wall and inferior wall were assigned to the left anterior 
descending artery. At the end of the analysis the observers had to relate the myocardial 
perfusion defect to the coronary artery territory.
Wall motion assessment: Wall motion was scored by a third experienced observer using 
the same 16-segment left ventricular model. The observer was unaware of clinical data and 
MCE perfusion data. Each segment was examined for systolic thickening and wall motion 
was scored using a 4-point scale: normal =1, hypokinetic = 2, akinetic = 3, and dyskinetic = 
4. Baseline and follow-up (after 6 weeks) data were compared to evaluate late wall motion 
recovery of dysfunctional segments.
Single-photon emission computed tomography: SPECT was performed at rest for assess-
ment of myocardial perfusion by intravenous administration of 600 MBq of technetium-99m-
sestamibi. Images were acquired by a large fi eld-of-view gamma camera (Siemens Corp., 
Erlangen, Germany). Tomographic images were created. The horizontal and vertical longaxis 
images closest to the echocardiographic apical 4-and 2- chamber views were chosen for the 
analysis (12-segment model). Two observers, blinded to the MCE and coronary angiography 
data, scored the myocardial perfusion as normal or abnormal in each available segment that 
was assigned a priori to 1 of the 3 coronary arteries, which is consistent with the model used 
for MCE analysis.
Coronary angiography: Angiography was performed before hospital discharge for identifi -
cation of the infarct-related coronary artery as the end point test.
Variability analysis: Inter- and intraobserver variability for MCE perfusion were determined 
by 2 independent observers and by 1 observer at 2 diff erent readings 30 days apart. Kappa 
coeffi  cients were calculated by test of symmetry.
Statistical analysis: Diff erences were evaluated by analysis of variance for repeated measures 
or by paired Student’s t test when appropriate. A p value <0.05 was considered statistically 
signifi cant.
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RESULTS
Control group: Myocardial perfusion was detectable in all 15 healthy volunteers (mean age 
51 ± 11 years, 10 men). Using power Doppler imaging, normal perfusion was seen in 93% of 
healthy volunteers (14 of 15). One false-positive defect was detected in the lateral wall.
Patients characteristics: The clinical and angiographic characteristics of patients are de-
scribed in Table 1. No patients were excluded from the study for nonadequate acoustical 
window. All the 30 patients had had their fi rst acute myocardial infarction and were clinically
stable at day 2. At coronary angiography, 5 patients had >1 coronary lesion. In these patients, 
the infarct-related artery was determined according to the electrocardiographic data.
Variability of power Doppler myocardial contrast echocardiography: Table 2 shows 
the inter- and intraobserver concordance and agreement for power Doppler MCE images. 
Concordance was calculated for segmental score and for normal versus abnormal perfusion 
(score 1 vs 0, 0.5). Inter- and intraobserver concordance and agreement were excellent.
Myocardial contrast echocardiography: As was mentioned previously, no adverse events 
occurred during the PESDA infusion. Myocardial perfusion was detectable in all the patients. 
Of the 480 potentially available segments, 429 were analyzable. Thirty-seven percent of seg-
ments (158 of 429) were supplied by an infarct-related coronary artery as shown by coronary 
TABLE 1 Clinical and Angiographic characteristics (n  30)
Age (yrs) 56  11
Men 22 (73%)
Anterior MI on ECG 11 (37%)
Inferior and/or posterolateral MI on ECG 19 (63%)
Thrombolytic therapy 20 (67%)
No thrombolysis 10 (33%)
Peak creatine kinase 1,545  1,031
Q-wave infarction 28 (93%)
Non–Q-wave infarction 2 (7%)
Infarct artery
Left anterior descending 11 (37%)
Left circumflex 13 (43%)
Right 6 (20%)
Occluded vessel 3 (10%)
Occluded vessel with collateral flow 3 (10%)
Stenotic vessel (	70%)  TIMI 2 flow 11 (37%)
Stenotic vessel (	70%) TIMI 3 flow 11 (37%)
Mild stenotic vessel (70%) TIMI 3 flow 2 (6%)
ECG  electrocardiogram; MI  myocardial infarction.
TABLE 2 Concordance Between Observers for Power
Doppler Contrast Echocardiography
Intraobserver Interobserver
For actual segmental
scores
95% (k0.90) 92% (k0.84)
For abnormal vs
normal segments
97% (k0.94) 95% (k0.89)
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angiography, which was the end point of the study. Mean perfusion score in normal seg-
ments was higher than in segments supplied by infarct-related coronary artery (0.97 ± 0.12 
vs 0.50 ± 0.32; p<0.001). Sensitivity and specifi city for detection of segments supplied by 
the infarct-related coronary artery were 82% (129 of 158) and 95% (407 of 429), respectively.
Table 3 compares sensitivity and specifi city of power Doppler MCE and SPECT for the 
detection of the infarct-related vessel as assessed by coronary angiography. The results of 
power-Doppler MCE and SPECT were comparable (Figure 1). Concordance between power 
Doppler MCE and SPECT for detection of abnormal versus normal myocardial perfusion in a 
segment-by-segment analysis was high (93% [181 of 195], kappa = 0.82). The angiographic 
TABLE 3 Accuracy for Infarct-Related Coronary Artery (left
anterior descending, circumflex, and right coronary)
SPECT
Power Doppler
MCE
Segment by segment analysis
Sensitivity 84% (48/57) 82% (130/158)
Specificity 94% (151/159) 95% (257/271)
Accuracy 92% (199/216) 90% (387/429)
Territory by territory analysis
Sensitivity 94% (17/18) 93% (28/30)
Specificity 100% (36/36) 100% (60/60)
Accuracy 98% (53/54) 98% (88/90)
No significant difference was found between SPECT and power Doppler
MCE.
Figure 1: An apical defect of myocardial perfusion is visible both in the power Doppler myocardial contrast echocardiography 4-chamber view 
(A) and in SPECT (B). Gray-scale contrast echocardiography is shown for comparison (C). Angiography shows the lesion of the left anterior 
descending coronary artery related to the infarction (D).
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Thrombolysis In Myocardial Infarction (TIMI) fl ow had a strong correlation with MCE perfu-
sion: excluding the 3 patients with occluded vessels but collateral fl ow, 10 of the 13 patients 
(69%) with TIMI 3 fl ow had MCE perfusion in the infarct-related area, whereas only 1 of the 
14 patients (7%) with TIMI fl ow ≤2 had MCE perfusion in the infarct-related area (10 of 13 vs 
1 of 14; p = 0.003). Creatine kinase peak was also strongly related to MCE perfusion (inverse 
correlation): excluding the 2 patients with prolonged resuscitation, the 13 patients with MCE 
perfusion (score1, 0.5) had signifi cantly lower creatine kinase peaks compared with the 15 
patients with no perfusion in the infarct-related area (948 ± 866 vs 2,019 ± 935; p = 0.004).
Follow-up: Figure 2 shows wall motion changes of dysfunctional segments from baseline 
to 6-week follow-up, comparing hypo- or normoperfused segments with nonperfused seg-
ments as assessed by power Doppler. Late wall motion recovery was higher in dysfunctional 
segments that were perfused at day 2 after infarction (- 0.41 ± 0.38 vs.+0.06 ± 0.24; p<0.001).
DISCUSSION
This study demonstrates that harmonic power Doppler imaging, using intravenous infusion 
of ultrasound contrast agent, detects myocardial perfusion defects in patients with a recent 
Q-wave myocardial infarction. Power Doppler MCE imaging and SPECT imaging showed 
excellent concordance for myocardial perfusion in a segment-by-segment analysis (93% 
[kappa = 0.82]). In the group of healthy volunteers, power Doppler imaging assessed normal 
perfusion in 93% of patients.
Assessment of reperfusion: Follow-up echocardiographic results showed that dysfunction-
al but perfused myocardium recovered wall motion, whereas dysfunctional but nonperfused 
myocardium worsened. The diff erence was statistically signifi cant (p<0.001) (Figure 2). We 
Figure 2: Wall motion score (WMS) changes of dysfunctional myocardium from baseline (day 2 after the infarction) to 6-week follow-up. 
Dysfunctional but perfused myocardium (stunning myocardium) recovered wall motion at follow-up, whereas dysfunctional but nonperfused 
myocardium (necrotic myocardium) worsened. The diff erence was statistically myocardium signifi cant.
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considered reperfused both normoperfused and hypoperfused segments (partial or patchy 
perfusion), because both perfusion patterns indicate microvasculature integrity. Therefore, 
power Doppler MCE on day 2 after myocardial infarction was able to predict functional re-
covery of myocardium, diff erentiating stunning myocardium (dysfunctional but perfused or 
hypoperfused) from necrotic myocardium (dysfunctional and nonperfused).18 In this respect, 
these results confi rm earlier studies performed using intracoronary injection of ultrasound 
contrast agents.5,8 Moreover, there were strong correlations with angiographic TIMI fl ow and 
creatine kinase peak.
Rationale for power Doppler myocardial contrast echocardiography: Power Doppler 
modality is completely diff erent from the gray-scale modality. In gray-scale, the medium is 
interrogated only once with a short pulse. The scatter magnitude is displayed as a gray value. 
In power Doppler imaging, the medium is interrogated several times and the subsequent 
scatter responses are compared with each other. Usually, 3 to 8 pulse trains are sent in se-
ries with a short interval between them. The fi rst pulse train hits the microbubbles of the 
contrast agent. The microbubbles start to resonate, producing harmonics at the end break. 
The following pulse train fi nds the microbubbles in a diff erent state or does not fi nd the 
microbubbles at all (Figure 3). Therefore, the backscatter will be diff erent and the system 
will display this diff erence in colour. If the myocardium is not perfused, it does not receive 
any microbubbles and there will be no diff erence between the signal generated from the 
fi rst pulse and the following pulse. In this case, power Doppler imaging will not show any 
colour. If microbubbles are present in the myocardium (microvascular integrity), it will show 
the predefi ned colour that represents the number of microbubbles that change state and 
are destroyed in that region. By using power Doppler imaging, the presence of microbubbles 
(perfusion or no perfusion) is easy to assess. Therefore, in this study, intra- and interobserver 
variability for myocardial perfusion were excellent (Table 2).
Figure 3: Power Doppler mode sends several pulse trains in series with a short interval after each one (pulse repetition frequency). The fi rst 
pulse train hits the microbubble, which starts to resonate and at the end breaks. The second pulse train fi nds the microbubble in a diff erent 
state. The third pulse train does not fi nd the microbubble. The 3 refl ected scatter signals are diff erent. The power Doppler mode analyzes these 
diff erences of backscatter and displays the grade of comparison in color.
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Study limitations: The main clinical limitation of this study is that MCE was performed on 
day 2 after infarction. The higher usefulness of myocardial perfusion identifi cation should be 
in the acute phase of myocardial infarction for the assessment of refl ow immediately after 
thrombolysis. However, the infarct size may be underestimated by MCE immediately after 
refl ow because of the possibility of reactive hyperemia. Previous reports have suggested 
that the best time to assess microvascular perfusion may be 12 to 24 hours after myocardial 
infarction, when hyperemia is not present anymore.1,19 The main limitation of power Doppler 
mode is the presence of wall motion artifacts. Power Doppler mode analyzes diff erences 
between the backscatter of the fi rst pulse train and the following pulse train. This diff erence 
is generated by microbubbles that change state and at the end break when hit by ultrasound. 
Unfortunately, tissue movement also generates diff erences of backscatter. However, when 
baseline setting of power Doppler is well done before contrast injection, no signal comes 
from the contracting myocardium that is completely gray (without any colour). This setting is 
held constant throughout acquisition. Therefore, power Doppler imaging is not due to wall 
motion because colours appear only after contrast injection. Wall motion artifacts can ap-
pear only because of premature ventricular beats or deep breath, but the operator can easily 
recognize the problem and ignored the relative frame.
CONCLUSIONS
Power Doppler imaging during intravenous infusion of perfl uorocarbon microbubbles is 
accurate in detecting reperfusion early after an acute myocardial infarction. By assessing 
microvascular integrity and consequent myocardial viability, power Doppler contrast echo-
cardiography is a non-invasive technique able to predict late ventricular function recovery 
diff erentiating stunning (dysfunctional but perfused) from necrotic myocardium (dysfunc-
tional and nonperfused).
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ABSTRACT
Objectives: We sought to determine whether end-diastolic wall thickness (EDWT) can 
predict recovery of regional left ventricular contractile function after percutaneous coronary 
intervention (PCI).
Background: Regional contractile function does not recover in all patients after PCI for acute 
myocardial infarction (AMI). Prediction of functional recovery after AMI may help in clinical 
decision making.
Methods: Forty consecutive patients with AMI were studied with left ventricular contrast 
echocardiography for accurate wall thickness and function measurement and myocardial 
perfusion immediately after and two months following PCI.
Results: Out of 640 segments, 175 (27%) dysfunctional segments in the infarct territory were 
analyzed for EDWT, wall function, and perfusion. One hundred and three (59%) dysfunctional 
segments presented with an EDWT <11 mm and 72 (41%) presented with an EDWT ≥11 mm. 
Perfusion (partial or complete) was present in 63 segments with an EDWT <11 mm (61%) and 
71 segments with an EDWT ≥11 mm (99%) (p < 0.001). At two months’ follow-up, 66 of 72 seg-
ments with an EDWT ≥11 mm (92%) improved, whereas only 35 of 103 of the dysfunctional 
segments with an EDWT <11 mm (34%) improved (p< 0.0001).
Conclusions: Wall thickness is an easy parameter to predict recovery of function after revas-
cularization. Moreover, combining EDWT and perfusion, segments with an EDWT ≥11 mm, 
and presence of perfusion have the highest chance of recovery; segments with an EDWT <11 
mm and perfusion have an intermediate chance of recovery. In segments with an EDWT <11 
mm and no perfusion, chances of recovery are very low.
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INTRODUCTION
Early revascularization by percutaneous coronary intervention (PCI) is associated with a 
good clinical outcome in patients with acute myocardial infarction (AMI).1 However, in some 
patients successful PCI does not result in recovery of contractile function in the infarct ter-
ritory.2 Two-dimensional contrast echocardiography allows assessment of wall function and 
myocardial perfusion simultaneously. It has been shown in several studies that myocardial 
contrast echocardiography (MCE) allows researchers to predict recovery of regional contrac-
tile function after reperfusion in AMI.3– 6 Until now, the end-diastolic wall thickness (EDWT) 
was not used as a simple parameter to predict functional recovery after PCI. Therefore, 
myocardial wall thickness was assessed to determine its value as a predictor of recovery of 
regional contractile function late after PCI. In this study, contrast echocardiography was used 
for optimal endocardial border delineation.7
METHODS
Study patients: This prospective study comprised 40 consecutive patients without history 
of hypertension, left ventricular hypertrophy, and primary cardiomyopathy, but with ST-
segment elevation AMI and who underwent PCI within 6 h of onset of symptoms. Baseline 
characteristics of the 40 patients (34 male, mean age 53 ± 13 years) are summarized in Table 1. 
The diagnosis of AMI was made on the basis of symptoms of myocardial ischemia for ≥30 min 
and ≥2 mm ST-segment elevation in ≥2 contiguous electrocardiographic leads. The infarct-
related artery was identifi ed by the site of the coronary occlusion, and stent implantation was 
performed. Left ventricular hypertrophy was defi ned according to recommendations of the 
Table 1. Patient Characteristics
Age (yrs,  SD) 53  13
Men 34 (85%)
Smoking 25 (62%)
Diabetes mellitus 4 (10%)
Hypertension 0
Hypercholesterolemia 6 (15%)
Family history of CAD 13 (32%)
Previous myocardial infarction 5 (12%)
EF (%) 45  6
CK peak (IU) 3,074  2,245 (n  200 IU)
Site of infarction
Anterior 22 (55%)
Lateral 16 (40%)
Septal 2 (5%)
Inferior/posterior 19 (47%)
TIMI flow grade 3 after PCI 33 (82%)
CAD coronary artery disease; CK creatine kinase; EF ejection fraction; SD
standard deviation; TIMI  Thrombolysis In Myocardial Infarction.
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American Society of Echocardiography and corrected following the suggestions of Devereux 
et al.8 The left ventricular mass index was derived with normal limits defi ned as ≤125 g/m2 
for men and ≤110 g/m2 for women.9 The local hospital ethics committee approved the study 
protocol, and all patients gave informed consent.
Abbreviations and Acronyms
AMI  acute myocardial infarction
EDWT  end-diastolic wall thickness
LVEF  left ventricular ejection fraction
MCE  myocardial contrast echocardiography
PCI  percutaneous coronary intervention
Echocardiography and contrast studies: Echocardiography was performed with a Sonos 
5500 (Philips, Andover, Massachusetts) using second harmonic mode (1.8-MHz/3.6-MHz), 
within 24 h following revascularization. After recording baseline, myocardial perfusion im-
ages were obtained in real time (power modulation) using a low mechanical index (0.1). A 
slow bolus of 0.75 ml of Sonovue (Bracco, Milan, Italy) was intravenously injected followed by 
a slow saline fl ush (5 ml) over 5 s. Imaging was started before contrast injection and “fl ash” im-
aging with high mechanical index (1.6) was used at peak contrast intensity for four frames to 
destroy the microbubbles in the myocardium, to exclude artifacts, and to visualize myocardial 
contrast replenishment. To obtain maximal image information, the segments related to the 
infarct territory were placed in the center of the echo sector reducing the problem of arti-
facts. After the real-time perfusion study, left ventricular opacifi cation images were recorded 
in all standard parasternal and apical views to improve quantitative assessment of myocardial 
function.7 Left ventricular ejection fraction (LVEF) was measured using the standard biplane 
Simpson method. Improvement of LVEF ≥5% was considered signifi cant.10 A follow-up study 
with MCE to reassess EDWT, function, and perfusion was performed at two months.
EDWT measurement: The EDWT was measured by two experienced observers unaware 
of the clinical data as previously described11, using intravenous echo-contrast for better 
endocardial border detection.7 The EDWT was assessed at the center of each myocardial seg-
ment from the leading endocardial edge to the leading epicardial edge as the mean of three 
measurements. Dysfunctional segments were categorized as segments with an EDWT <11 
mm and an EDWT ≥11 mm.
Analysis of echocardiograms: Regional wall motion and myocardial perfusion were scored 
using standard parasternal long- and short-axis views and apical two-, three-, and four-
chamber views, employing a 16-segment model.12 Only segments related to acute infarct 
territory were considered for the analysis. Segments were graded as: 1 = normal, 2 = severe 
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hypokinetic, 3 = akinetic, and 4 = dyskinetic. Myocardial contrast perfusion was scored 
semi- quantitatively using a 3-point grading scale: 2 = normal/homogenous opacifi cation, 1 
= reduced/patchy opacifi cation, and 0 = no opacifi cation. Segments with a severely hypoki-
netic, akinetic, or dyskinetic wall motion pattern were considered dysfunctional. Recovery of 
contractile function was defi ned as an improvement of segmental wall motion score by ≥1 
grade at the follow-up.
Statistical analysis: All continuous data are expressed as mean ± SD; percentages are 
rounded. Diff erences between proportions were compared with the chi-square test. The 
agreement for the measurements of EDWT was assessed from 3 x 3 tables using weighted 
kappa statistics.13 A value of p < 0.05 was considered statistically signifi cant. The EDWT that 
was related to a high likelihood of improvement of segmental contraction was determined 
by receiver operating characteristic curve analysis. The optimal cutoff  value was the EDWT 
that yielded the highest sum of sensitivity and specifi city.
RESULTS
Mean time from onset of chest pain to PCI was 3.8 ± 1.8 h. Of a total of 640 segments, 175 
(27%) dysfunctional segments were located in the infarct-related territory, and EDWT, wall 
function, and myocardial perfusion were analyzed. A total of 103 (59%) segments had an 
EDWT <11 mm, and 72 (41%) had an EDWT ≥11 mm. Both intra- and inter-observer agree-
ments for the assessment of EDWT were 0.96 and 0.93, respectively (kappa value).
Mean EDWT was 9 ± 1 mm for the group with an EDWT <11 mm, and 12 ± 1 mm for the 
group with an EDWT ≥11 mm. Real-time perfusion MCE imaging demonstrated that 11 (11%) 
of the 103 dysfunctional segments with an EDWT <11 mm had normal perfusion, 52 (50%) 
had partial perfusion, and 40 (39%) had no perfusion. Of the 72 dysfunctional segments with 
an EDWT ≥11 mm, 33 (46%) had normal perfusion, 38 (53%) had partial perfusion, and 1 had 
absent perfusion.
Functional outcome: At two months’ follow-up, 35 of the 103 (34%) segments with an EDWT 
<11 mm improved, whereas 66 of the 72 (92%) segments with an EDWT ≥11 mm improved 
(p < 0.0001) (Figure 1). Sixty-nine of the 72 (96%) segments with an EDWT ≥11 mm became 
thinner at follow-up (12 ± 1 mm to 9 ± 1.5 mm; p < 0.05). Of these 69 segments, 64 (93%) 
had an EDWT <11 mm at follow-up. Seventy-two of the 103 dysfunctional segments with an 
EDWT <11 mm (70%) became thinner at follow-up (9 ± 1 mm to 7 ± 1.7 mm; p < 0.05). Of the 
103 dysfunctional segments with an EDWT <11 mm, 33 (32%) had normal perfusion, 39 (38%) 
had partial perfusion, and 31 (30%) showed no perfusion at follow-up. In the 72 dysfunctional 
segments with an EDWT ≥11 mm, myocardial perfusion at follow-up was normal in 49 (68%), 
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partial in 20 (28%), and absent in 3 (4%) segments. A subanalysis was performed considering 
only the akinetic segments. Of the 100 akinetic segments, 31 of 33 (94%) with an EDWT ≥11 
mm improved at follow-up, whereas only 20 of 67 (30%) segments with an EDWT <11 mm 
improved (p < 0.001).
Nearly all patients (15 of 16 patients, 94%) in which ≥50% of the dysfunctional segments 
had an EDWT ≥11 mm showed an improved LVEF at follow-up. Conversely, none of the 24 pa-
tients in which <50% of the dysfunctional segments had an EDWT ≥11 mm had an improved 
LVEF at follow-up.
Prediction of recovery by perfusion and wall thickness: To accurately predict functional 
recovery after revascularization in dysfunctional infarcted areas, information about perfusion 
and wall thickness should be combined (Table 2). Real-time perfusion MCE imaging demon-
strated that perfusion was present in 134 of 175 (77%) dysfunctional segments. In particular, 
MCE showed that 44 (25%) of the 175 dysfunctional segments had normal perfusion, 90 
(51%) had partial perfusion, and 41 (23%) showed no perfusion. However, only 98 (73%) of 
Table 2. Comparison Between EDWT and Myocardial
Perfusion as Prognostic Indexes of Recovery of Contractile
Function at Two Months’ Follow-Up
Category
Number (%) of Segments
With Functional Recovery
EDWT 11 mm
P 66/71 (93)
P 0/1 (0)
EDWT 11 mm
P 32/63 (51)
P 3/40 (7)
EDWT  end-diastolic wall thickness; P  perfusion (normal or patchy);  
present;   absent.
Figure 1: Relation between improvement of left ventricular contractile function and end-diastolic wall thickness (EDWT).
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the adequately reperfused segments recovered at follow-up. Adding EDWT measurements of 
the adequately reperfused segments, 71 (53%) had an EDWT ≥11 mm and 63 (47%) had an 
EDWT <11 mm. At two months’ follow-up, recovery of contractility was present in 66 (93%) 
of the adequately perfused segments with an EDWT ≥11 mm, whereas only 32 (51%) of the 
adequately perfused segments with an EDWT <11 mm recovered (p < 0.001) (Table 2, Figure 
2,3).
DISCUSSION
Restoration of coronary vessel patency does not automatically result in recovery of contrac-
tile function in patients undergoing PCI in the setting of AMI. The main fi nding of the present 
study is that a relatively simple measurement of EDWT, obtained with two-dimensional 
Figure 2: Two-dimensional echocardiograms showing end-diastolic wall thickness (upper panels) and perfusion (lower panels) in an 
infracted region directly after percutaneous coronary intervention (left panels), and after recovery at two months’ follow-up (right panels).
IVS = interventricular septum; LV = left ventricle.
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echocardiography combined with contrast agent, predicts recovery of regional contractile 
function after PCI for AMI. Using EDWT alone, dysfunctional segments with an EDWT ≥11 
mm showed a high likelihood of recovery of regional contractile function two months after 
PCI. Moreover, it appears that when at least 50% of the dysfunctional segments show an 
EDWT ≥11 mm, global recovery may be anticipated. In the present study only 98 (73%) of the 
adequately reperfused dysfunctional segments had recovery of function at follow-up.
Combining wall thickness and perfusion, segments with an EDWT ≥11 mm and presence of 
perfusion have the highest chance of recovery (93%). An intermediate likelihood of recovery 
was observed in segments with an EDWT <11 mm and presence of perfusion (51%), whereas 
segments with an EDWT <11 mm and no perfusion nearly never improved. The present results 
indicate that perfusion data do not provide much additional information for the prediction 
of recovery of contractile function in segments with an EDWT ≥11 mm, because most of 
them recover at follow-up. Perfusion data are more relevant for the prediction of functional 
outcome in segments with an EDWT <11 mm.
Figure 3: Two-dimensional echocardiograms showing end-diastolic wall thickness (upper panels) and perfusion (lower panels) in a patient directly 
after percutaneous coronary intervention (left panels) and at two months’ follow-up (right panels), in a case where regional function did not recover.
IVS = interventricular septum; LV = left ventricle.
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Comparison to previous studies: In patients with AMI undergoing PCI, assessment of the 
amount of myocardial salvage is important for prediction of functional recovery and long-
term prognosis. Main et al.4 demonstrated that MCE compares favorably with low-dose do-
butamine echocardiography for the assessment of myocardial viability after an acute anterior 
infarction. Balcells et al.5 demonstrated that the extent of microvascular integrity assessed 
by MCE after PCI correlates with recovery of resting left ventricular function and contractile 
reserve. Lepper et al.6 showed that assessment of restoration of myocardial perfusion by MCE 
after PCI corresponds closely to the evaluation of the microvascular integrity by coronary 
fl ow reserve. Moreover, an improvement of myocardial perfusion after revascularization was 
predictive for subsequent functional recovery. However, EDWT as a predictor of recovery of 
regional contractile function after PCI has not been specifi cally addressed.
Possible explanation for the fi ndings: The pathophysiological mechanism underlying the 
relation between EDWT and long-term recovery of regional contractile function after PCI 
for AMI is currently not clear. It is conceivable (but speculative) that the high likelihood of 
recovery in segments with an EDWT ≥11 mm is related to hyperemia and tissue edema in 
adequately reperfused myocardium. During the early phase of reperfusion, reactive hyper-
emia may occur14 followed by myocardial tissue edema within the reperfused myocardium.15 
Further studies are needed to elucidate this issue.
Study limitations: A potential limitation of echocardiography to determine myocardial 
wall thickness is image quality. The use of contrast echocardiography in the present study 
overcame this limitation because endocardial border detection and EDWT measurements 
were more accurately assessed, as was shown by Thomson et al.7 Another limitation is that 
wall thickness is heterogeneous throughout the left ventricle. The cut-off  value of 11 mm, 
which was described previously16, is therefore to some extent arbitrary.
CLINICAL IMPLICATIONS AND CONCLUSIONS
The main fi nding of the present study is that a relatively simple measurement of EDWT, 
obtained with two-dimensional echocardiography combined with contrast agent, predicts 
recovery of regional contractile function after PCI for AMI. Dysfunctional segments with an 
EDWT ≥11 mm had a high likelihood of functional recovery two months after PCI. Moreover, 
combining wall thickness and perfusion, dysfunctional segments with an EDWT ≥11 mm and 
presence of perfusion have the highest chance of recovery, segments with an EDWT <11 mm 
and perfusion have an intermediate chance, whereas segments with an EDWT <11 mm and 
no perfusion have a very low likelihood of functional recovery at two months’ follow-up. Pre-
diction of recovery of contractile function early after AMI could be useful to identify patients 
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who have irreversible left ventricular dysfunction. In these patients, tailored therapy can be 
started, also considering the possibility of automatic defi brillator implantation.17 Moreover, 
identifi cation of stunning as the cause of ventricular dysfunction may provide a rationale 
for the aggressive support of the patients with mechanical methods and perhaps caution 
against the use of inotropic agents, which may adversely infl uence the recovery of potentially 
ischemic segments.18
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ABSTRACT
Background: Patients with severe aortic stenosis (AS) require valve replacement before 
development of irreversible left ventricular (LV) dysfunction. It has been postulated that 
Doppler tissue imaging (DTI) parameters are more sensitive to detect subtle LV dysfunction 
compared to conventional echocardiographic parameters.
Objective: We sought to assess early LV dysfunction with DTI-derived echo parameters and 
N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with severe AS and normal 
LV ejection fraction.
Methods: A total of 29 patients (mean age 65 ± 12 years, 15 male) with symptomatic severe 
AS and 17 control subjects were included in the study. DTI was performed at the level of the 
mitral lateral (mlat) and septal (msep) annulus. Systolic (Sm), early (Em) and late (Am) diastolic 
velocities were measured, and E/Em ratio was calculated. NT-proBNP was determined by an 
electrochemiluminescence immunoassay.
Results: Baseline characteristics between patients and controls were similar regarding LV 
ejection fraction and mitral infl ow E/A ratio. However, AS patients had signifi cantly lower 
DTI values (Sm, Em, Am) compared with control subjects. Moreover, LV fi lling pressures, ex-
pressed by the E/Em ratio, were signifi cantly higher in patients. Correlation analysis showed 
a relationship between the natural logarithm of NT-proBNP and aortic valve area, Smlat, and 
E/Emsep ratio. Using stepwise multiple linear regression, Smlat was found to be independently 
related to NT-proBNP.
Conclusions: In patients with severe AS and normal LV ejection fraction, DTI showed LV 
systolic and diastolic dysfunction compared to controls. DTI-derived variables, and especially 
Smlat, were correlated with NT-proBNP levels.
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INTRODUCTION
Patients with symptomatic severe aortic stenosis (AS) are treated with aortic valve replace-
ment for improvement of both symptoms and prognosis.1 Valve replacement has to take 
place before irreversible left ventricular (LV) dysfunction develops as this adversely aff ects 
postoperative prognosis.2 LV systolic dysfunction is most commonly defi ned as LV ejection 
fraction (LV-EF) less than 50%, assessed by the modifi ed Simpson’s biplane disc method.3 
Unfortunately, LV-EF and other conventional echocardiographic parameters are relatively 
insensitive to detect early forms of LV dysfunction. It has been shown that Doppler tissue 
imaging (DTI) and N-terminal (NT) pro-B-type natriuretic peptide (BNP) levels can identify 
early LV dysfunction.4,5 In this study we assessed the presence of DTI parameters of early 
systolic and diastolic LV dysfunction in patients with symptomatic severe AS and normal LV-
EF. Furthermore, we investigated the correlation between NT-proBNP, and conventional and 
DTI echocardiographic parameters.
METHODS
Study Population: The study compromised 29 consecutive patients (mean age 65 ± 12 
years, 15 male) with symptomatic severe AS, defi ned as an aortic valve area (AVA) equel to 
or less than 1.0 cm2 or a peak aortic jet velocity greater than or equal to 4.0 m/s and normal 
LV-EF (≥50%). None of the patients had atrial fi brillation, a pacemaker device, signifi cant 
mitral valve disease or signifi cant aortic regurgitation. Fourteen patients had angiographic 
coronary artery disease. Seventeen subjects without known cardiac disease, matched for age, 
sex, LV EF and cardiovascular risk factors, served as control group. The local ethics committee 
approved the study protocol, and all patients gave written informed consent.
Conventional Transthoracic Echocardiography: Doppler echocardiography was performed 
with one system (Sonos 7500, Philips, Best, The Netherlands) by a single experienced sonog-
rapher. All images were acquired in the standard cardiac views according to the guidelines of 
the American Society of Echocardiography and digitally stored for offl  ine analysis.6 The aortic 
jet velocity was obtained from multiple windows. Three measurements from the window 
with the highest velocity were averaged. AVA was calculated with the use of the continuity 
equation.7 LV-EF was assessed by the modifi ed Simpson’s biplane disc method.3 For assess-
ment of diastolic function, peak velocities of early (E) and late (A) diastolic fi lling, E/A-ratio, 
deceleration time (DT), and isovolumic relaxation time were derived from Doppler recordings 
of the mitral infl ow at the mitral leafl et tips and aortic outfl ow. LV mass was calculated using 
the modifi ed Devereux formula.8
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Tissue Doppler Measurements: Doppler tissue was applied in the pulsed wave Doppler 
mode at the level of the mitral annulus from the apical 4-chamber view. A 5-mm sample was 
placed sequentially on the mitral lateral (mlat) and septal (msep) annulus. To acquire the high-
est wall tissue velocities, the angle between the Doppler beam and the longitudinal motion 
of the mitral annulus was adjusted to a minimal level. All recoding were done end-expiratory. 
The average of 3 peak systolic (Sm), early (Em) and late (Am) diastolic velocities and E/Em 
ratio were calculated, where E is the peak velocity of early diastolic mitral fl ow.9 DTI record-
ings were adequately obtained in all patients.
Measurements of Neurohormone Level: Venous blood samples were drawn from patients 
with AS after the Doppler echocardiography study from an antecubital vein into EDTA acid 
Vacutainer test tubes (Mediost BV, Doesburg, The Netherlands) after 30 minutes of supine 
rest. Samples were placed immediately on ice, and plasma separation was performed at 4°C. 
For NT-proBNP determination, an electrochemiluminescence immunoassay (ProBNP Elecsys, 
Roche Diagnostics GmbH, Mannheim, Germany) was used.
Statistical analysis: Continuous variables are expressed as mean ± SD or median and ranges, 
where appropriate. Diff erences between groups were analyzed with the unpaired t test 
for continuous variables or χ2 test for categorical variables. Correlations were sought with 
Pearson’s correlation coeffi  cient. Stepwise multiple linear regression analysis was performed 
for variables found to be signifi cant in the univariate analysis. A value of P less than .05 was 
considered signifi cant. For all analyses, commercially available statistical software package 
was used (SPSS, Version 12.0, SPSS Inc, Chicago, IL).
RESULTS
Clinical data: All patient characteristics are listed in Table 1. Patients with severe AS and the 
control group were similar with respect to body surface area and heart rate. Main symptoms 
in the patients with AS were angina in 18 patients (62%), exertional dyspnea in 10 patients 
(34%) and dizziness in one patient (4%).
Conventional echocardiographic parameters: As shown in Table 1, mean AVA in the AS 
group was 0.7 ± 0.3cm². LV mass was higher in patients wirh AS as compared with control 
subjects. No signifi cant diff erences were observed with respect to LV dimensions, volumes, 
or LV EF. In patients with AS, mitral E and A velocities were higher whereas deceleration time, 
E/A ratio, and isovolumic relaxation time were not diff erent compared to control subjects 
(Figure 1, Table 2).
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Figure 1 (A), Example of mitral infl ow profi le with measurement of peak early (E) and late (A) diastolic velocities in patient with aortic stenosis. 
E/A ratio of 0.9 is derived. (B), Example of Doppler tissue imaging tracing of lateral mitral annulus with measurement of peak systolic (Sm), 
peak early diastolic (Em), and peak late diastolic (Am) annular velocities in same patient. Note low Sm velocity (5.8 cm/s) and high E/Em ratio of 
17.4. Color fi gure online.
Table 1 Clinical and echocardiographic characteristics of
patients and control subjects
Variable
Control subjects
(n  17)
Patients
(n  29)
P
value
Age, y 61  5 65  12 NS
Male, n (%) 9 (53) 15 (52) NS
BSA, m2 1.9  0.2 1.9  0.2 NS
Heart rate, beats/min 76  13 74  10 NS
Aortic valve area, cm2 — 0.7  0.3
Peak aortic gradient, mm Hg — 85  21
Mean aortic gradient, mm Hg — 51  13
LV mass index, g/m2 86  24 152  53 .001
LVEDD, mm 45  5 47  8 NS
LVESD, mm 30  5 31  7 NS
FS, % 33  6 35  9 NS
LVEDV, mL 90  36 79  26 NS
LVESV, mL 31  12 30  14 NS
LV EF, % 65  8 62  11 NS
NT-proBNP, pmol/L — 82 (4-777)
Ln NT-proBNP, pmol/L — 4.3  1.2
BSA, Body surface area; EF, ejection fraction; FS, fractional shortening;
Ln, natural logarithm; LV, left ventricular; LVEDD, LV end-diastolic
diameter; LVEDV, LV end-diastolic volume; LVESD, LV end-systolic
diameter; LVESV, LV end-systolic volume; NS, not significant; NT-
proBNP, N-terminal pro-brain natriuretic peptide.
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Echocardiographic DTI parameters: In patients with AS, DTI measurements of the mitral 
annulus were signifi cantly lower with respect to peak systolic (Smlat and Smsep), early diastolic 
fi lling (Emlat and Emsep) and late diastolic fi lling (Amlat and Amsep) compared with control sub-
jects (Table 2). Moreover, E/Emlat and E/Emsep ratios were signifi cantly higher in patients with 
AS (Figure 1).
NT-proBNP and correlation with Echocardiographic Parameters: The median NT-
proBNP value in patients with AS was 82 pmol/l (range: 4-777). The correlation between the 
natural logarithm (ln) of NT-proBNP and all echocardiographic parameters are depicted in 
Table 3. Univariate analysis revealed a signifi cant negative relationship between ln NT-proBNP 
and AVA. Also, ln NT-proBNP was inversely correlated with Smlat and positively correlated with 
E/Emsep ratio. Stepwise multiple linear regression showed that ln NT-proBNP was indepen-
dently related to Smlat (Figure 2). When comparing ln NT-proBNP in patients with E/Emsep ratio 
between 8 and 15 (n=13) versus those with a ratio greater than or equal to 15 (n=12), there 
was a trend towards a higher ln NT-proBNP in patients with an E/Emsep ratio greatere than or 
equal to 15 (4.60 ± 1.28 vs. 3.87 ± 1.00, P = .10). Only two patients with AS had an E/Emsep ratio 
of 8 or less. When restricting the univariate analysis to patients with an E/Emsep ratio less than 
or equal to15, there still was a signifi cicant negative relationship between ln NT-proBNP and 
Smlat (R
2 = 0.28, P ≤ .05).
Table 2 Mitral inflow and Doppler tissue imaging–derived
variables between patients and control subjects
Variable
Control subjects
(n  17)
Patients
(n  29)
P
value
E, cm/s 56  13 80  22 .001
A, cm/s 70  16 87  27 .05
E/A ratio 0.9  0.3 1.0  0.6 NS
Deceleration time, ms 207  53 231  57 NS
Isovolumic relaxation time, ms 99  16 86  29 NS
Smsep, cm/s 7.7  1.8 5.8  1.7 .01
Emsep, cm/s 7.4  2.5 5.6  1.8 .01
Amsep, cm/s 10.2  2.6 7.8  2.4 .01
Emsep/Amsep ratio 0.8  0.5 0.8  0.5 NS
E/Emsep 8.1  2.8 15.5  6.2 .001
Smlat, cm/s 8.9  2.0 6.4  1.6 .001
Emlat, cm/s 9.0  3.0 6.9  2.7 .05
Amlat, cm/s 10.0  4.2 7.8  3.2 .05
Emlat/Amlat ratio 1.2  1.0 1.2  0.9 NS
E/Emlat 6.7  2.3 12.5  4.3 .001
A, Late diastolic filling; Am, late diastolic myocardial velocity; E, early
diastolic filling; Em, early diastolic myocardial velocity; lat, lateral mitral
annulus; NS, not significant; sep, septal mitral annulus; Sm, systolic
myocardial velocity.
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of lateral mitral annulus (Smlat) in patients with severe aortic stenosis.
Table 3 Relation of natural logarithm of N-terminal pro-B-type
natriuretic peptide levels to severity of aortic stenosis and
conventional and tissue Doppler echocardiographic
parameters of diastolic function
Univariate linear
regression
Multivariate
linear regression
Variable r P value  P value
Aortic valve area, cm2 0.40 .05 — NS
Peak aortic gradient, mm Hg 0.35 NS
Mean aortic gradient, mm Hg 0.25 NS
E, cm/s 0.32 NS
A, cm/s 0.14 NS
E/A ratio 0.16 NS
Deceleration time, ms 0.05 NS
Isovolumic relaxation time, ms 0.10 NS
A duration, ms 0.17 NS
Smsep, cm/s 0.12 NS
Emsep, cm/s 0.11 NS
Amsep l, cm/s 0.18 NS
Emsep/Amsep ratio 0.23 NS
E/Emsep 0.39 .05 — NS
Smlat, cm/s 0.45 .05 .45 .05
Emlat, cm/s 0.10 NS
Amlat, cm/s 0.31 NS
Emlat/Amlat ratio 0.23 NS
E/Emlat 0.12 NS
A, Late diastolic filling; Am, late diastolic myocardial velocity; E, early
diastolic filling; Em, early diastolic myocardial velocity; lat, lateral mitral
annulus; NS, not significant; sep, septal mitral annulus; Sm, systolic
myocardial velocity.
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DISCUSSION
A stenotic aortic valve leads to LV pressure overload, hypertrophy and a decreased LV 
compliance. As expected, patients with AS had an increased LV mass compared with control 
subjects; however, LV-EF, mitral infl ow E/A ratio, and deceleration time were comparable with 
control subjects. Whether this E/A ratio is normal or pseudonormal as an result of an increase 
in left atrial (LA) pressure can be assessed by combining mitral infl ow and DTI- derived pa-
rameters. The E/Em ratio has been found to be a reliable estimate of mean LA pressure, and 
E/Emsep greater than 15 indicates increased LA pressure, whether E/Emsep less than 8 indicates 
a normal pressure.9 In our patients with AS, the E/Emsep ratio was signifi cantly increased 
indicating elevated LA pressure and, thus, impaired LV diastolic function (pseudonormaliza-
tion). Although the peak velocity and duration of pulmonary atrial reversal fl ow also provides 
important information about diastolic function, we did not include these parameters in 
our study because in the majority of patients it was not possible to reliably measure these 
parameters.10,11 In contrast, DTI measurements could be obtained in all our patients with AS 
and control subjects, confi rming the high success rate reported by others.9
Concerning systolic LV function, our data raise the issue of whether patients with AS and 
normal LV-EF should be considered to have normal LV systolic function, as the systolic func-
tion measured by DTI was signifi cantly lower compared with control subjects. It has been 
postulated that DTI is more sensitive to assess systolic LV dysfunction.15 In studies in Fabry’s 
disease and patients with hypertensive it has been shown that DTI, but not conventional 
echocardiographic parameters, can detect subtle therapy-induced changes in LV function.12,13 
Although measurements of LV-EF refl ect the relative diff erence between end- diastolic and 
end-systolic volume (composite of longitudinal and radial LV function), DTI refl ects long-axis 
LV function. Long-axis LV function is primarily determined by contraction of the longitudi-
nally, mainly subendocardial-orientated muscle fi bres. It is known that the subendocardium 
is aff ected earlier by ischemia, because of the pressure gradient across the myocardium, than 
the more epicardial-orientated circumferential fi bres.14 This may explain the fi nding that DTI 
can detect LV systolic dysfunction earlier than LV EF.
Another marker of LV function is NT-proBNP, a neurohormone secreted by the ventricles in 
case of volume and pressure overload. This hormone is elevated in patients with hyperten-
sion15, congestive heart failure and LV hypertrophy.16 NT-proBNP is also elevated in some 
patients with severe AS, and may diff erentiate between symptomatic and asymptomatic 
patients.17,18 In our study, however, all patients were already symptomatic. As described by 
others, NT-proBNP levels were inversely related to AS severity.19,20 In the present study, 
NT-proBNP was not related to any of the conventional echocardiographic parameters of LV 
dysfunction, but signifi cantly related to DTI parameters of both systolic (Smlat ) and diastolic 
(E/Emsep) dysfunction. Multivariate analysis showed only a correlation between NT-proBNP 
and systolic LV dysfunction assessed by DTI. No clear explanation exists as to why E/Emsep 
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was not indepently related to NT-proBNP. Perhaps the correlation between E/Em ratio and N-
proBNP is curvilinear, ie, at higher Nt-proBNP levels the relationship with E/Em ratio fl attens. 
Our patient population consisted of patients with symptomatic severe AS, forming one end 
of the spectrum of patients with AS with high Nt-proBNP levels.
Future studies should assess whether DTI markers for early LV dysfunction are reversible 
and in particular whether these markers predict LV dysfunction in terms of reduction in LV-EF 
after aortic valve replacement. If a certain level of DTI abnormality predicts postoperative 
impairment in LV-EF this may help identify patients with AS who should be operated on 
earlier, in an asymptomatic status. However, it is well known that even patients with severely 
impaired LV-EF may improve substantially in LV EF after aortic valve replacement.
Study limitations
Several potential limitations must be noted. First, 14 of 29 patients with AS (48%) had estab-
lished coronary artery disease, which could infl uence the DTI measurements. However, no 
diff erences in DTI values were found between patients with AS with and without coronary 
artery disease.
Second, although both lateral and septal measured mitral annulus DTI values were signifi -
cantly diff erent in patients with AS and control subjects, the relationship with NT-proBNP was 
most signifi cant with E/Emsep and Smlat. However, all correlations between DTI-derived values 
and NT-proBNP were in the same direction, regardless of whether septal or lateral values 
were considered. Finally, because of the small sample size the conclusions of this study must 
be drawn with caution.
CONCLUSIONS
In patients with severe AS and normal LV-EF, DTI-derived parameters identifi ed early systolic 
and diastolic LV dysfunction. Furthermore, DTI-derived parameters showed a signifi cant cor-
relation with NT-proBNP. Further studies are needed toexamine the value of DTI and NT-
proBNP in selecting patients with severe asymptomatic AS who will benefi t from surgery.
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ABSTRACT
Background: Patients with aortic stenosis (AS) should undergo aortic valve replacement 
(AVR) before irreversible LV dysfunction has developed. Assessment of long-axis left ventricu-
lar (LV) function may assist in proper timing of AVR.
Objectives: To assess serial changes in long-axis LV function before and after AVR in patients 
with severe AS and preserved LV ejection fraction.
Methods: The study comprised 27 consecutive patients (mean age 64.9 ± 11.7 years, 15 
males) with symptomatic severe AS, scheduled for AVR. Seventeen subjects without known 
cardiac disease, matched for age, gender, LV ejection fraction and cardiovascular risk factors, 
served as a control group. Long-axis LV function assessment was done with tissue Doppler 
imaging at 3 weeks, 6 months, and 12 months after AVR.
Results: Mean aortic valve area in the AS group was 0.70 ± 0.24 cm2. Pre-AVR peak systolic 
mitral annular velocities were signifi cantly lower compared to controls (6.7 ± 1.5 vs. 8.9 ± 
2.0 cm/s, P <0.05)). Post-AVR peak systolic mitral annular velocities improved to 9.1 ± 2.9 
at 3 weeks, 8.6 ± 2.7 at 6 months, and 8.1 ± 1.7 cm/s at 12 months (P <0.05). Improvements 
were seen over the whole range of pre-AVR peak systolic mitral annular velocities. Patients 
with improved Sm after AVR (defi ned as ≥10% compared to baseline values) did not diff er in 
baseline characteristics as compared to those who did not improve.
Conclusions: In patients with severe AS and preserved LV ejection fraction, abnormal systolic 
mitral annular velocities improve after AVR, independent of the pre-AVR value.
Key words: Aortic valve disease, aortic stenosis, aortic valve replacement, tissue Doppler
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INTRODUCTION
In patients with severe aortic stenosis (AS) long-standing left ventricular (LV) pressure overload 
results in LV hypertrophy, fi brosis, and ultimately LV dysfunction.1 Aortic valve replacement 
(AVR) has to take place before irreversible LV dysfunction develops because this adversely 
aff ects post-operative prognosis.2-3 Long-axis LV function assessed with tissue Doppler imag-
ing may identify early abnormalities in LV dysfunction, before LV ejection fraction (EF) is de-
pressed.4 Others and us haven shown that in patients with severe AS and normal LV-EF, systolic 
velocities of the mitral annulus may indeed be already abnormal.5-6 Occult LV dysfunction in 
AS may have important prognostic implications.1,3 Therefore, we investigated serial changes 
in long-axis LV function before and after AVR in patients with severe AS and preserved LV-EF.
METHODS
Study population
The study comprised 27 consecutive patients (mean age 64.9 ± 11.7 years, 15 males) with 
symptomatic severe AS, defi ned as an aortic valve area (AVA) ≤1.0 cm2 or a peak aortic jet 
velocity ≥4.0 m/s and normal LV-EF (≥50%), scheduled for AVR. None of the patients had 
atrial fi brillation, a pacemaker device, signifi cant mitral valve disease or signifi cant aortic re-
gurgitation. Six patients with angiographically signifi cant coronary artery disease underwent 
also concomitant bypass surgery. Echocardiographic and clinical follow-up was performed 3 
weeks, 6 months, and 12 months after AVR. Seventeen subjects without known cardiac dis-
ease, matched for age, gender, LV-EF and cardiovascular risk factors, served as control group 
to compare the echocardiographic measurements. The local ethics committee approved the 
study protocol and all patients gave written informed consent.
Conventional echocardiography
Doppler echocardiography was performed with a Sonos 7500 system (Philips, Best, The Neth-
erlands). All images were acquired from the standard cardiac views according to the guidelines 
of the American Society of Echocardiography and digitally stored for offl  ine analysis.7 To obtain 
the highest aortic jet velocity multiple windows were used. Peak and mean aortic pressure gra-
dient were calculated using the modifi ed Bernoulli equation and tracing of the aortic velocity 
profi le.8 Three measurements from the window with the highest velocity were averaged. AVA 
was calculated using the continuity equation. LV-EF was assessed by the modifi ed Simpson’s 
biplane disc method.9 For assessment of diastolic function, peak velocities of early (E) and late 
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(A), E/A-ratio and deceleration time were derived from Doppler recordings of the LV infl ow at 
the mitral leafl et tips. LV mass was calculated using the modifi ed Devereux formula.10
Tissue Doppler measurements
Tissue Doppler was applied in the pulsed wave Doppler mode at the level of the lateral mitral 
annulus from the apical 4-chamber view. This side was chosen because it is most easy to 
quantify11 and is less infl uenced by cardiac surgery.12 To acquire the highest wall tissue veloci-
ties, the angle between the Doppler beam and the longitudinal motion of the mitral annulus 
was adjusted to a minimal level. The average of three end-expiratory peak systolic (Sm), early 
(Em) and late (Am) diastolic velocities and E/Em ratio13 were calculated, where E is the peak 
velocity of early diastolic mitral fl ow.14
Statistical analysis
Continuous variables are expressed as mean ± SD. Diff erences between groups were analyzed 
with the unpaired t test for continuous variables or λ² test for categorical variables. A value 
of p<0.05 was considered signifi cant. A commercially available statistical software package 
was used (SPSS version 12.0).
RESULTS
Clinical data
The baseline clinical characteristics of the control subjects and patients are listed in Table 1. 
Main cardiac symptoms were angina in 16 patients (59%), exertional dyspnoea in 10 patients 
Table 1. Baseline characteristics of control subjects and patients with aortic stenosis
Variable
Control subjects
n = 17
Patients
n = 27
Age (years) 61.2 ± 5.3 64.9 ± 11.7
Male (%) 9 (53) 15 (55)
BMI (kg/m2) 29.0 ± 4.5 28.0 ± 5.5
Heart rate (bpm) 76 ± 13 74 ± 10
AVA (cm2) - 0.70 ± 0.24
AVA index (cm2/m2) - 0.36 ± 0.11
Aortic jet velocity (m/s) - 4.63 ± 0.65
Peak aortic valve gradient (mm Hg) - 87.4 ± 24.1
Mean aortic valve gradient (mm Hg) - 51.2 ± 14.2
BMI = body mass index, bpm = beats per minute, AVA = Aortic valve area.
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(37%) and dizziness in one patient (4%). Implanted prostheses were: St Jude mechanical, 
sizes 17-27 mm (n = 11), Carpentier Edwards Perimount bio, sizes 21-29 mm (n =15), and in 
one patient a homograft 23 mm was implanted.
Baseline echocardiographic data
As shown in Table 1, mean AVA in the AS group was 0.70 ± 0.24 cm2. No signifi cant diff erences 
were observed between AS patients and control subjects with respect to LV-EF, whereas 
systolic mitral annular velocities were signifi cantly lower (Table 2). Also, in patients with AS, 
the mitral E velocity and the E/Em ratio were signifi cantly higher whereas the deceleration 
time and the E/A ratio were not diff erent compared with control subjects.
Changes in echocardiographic data post aortic valve replacement
Three weeks after AVR, systolic and diastolic mitral annular velocities (including the E/Em 
ratio) improved, although the E/Em ratio remained higher compared to control subjects 
(Table 2). Individual changes in Sm values pre- and post AVR are displayed in Figure 1; in all 
but 4 patients Sm values improved. In the 6 patients with a Sm value <60% from normal a 
Table 2. Echocardiographic variables in control subjects and patients before and after aortic valve replacement 
Controls Pre-operative 3 Weeks 6 Months 12 Months
Aortic valve area -- 0.7 ± 0.2 1.9 ± 0.6 1.9 ± 0.6 1.6 ± 0.5
Peak aortic valve gradient 
(mm Hg)
-- 87.4 ± 24.1 19.2 ± 7.2 17.4 ± 7.1 18.6 ± 6.2
Mean aortic valve gradient 
(mm Hg)
-- 51.2 ± 14.2 9.4 ± 3.9 8.9 ± 3.9 9.5 ± 3.7
LV-EDD (mm) 45.3 ± 5.1 46.8 ± 9.6 46.3 ± 8.6 46.8 ± 7.3 47.2 ± 5.1
LV-ESD (mm) 30.5 ± 5.1 31.2 ± 9.2 32.2 ± 8.9 30.9 ± 7.6 31.0 ± 6.5
LV-EF (%) 65.1 ± 7.7 63.2 ± 9.1 59.2 ± 12.9 59.8 ± 10.1 63.1 ± 10.7
LA diameter (mm) 32.8 ± 3.9 43.2 ± 7.6# 43.4 ± 7.9# 45.6 ± 8.0# 43.9 ± 8.2#
LV mass (g) 139 ± 43 250 ± 104# 221 ± 83# 201 ± 58# 220 ± 58#
LV mass index (g/m2) 86 ± 24 127 ± 44# 113 ± 39# 103 ± 25# 113 ± 25#
E-wave (cm/s) 56 ± 13 81 ± 26# 79 ± 21# 74 ± 17# 80 ± 21#
A-wave (cm/s) 70 ± 16 80 ± 24 84 ± 25# 76 ± 18 84 ± 25#
E/A ratio 0.9 ± 0.3 1.1 ± 0.7 1.1 ± 0.8 1.0 ± 0.4 1.0 ± 0.2
Deceleration time (ms) 207 ± 53 211 ± 66 224 ± 60 228 ± 46 229 ± 52
Em lateral annulus (cm/s) 9.0 ± 3.0 7.3 ± 2.9 10.2 ± 2.8& 9.5 ± 2.5& 9.2 ± 2.2&
Am lateral annulus (cm/s) 10.0 ± 4.2 8.3 ± 2.9 9.4 ± 2.9 9.8 ± 3.2 9.8 ± 3.5
Sm lateral annulus (cm/s) 8.9 ± 2.0 6.7 ± 1.5# 9.1 ± 2.8& 8.6 ± 2.7& 8.1 ± 1.7&
E/Em lateral ratio 6.7 ± 2.3 11.7 ± 3.5# 8.1 ± 3.0& 8.5 ± 3.1&, # 9.4 ± 3.4&, #
& = p <0.05 compared to pre-operative values 
# = p <0.05 compared to control subjects
LV-EDD = Left ventricular end-diastolic diameter. LV-ESD = Left ventricular end-systolic diameter. LV-EF = Left ventricular ejection fraction, LA 
= Left atrial, E= peak early diastolic fi lling, A= peak late diastolic fi lling, Em = peak early diastolic myocardial velocity, Am= peak late diastolic 
myocardial velocity, Sm = peak systolic myocardial velocity.
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149% improvement was noted, in the 10 patients with a Sm value between 60 and 80% from 
normal a 133% improvement was noted, and in the 11 patients with a Sm value >80% from 
normal a 113% improvement was noted (Figure 2). As seen in Table 3, patients with improved 
Sm after AVR (defi ned as ≥10% compared to baseline values) did not diff er in baseline char-
acteristics as compared to those who did not improve.
Figure 1 Peak systolic mitral annular velocities pre (black bars) and post (white bars) aortic valve replacement according to the preoperative 
normalized values.
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Figure 2 Individual peak systolic mitral annular velocity pre- and post aortic valve replacement.
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DISCUSSION
The main fi ndings of this study are 1) in patients with severe AS and preserved LV-EF systolic 
mitral annular velocities are abnormal and 2) these velocities improve after AVR, independent 
of the pre-AVR value.
In patients with AS, the increased pressure gradient across the aortic valve leads to sub-
endocardial ischemia with contractile dysfunction of the longitudinal myocardial fi bers, LV 
hypertrophy and reactive fi brosis.15 These alterations are major determinants of diastolic and 
systolic LV dysfunction in AS patients. Diastolic dysfunction or LV stiff ness causes an increase 
in LV end-diastolic pressure, expressed in our study as high E/E’ ratios in AS patients com-
pared to controls. Systolic dysfunction may ultimately become visible by impairment in LV-EF, 
but as shown in this study mitral annular velocities are more sensitive to detect changes in 
long-axis LV systolic function.5-6
AVR reduces the pressure overload caused by AS. By this immediate decrease in afterload 
and a later correction in neurohormonal imbalance the LV may be reversely remodeled.16 We 
observed an improvement in mitral annular velocities both in diastole and systole as early as 
3 weeks after AVR, although the E/Em ratio did not normalize. This improvement was most 
obvious after 3 weeks.
Timing of aortic valve surgery in patients with severe AS depends on symptoms and LV sys-
tolic function. According to current guidelines a LV-EF <50% is an indication for AVR because 
LV dysfunction adversely aff ects prognosis.2-3,17 Ideally, AVR should take place at an earlier 
moment when LV-EF is still preserved to defi nitely prevent irreversible LV dysfunction. Some 
have advocated systolic velocities of LV longitudinal contraction assessed with tissue Dop-
pler imaging to time AVR, since these velocities are more sensitive to detect subtle changes 
in systolic LV function.18 Long-axis LV function is primarily determined by contraction of the 
longitudinally, mainly subendocardial-orientated muscle fi bers. A critical lowering of systolic 
long-axis LV function in a patient with preserved LV-EF may predict post-AVR LV dysfunction. 
In our study the most severely depressed systolic LV long-axis velocities showed the best rela-
tive improvement after AVR, although they still did not normalize. In our opinion this makes 
it not very likely that this variable can be used to time AVR in routine clinical practice. One 
Table 3. Baseline characteristics of patients with aortic stenosis with and without improved Sm
Variable
Patients with improved Sm
n = 20
Patients without improved Sm
n = 7
Age (years) 66.6 ± 10.5 60.1 ± 14.5
Male (%) 9 (60) 6 (86)
Heart rate (bpm) 74 ± 11 73 ± 11
AVA (cm2) 0.64 ± 0.19 0.80 ± 0.36
Peak aortic valve gradient (mm Hg) 87.6 ± 17.6 86.2 ± 36.8
Mean aortic valve gradient (mm Hg) 52.5 ± 11.2 48.4 ± 19.9
All P = non-signifi cant
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problem of the use of LV longitudinal contraction is that it is not only aff ected by irreversible 
fi brosis but also by reversible subendocardial ischemia caused by the LV pressure overload.19
Comparison with other studies
Acute (24 hours after percutaneous AVR) improvements in long-axis LV function in patients 
with impaired LV function were reported by Bauer et al.20 This acute improvement in long-axis 
LV function makes it most likely that afterload reduction is the main mechanism. Sub-acute (2 
weeks after AVR) improvements in long-axis LV function in patients with preserved LV function 
were reported by Iwahashi et al 1 More chronic (3 and 12 months after AVR) improvements 
in long-axis LV function in patients with preserved LV function were reported by Poulsen et 
al. 18 Our study is the fi rst to study both sub-acute (3 weeks after AVR) and chronic (6 and 12 
months after AVR) changes in long-axis LV function in patients with preserved LV function. In 
the study by Poulsen et al. a progressive improvement in long-axis LV function was reported 
whereas in our study the best long-axis LV function was seen 3 weeks after AVR, thereafter a 
small, non-signifi cant progressive deterioration was seen at 6 and 12 months post-AVR.18 The 
acute reduction in afterload after AVR may temporary increases long-axis systolic function 
and returns to baseline values after adaptation to the new situation. Only one study showed 
a relation between outcome and TDI deformation imaging in 32 AS patients after AVR: a low 
radial deformation was a marker of persistent heart failure.21
CONCLUSIONS
In patients with severe AS and preserved LV-EF, abnormal systolic mitral annular velocities 
improve after AVR, independent of the pre-AVR value. This improvement is already present 
after 3 weeks, and sustained 12 months after valve replacement.
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ABSTRACT
Aims: Cardiac investigations in patients with chronic chest pain (CCP) are focused on the 
detection of ischemia. In addition to stress tests, current guidelines recommend rest echo-
cardiography in patients referred for the evaluation of CCP with an abnormal ECG, suspicion 
of heart failure and in the presence of murmurs. However, there are no prospective studies 
supporting this strategy.
Methods: In 500 consecutive patients without known coronary artery disease (CAD) and 
with intermediate and high risk for CAD we performed a diagnostic protocol that consists 
of physical examination, ECG, bicycle exercise test and CT angiography. Also we performed 
handheld echocardiography (HHE) in all patients and compared these results with the fi nal 
diagnosis made by the other exams.
Results: Abnormal HHE results were found in 15,6% of all patients. In 346 patients with nor-
mal blood pressure, no murmurs or signs of heart failure and a normal ECC only 10,4% had 
abnormal HHE. The majority of the fi ndings by HHE had no implications for patient manage-
ment. In contrast, abnormal fi ndings were detected in 49 out of 154 patients (32%) with a 
guideline indication for HHE.
Conclusions: Although systematic echocardiography in patients with chronic chest pain 
yields unexpected abnormalities in 10,4% of patients without abnormal fi ndings by other 
investigations, the clinical relevance of these fi ndings is limited. These results support the 
current guideline to perform echocardiography in selected cases only.
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INTRODUCTION
In patients referred to a cardiologist for evaluation of chronic chest pain (CCP) the diagnostic 
process is focused primarily on detecting myocardial ischemia caused by signifi cant coronary 
artery disease (CAD). Several non-invasive techniques can be used in the diagnostic as-
sessment of CAD such as a resting ECG, ECG stress testing, and stress echocardiography or 
myocardial perfusion scintigraphy 1 2. In addition, echocardiography at rest may be used to 
detect other causes of CCP such as severe aortic stenosis 3 and hypertrophic cardiomyopa-
thy.4 According to current ESC guidelines, echocardiography is indicated in CCP patients with 
suspected valve disease, heart failure, prior myocardial infarction or ECG abnormalities such 
as left bundle branch block, Q-waves or other signifi cant, abnormal fi ndings.5 However, to 
our knowledge no studies are published in which echocardiography has been systematically 
performed in a series of consecutive patients with CCP.
Handheld echocardiography (HHE) has been evaluated as a useful tool for screening of 
patients for cardiac abnormalities such as hypertrophic cardiomyopathy, pericardial eff u-
sion, left ventricular dysfunction and valve disease.6 We prospectively performed HHE in a 
consecutive series of patients referred to the outpatient clinic for the evaluation of CCP and 
investigated whether systematic HHE ads important information in the diagnostic process in 
patients with CCP.
METHODS
Study population
Five hundred and twenty patients without a history of CAD were referred to the outpatient 
clinic of the Erasmus MC for the evaluation of CCP from September 2006 to February 2009. All 
patients underwent a standardized protocol including an ECG, blood examination, physical 
examination (focused on signs of heart failure and valve disease), computed tomography 
coronary angiography and HHE. Twenty patients (4%) with insuffi  cient quality of HHE were 
excluded from the analysis. Invasive coronary angiography was performed when indicated. 
Signifi cant CAD was defi ned as more than 50% narrowing of at least one epicardial coronary 
artery as detected by either CT-angiography of invasive coronary angiography.
Handheld echocardiography
HHE was performed with the OptiGo (Philips Medical Systems) device by one single experi-
enced cardiologist (TWG). This system is equipped with a 2.5 MHz phased array broadband 
transducer and operates on a rechargeable lithium ion battery or alternating current. Two-
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dimensional imaging, color fl ow Doppler imaging, and calipers for linear measurements are 
integrated in the system. The focus for the HHE was to detect cardiovascular abnormalities 
potentially causing CCP (Table 1). Also, fi ndings that were not related to the symptoms but 
require echocardiographic follow-up or (more intensive) prescription of medication accord-
ing to the current guidelines were reported.7-9
RESULTS
Patients
Mean age of the patients was 55 ± 11 years (range 18 to 84) and 51% were male. Chest pain was 
characterized as typical angina in 154 (31%), atypical angina in 268 (54%) and non-anginal in 
78 (14%).10 Diabetes, hypertension, hypercholesterolemia, and a family history of CAD were 
present in 14%, 49%, 57%, and 46% of patients respectively and 30% were current smokers. 
The fi nal diagnosis of signifi cant CAD was established in 152 out of 500 patients (30%), based 
on CT-angiography in 90 patients and invasive coronary angiography in 62 patients.
Handheld echocardiography
Adequate HHE images were obtained in 500 out of 520 patients. In 10 patients (2,0%) 
echocardiographic abnormalities were found that could relate to CCP (Table 2). Eight (1,6%) 
Table 1. Cardiac abnormalities associated with chest pain and the echocardiographic abnormality
Cardiac abnormalities causing chest pain Echocardiographic abnormality
Coronary artery disease (CAD) Regional wall motion abnormality
Mitral valve prolaps Bulging part of the mitral valve in left atrium
Pericarditis Pericardial fl uid, thickened pericardium
Hypertrophic cardiomyopathy Severe left ventricular hypertrophy >16 mm
Severe aortic stenosis Thickened aortic valve, CW Doppler >4 m/s
Pulmonary embolism Dilated right ventricle and inferior vena cava 
Aortic dissection Dilated ascending aorta, intimal fl ap
Table 2. Echocardiographic fi ndings related to chest pain
Cardiac abnormalities Patients Echo
indicated 
Echo not indicated
Number of patients 500 154 346
Abnormal wall motion (CAD) 8 (1,6%) 7 (4,5%) 1 (0,3%)
Mitral valve prolaps 0 0 0
Pericarditis 2 (0,4%) 0 2 (0,6%)
Hypertrophic cardiomyopathy 0 0 0
Severe aortic stenosis 0 0 0
Pulmonary embolism 0 0 0
Aortic dissection 0 0 0
All fi ndings 10 (2,0%) 7 (4,5%) 3 (0,9%)
Tjebbe BW 19-5b.indd   122 20-05-10   10:48
123
Usefulness of Handheld Echocardiography in Patients referred for Evaluation of Chronic Chest Pain
Ch
ap
te
r 1
1
patients had regional wall motion abnormalities and 2 (0,4%) pericardial fl uid. According to 
the current guidelines, only 154 patients (31%) had an appropriate indication for echocar-
diography. In 7 of these 154 patients (4,5%) a CCP related abnormality was found. In 346 
patients without an indication for echocardiography 3 (0,9%) CCP related fi nding was found. 
When HHE was restricted to the 154 patients with an indication for echocardiography, 3 of 10 
(30%) diagnoses would have been missed (Table 2).
Abnormalities not related to CCP but with an established indication for follow-up were 
found in 78 (15,6%) patients. In 154 patients with an indication for echocardiography 42 
(27,3%) diagnosis not related to CCP were established As well as in 36 (10,4%) patients 346 
without an indication. When HHE would be restricted to patients with a formal indication, 36 
of 78 (46,0%) fi ndings would have been missed, including 18 cases of mild valve insuffi  ciency 
and 18 with left ventricular hypertrophy or impaired left ventricular function (Table 3).
DISCUSSION
Patient with CCP are frequently referred to the cardiologist. The primary focus in these 
patients is to detect or exclude signifi cant CAD, while also other causes for CCP should be 
investigated. Echocardiography is an important tool to detect or exclude most cardiac causes 
for CCP apart from coronary artery disease. Therefore, according to current guidelines, echo-
Table 3. Echocardiographic fi ndings not related to chest pain
Echocardiographic fi nding Patients Echo
indicated
Echo not indicated
Number of patients 500 154 346
Impaired LV function (EF < 40%) 12 (2,4%) 5 (3,2%) 7 (2,0%)
Aortic stenosis
- mild 9 (1,8%) 4 (2,6%) 5 (1,4%)
- moderate 0
Aortic regurgitation
- mild 10 (2,0%) 8 (5,2%) 2 (0,6%)
- moderate 1 (0,2%) 1 (0,6%) 0
- severe 0 0
Mitral regurgitation
- mild 25 (5,0%) 14 (9,1%) 11 (3,2%)
- moderate 0 0
- severe 0 0
Left ventricular hypertrophy 21 (4,2%) 10 (6,5%) 11 (3,2%)
All fi ndings (%) 78 (15,6%) 42 (27,3%) 36 (10,4%)
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cardiography is recommended in the presence of symptoms of heart failure, murmurs or ECG 
abnormalities although prospective data to support this strategy are limited.5
In order to verify whether systematic or selective HHE provides a signifi cant contribution to 
the diagnostic protocol, including stress ECG and CT-angiography, we evaluated 500 consecu-
tive patients with CCP and suffi  cient quality HHE who were referred to our chest pain clinic. HHE 
yielded possible CCP-related fi ndings in 10 patients, of which approximately one third would 
have been missed when echocardiography was used selectively, according to the guidelines: 
2 patients with pericardial eff usion and one patient with abnormal regional wall motion. No 
patients with severe aortic stenosis or hypertrophic cardiomyopathy were present in our study 
population. This may be explained by the low prevalence of hypertrophic cardiomyopathy 
in the overall population (estimated 1 in 500 patients)11 and the relative young age of the 
referred patients, while severe aortic stenosis occurs more frequently in the elderly.3 Because 
of the absence of hypertrophic cardiomyopathy and severe aortic stenosis in our patients with 
chest pain we can not be certain whether we would have missed patients with such disease 
if we performed HHE in selected cases only. However, others have reported that only 6% of 
patients with hypertrophic cardiomyopathy present with a normal ECG. Furthermore, these 
patients had better cardiovascular outcome compared to patients with ECG abnormalities.12 
So it’s very unlikely that patients with a clinically relevant severe hypertrophic cardiomyopathy 
would have been missed when HHE would have been performed according to the guideline. 
The same is true for patients with severe aortic stenosis. These patients usually present with a 
murmur or abnormal ECG. In our study of 27 patients with severe aortic stenosis all patients 
had a murmur and 26 of 27 (96,3%) an abnormal ECG and would not have been missed if HHE 
was performed according to the guideline.13 Taken together, these data confi rm that HHE in 
selected patients with chest pain is an adequate and safe procedure indeed.
The relevance of detecting (or missing) regional wall motion abnormalities and pericardial 
eff usion with echocardiography in this particular patient group is not clear. Pericardial ef-
fusion can readily be detected by computed tomography, as was the case in our patients. 
The relevance of detection of regional wall motion abnormalities may be questioned. These 
fi ndings increase the probability of CAD, however, all patients in our chest pain protocol 
do undergo CT-angiography. Surprisingly, in our study only two out of eight patients with 
regional wall motion abnormalities actually had signifi cant CAD, although it can not be 
excluded that these patients previously suff ered from a thrombotic event in a non-signifi cant 
coronary lesion. Five of these patients without signifi cant CAD had isolated basal inferior 
and/or inferoseptal wall motion abnormalities which are known to be not specifi c for CAD.14
Findings that were not related to the symptoms but which may require (more intensive) 
prescription of medication according to the current guidelines were seen in 78 (15,6%) 
patients of whom 36 would have been missed when echocardiography was not performed 
systematically (Table 3). The question is whether these 36 abnormalities, fi nd by echocar-
diography, are important to prevent structural and irreversible damage to the heart during 
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long time follow-up? This is only true if these unexpected fi ndings would lead to treatment 
with medication or other relevant changes that could prevent cardiac damage and worse 
outcome in the future. Seven patients had impaired LV function and would have been missed 
if echocardiography would be performed according to the guidelines.5 Heart failure guide-
lines recommend starting ACE inhibition therapy in asymptomatic patients with LV ejection 
fraction of less than 40%. However, this recommendation is based on a single study in which 
had established cardiac disease such as a previous myocardial infarction.15 The 7 patients in 
our study without an indication for echocardiography but with impaired LV function had no 
coronary artery disease on CT-angiography and it’s not clear if they would benefi t from ACE 
inhibition. In 21 (4,2%) patients left ventricular hypertrophy was present on echocardiog-
raphy. Eleven patients had normal ECG and blood pressure and would have been missed if 
echocardiography would have been restricted to patients with those characteristics. Since 
these 11 patients did not have hypertension its not clear if they would benefi t from treatment 
with an ACE-inhibitor or other drugs in the same way as hypertensive patients.9
Another cardiac abnormality that was found is valve disease. In 45 (9,0%) patients valve 
disease was detected and in 18 (3,6%) this would have been missed if echocardiography was 
restricted to patients with heart murmurs or signs of heart failure. The latter included mild 
aortic stenosis in 5 (1,0%), mild aortic regurgitation in 2 (0,4%) and mild mitral regurgitation 
in 11 (2,2%) patients. None of these patients was symptomatic with respect to valve disease 
and no patient had an indication for valve surgery. The relevancy of fi nding mild native valve 
disease is low in particular since current guidelines state that prophylactic administration of 
antibiotics for prevention of endocarditis in such cases is no longer indicated.16 We should also 
consider the possibility that mild disease progresses to severe and the optimal moment of cor-
recting this disease can be missed. Current ESC guidelines state that mild aortic regurgitation 
and mild aortic stenosis warrant follow up every 2 year, while follow up is not recommended 
in mild mitral regurgitation.7 Accordingly, in our 18 patients with unexpected valve disease 
only in 7 follow up would be indicated. Since it is known that the majority of patients with 
severe aortic stenosis and regurgitation develop symptoms before left ventricular dysfunction 
develops, it is unlikely that major damage would occur if these patients went undetected.7
As a limitation of our study it should be appreciated that HHE may be inferior to standard 
echocardiography. However, it has been shown in several studies that the agreement be-
tween these two modalities is excellent6, in particular when patients with poor image quality 
are excluded as was the case in 20 patients in this series.
In our study of 500 patients with CCP evaluated for coronary artery disease echocardiography 
was indicated according to current guidelines in 154 patients and yielded additional informa-
tion compared with the other investigations in one third of the patients. In 346 patients without 
a clear indication for echocardiography no clinically relevant abnormalities were found with 
CCP. Therefore we do not recommend to perform systematic echocardiography in every patient 
with CCP, but rather to use this method selectively in accordance with current guidelines. 
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ABSTRACT
The aim of this study was to investigate the value of coronary calcium detection by computed 
tomography compared to computed tomographic angiography (CTA) and exercise testing to 
detect obstructive coronary artery disease (CAD) in patients with stable chest pain. A total 
of 471 consecutive patients with new stable chest complaints were scheduled to undergo 
dual-source multislice computed tomography (Siemens, Germany; coronary calcium score 
[CCS] and coronary CTA) and exercise electrocardiography (XECG). Clinically driven invasive 
quantitative angiography was performed in 98 patients. Only 3 of 175 patients (2%) with a 
negative CCS had signifi cant CAD on CT angiogram, with only 1 confi rmed by quantitative 
angiography. In patients with a high calcium score (Agatston score >400), CTA could exclude 
signifi cant CAD in no more than 4 of 65 patients (6%). In patients with a low–intermediate 
CCS, CTA more often yielded diagnostic results compared to XECG and could rule out obstruc-
tive CAD in 56% of patients. For patients with CAD on CT angiogram, those with abnormal 
exercise electrocardiographic results more often showed severe CAD (p <0.034). In patients 
with diagnostic results for all tests, the sensitivity and specifi city to detect >50% quantitative 
angiographic diameter stenosis were 100% and 15% for CCS >0, 82% and 64% for CCS >100, 
97% and 36% for CTA, and 70% and 76% for XECG, respectively. In conclusion, nonenhanced 
computed tomography for calcium detection is a reliable means to exclude obstructive 
CAD in stable, symptomatic patients. Contrast-enhanced CTA can exclude signifi cant CAD 
in patients with a low–intermediate CCS but is of limited value in patients with a high CCS.
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INTRODUCTION
Noninvasive computed tomographic angiography (CTA) is regarded as a diagnostic option to 
evaluate patients with chest pain, particularly when stress tests cannot be performed or fail 
to achieve conclusive results.1,2 Although mostly used for risk stratifi cation, coronary calcium 
also yields diagnostic value to exclude obstructive coronary artery disease (CAD), which has 
been demonstrated in stable and acute chest pain, and unexplained heart failure.3,4 Recently, 
concerns about the radiation and contrast medium exposure of CTA have regenerated inter-
est in calcium imaging in symptomatic patients. In this study we investigated the diagnostic 
value of calcium scanning compared to CTA, exercise electrocardiography (XECG), and cath-
eter angiography in the diagnostic workup of stable angina.
METHODS
From September 2006 to December 2008, 471 consecutive patients with stable chest pain 
and no history of CAD were evaluated at our 1-day chest pain clinic. All patients with a pre-
test probability >5% were planned to undergo cardiac computed tomography and XECG, 
in addition to clinical examination, blood analysis, and echocardiography.5 Information on 
risk factors was prospectively acquired. Chest pain was categorized as typical (retrosternal, 
precipitated by exercise or emotion, relieved <10 minutes after rest or nitroglycerin), atypical 
(with only 2 of the previous characteristics), or nonanginal (with none or only 1 characteristic 
of typical angina; Table 1). The study complied with the Declaration of Helsinki, the institu-
tional ethical committee approved the study, and informed consent was obtained from all 
patients.
Dual-source multislice computed tomography (Siemens Defi nition, Forchheim, Germany; 
collimation 32 × 0.6 mm, 64-channel acquisition by z-axis focal spot alternation, rotation time 
330 ms, temporal resolution 83 ms) was performed in the absence of pregnancy, contrast 
allergies, or renal dysfunction.
Nonenhanced computed tomography
Electrocardiographically triggered, sequential step-and-shoot acquisition mode, with 120-kV 
tube voltage, 78 ± 26-mAs tube current, and 3-mm slice thickness, was performed for calcium 
detection and quantifi cation by the Agatston method and a standard 130-HU attenuation 
threshold.6
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Contrast-enhanced CT angiographic parameters
Spiral acquisition consisted of 120-kV tube voltage, 380- to 412-mAs tube current depending 
on patient size, and variable pitch depending on heart rate. Prospectively electrocardio-
graphically triggered tube modulation was applied in all patients with a regular heart rate.
Table 1
Patient characteristics (n  471)
Age (years) 56 10
Women 227 (48%)
Nicotine abuse 138 (29%)
Hypertension 233 (50%)
Diabetes mellitus 68 (14%)
Dyslipidemia 280 (59%)
Family history of cardiovascular disease 214 (45%)
History of vascular disease 31 (7%)
Median cardiovascular risk (SCORE20, %) 4 (2–11%)
Typical angina pectoris 146 (31%)
Atypical angina pectoris 251 (53%)
Nonanginal 74 (16%)
Pretest probability (%)5 53  28
CCS—performed 463 (98%)
Median calcium score7 15 (0–145)
CTA—performed 455 (97%)
CT angiographic diameter stenosis 50% 312 (69%)
CT angiographic diameter stenosis 50% 140 (31%)
Nondiagnostic examinations 3 (1%)
Heart rate (min1) 68  12
Atrial fibrillation 3 (1%)
XECG—performed 423 (90%)
Normal result 190 (45%)
Abnormal result 93 (22%)
Nondiagnostic result 140 (33%)
Catheter angiography 98 (21%)
Quantitative coronary angiographic diameter
stenosis 50%
41 (42%)
Quantitative coronary angiographic diameter
stenosis 50%
57 (58%)
1-vessel disease 26 (27%)
2-vessel disease 19 (19%)
3-vessel disease 12 (12%)
70% diameter stenosis 29 (30%)
Revascularization 59 (13%)
Percutaneous intervention 46 (10)
Bypass graft surgery 13 (3%)
Patient characteristics are presented as absolute numbers of patients
(percentages) or means  SDs, unless otherwise stated. Dyslipidemia
defined as a total cholesterol level 5 mmol/L, low-density lipoprotein
level 3 mmol/L, or on lipid-lowering medication. Estimated annual risk
of cardiovascular death was done using SCORE.25 Pretest probability used
criteria of Diamond and Forrester.5
SCORE  Systematic Coronary Risk Evaluation.
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Contrast medium
Iopromide 70 to 100 ml (Ultravist 370 mgI/ml, Schering AG, Berlin, Germany), followed by 
a 40-ml saline bolus chaser, was peripherally injected at 5.0 to 5.5 ml/s. A bolus tracking 
technique was used to synchronize data acquisition with contrast delivery. Patients received 
a sublingual dose of nitroglycerin just before the scan, but no additional β blockers. Retro-
spective electrocardiographically gated end-systolic and/or diastolic datasets (0.75-mm slice 
thickness, 0.4-mm reconstruction increment) were created depending on heart rate and tube 
modulation protocol. Eff ective radiation doses for CCS and CTA were 0.8 ± 0.2 mSv (range 0.4 
to 1.6) and 11.0 ± 3.5 mSv (range 4.7 to 17.8).
The right coronary artery, left main branch, left anterior descending coronary artery, and left
circumfl ex branch were evaluated on axial images, multiplanar reformations, and maximum 
intensity projections according to readers’ preferences. Readers were not informed about pa-
tients’ symptoms or exercise test results. Vessels were qualitatively scored as stenosed (>50% 
diameter narrowing), less than signifi cantly stenosed (<50%), or normal.
Bicycle XECG was performed by standardized protocol, with established criteria for perfor-
mance and exercise discontinuation. Criteria for myocardial ischemia included horizontal or 
downsloping ST-segment depression or elevation >0.1 mV during or after exercise, or typi-
cal, increasing angina during exercise. XECG was considered nondiagnostic if discontinued 
without evidence of myocardial ischemia before reaching the 85% target heart rate.
Clinically indicated quantitative coronary angiography (QCA) was performed using standard 
techniques, with assessment of the most severe obstruction from ≥2 orthogonal projections 
using quantitative software (CAAS, Pie Medical, Maastricht, The Netherlands). Maximum lu-
men diameter stenosis >50% was considered signifi cant.
Summary data are presented as numbers (proportions), means ± SDs, or medians (inter-
quartile ranges) when indicated. Diagnostic performance parameters, sensitivity, specifi city, 
positive predictive value, and negative predictive value, were calculated with 95% confi dence 
intervals. Diff erences between groups were compared using 2-sided unpaired t test, chi-
square test, or analysis of variance, as appropriate. A p value <0.05 was considered signifi cant. 
Statistical analysis was performed using SPSS 15.0 (SPSS, Inc., Chicago, Illinois).
RESULTS
Neither CCS nor CTA could be performed in 8 patients (1.7%), and CTA could not be per-
formed in another 8 patients (1.7%) because of renal failure, contrast allergy, patient prefer-
ence, Parkinson disease, patient nonco-operation, failed venous access, and severe obesity. 
All calcium scans were successful. Three CTAs (0.7%) failed because of patient movement 
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(2) and premature scan initiation (1). Mild to moderate allergic reactions were observed in 3 
patients (0.7%).
XECG could not be performed in 48 patients (10.2%) because of orthopedic reasons (13), 
neurologic impairment (4), severe obesity (2), electrocardiographic abnormalities at rest (6), 
pulmonary disease (2), and a combination/unspecifi ed (21). XECG was inconclusive in 140 of 
423 patients (33%), mostly due to failure to reach the target heart rate.
Catheter angiography (QCA) was performed in 98 patients, of whom 57 showed >50% 
diameter obstruction. Percutaneous coronary intervention was performed in 46 patients; 
coronary artery bypass graft surgery was performed in 13. Another 32 patients with abnormal 
CT angiographic and exercise electrocardiographic results were treated medically without 
undergoing cardiac catheterization.
A high CCS was associated with older age, male gender, a less favorable risk profi le, typi-
cal angina rather than nonanginal pain, and a higher pretest probability of obstructive CAD 
(Table 2).
No calcium was detected in 175 patients (37%), of whom only 3 of 170 diagnostic CT 
angiograms showed obstructive CAD (2%; Figure 1, Table 3). None of these 3 patients had di-
agnostic exercise electrocardiograms, and all underwent invasive angiography. Two patients 
underwent percutaneous coronary intervention of the left anterior descending coronary 
artery. One of these (43-year-old man) showed undisputable, severe stenosis (Figure 2), 
and the other (61-year-old man) had a borderline bifurcation lesion, without quantitative 
angiographically confi rmed signifi cance, and was treated on clinical grounds. The patient in 
whom CTA overestimated disease severity was a 79-years-old woman. In patients without 
Table 2
Coronary calcium score subgroups characteristics (n  463)
CCS p Value*
0
(n  175)
0.1–10
(n  48)
11–100
(n  101)
101–400
(n  74)
400
(n  65)
Age (years) 51  10 53  10 58  9 59 8 63  8 0.001
Women 112 (64%) 26 (54%) 46 (46%) 25 (34%) 14 (22%) 0.001
Nicotine abuse 44 (25%) 18 (38%) 23 (23%) 27 (36%) 25 (38%) 0.049
Hypertension 70 (40%) 21 (44%) 58 (57%) 31 (42%) 45 (69%) 0.001
Diabetes mellitus 21 (12%) 3 (6%) 10 (10%) 10 (14%) 21 (32%) 0.001
Dyslipidemia 76 (43%) 34 (71%) 65 (64%) 56 (74%) 44 (68%) 0.001
Family history of cardiovascular disease 80 (46%) 28 (58%) 45 (45%) 35 (47%) 23 (35%) 0.20
History cardiovascular disease 10 (6%) 1 (2%) 6 (6%) 6 (8%) 8 (12%) 0.24
Cardiovascular risk (%)† 1 (1–3) 2 (1–5) 4 (2–7) 5.5 (3–9) 7 (4–12) 0.001
Angina score‡ 2.2  0.6 1.8  0.6 2.2  0.6 2.0 0.7 2.5 0.7 0.001
Pretest probability (%)§ 45  26 38 26 57  27 55  26 74  26 0.001
Interpretable CT angiogram 170 (97%) 48 (100%) 99 (98%) 73 (99%) 62 (95%) 0.54
50% stenosis 3 (2%) 5 (10%) 37 (37%) 37 (51%) 58 (94%) 0.001
Conclusive exercise electrocardiogram 108 (62%) 34 (71%) 64 (65%) 40 (55%) 34 (52%) 0.22
Abnormal result 28 (26%) 5 (15%) 23 (36%) 14 (35%) 21 (62%) 0.001
Catheter angiogram 7 (4%) 4 (8%) 25 (25%) 22 (30%) 39 (60%) 0.001
50–70% stenosis 0 0 5 (20%) 5 (23%) 18 (46%) 0.001
70% stenosis 1 (14%) 1 (25%) 4 (16%) 6 (27%) 16 (41%) 0.23
Revascularization 2 (1%) 1 (2%) 10 (10%) 11 (15%) 35 (54%) 0.001
Abbreviation as in Table 1.
* Analysis of variance.
† Estimated annual risk of cardiovascular death (SCORE25).
‡ Angina score: typical angina  3, atypical angina  2, nonanginal  1.
§ Pretest probability of obstructive CAD using criteria of Diamond and Forrester.5
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obstructive CAD on CT angiogram, 28 patients (17%) had a positive exercise electrocardio-
gram, although quantitative coronary angiogram did not show signifi cant stenosis in the few 
who underwent catheterization. A low CCS (<10) was found in 48 patients (10%), 5 of whom 
had obstructive CAD on CT angiogram. After a positive exercise electrocardiogram in 3, 1 had 
Figure 1: Number of patients with unavailable, negative (normal), and positive (abnormal) CT angiographic and exercise electrocardiographic 
results (percentage of total) stratifi ed by CCS group.
Table 3
Diagnostic correlation calcium score, computed tomographic angiography, exercise electrocardiography, and invasive angiography
CCS CTA XECG Quantitative Catheter Angiographic
Diameter Stenosis 50%
0 170 (38%) 0–49% 167 (95%) normal 76 (46%) 0/2
ischemia 28 (17%) 0/2
unavailable 63 (38%)
50% 3 (2%) normal —
ischemia —
unavailable 3 (100%) 1/3
0.1–10 48 (11%) 0–49% 43 (90%) normal 27 (63%) 0/2
ischemia 2 (5%)
unavailable 14 (33%) 0/1
50% 5 (10%) normal 2 (40%)
ischemia 3 (60%) 1/1
unavailable —
11–100 99 (22%) 0–49% 62 (61%) normal 24 (39%) 0/1
ischemia 10 (16%) 0/1
unavailable 28 (45%) 1/4
50% 37 (37%) normal 16 (43%) 2/8
ischemia 13 (35%) 3/5
unavailable 8 (19%) 3/6
101–400 73 (16%) 0–49% 36 (49%) normal 11 (31%) 0/1
ischemia 4 (11%) 1/1
unavailable 21 (58%) 0/1
50% 37 (50%) normal 14 (38%) 1/7
ischemia 10 (27%) 4/5
unavailable 13 (35%) 5/7
400 62 (14%) 0–49% 4 (6) normal —
ischemia —
unavailable 4 (100%) 0/1
50% 58 (89%) normal 13 (22%) 7/8
ischemia 21 (36%) 14/14
unavailable 24 (41%) 12/15
452 452 452 55/96
Diagnostic results per test are presented as numbers of patients (percentages). Patients without diagnostic calcium scores or CT angiograms (n  19) were
in not included in this table. Quantitative catheter angiographic results are presented as number of patients with 50% stenosis/total catheterizations.
Unavailable tests include tests not performed, not interpretable, or not conclusive.
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quantitative angiographic confi rmation of severe obstructive disease. The others had relief of 
symptoms on medical treatment.
A CCS from 10 to 400 was found in 175 patients (37%). Obstructive CAD was found on CT 
angiogram in 74 patients (42%), and exercise electrocardiogram was positive in 37 patients 
(21%, 36% of conclusive tests), with poor agreement between tests (kappa = 0.10).
A CCS >400 was found in 65 patients (14%). CTA could exclude obstructive CAD in no more 
than 4 (6%). In patients with a diagnostic exercise electrocardiogram, the test was normal in 
13 of 34 (38%). By QCA 34 of 39 patients (87%) showed signifi cant CAD.
For patients in whom all tests produced diagnostic results, overall diagnostic accuracy to 
assess signifi cant coronary stenosis compared to QCA was comparable among CCS, CTA, 
and XECG (Table 4). CTA and CCS with a low threshold (>0) were more sensitive than XECG, 
whereas XECG and CCS with a high threshold (>400) were signifi cantly more specifi c than 
CTA.
Figure 2: Exceptional case of severe coronary obstruction without detectable calcium by computed tomography. This 45-year-old man with 
a positive family history for cardiovascular disease presented with recently progressive, typical, stress-induced chest pain. No exercise testing 
was performed because of precordial STT changes at rest. Although no calcium was detected, (A) CT angiogram showed severe (noncalcifi ed) 
obstruction of the proximal left anterior descending coronary artery (LAD) (arrows), which was confi rmed by (C) catheter angiogram, and then 
followed by (D) percutaneous revascularization. (B) Enlarged view of obstruction.
Table 4
Diagnostic accuracy of computed tomographic angiography and exercise electrocardiography to detect 50% diameter stenosis by quantitative catheter
angiography
Analysis TP TN FP FN Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy
All (n  58)
CCS 0 33 4 21 0 100 16 (2–30) 61 (48–74) 100 64 (51–76)
CCS 100 27 16 9 6 82 (69–95) 64 (45–83) 75 (61–89) 73 (58–87) 74 (63–85)
CCS 400 21 24 1 12 64 (47–80) 96 (88–100) 96 (87–100) 67 (47–86) 78 (67–88)
CTA 32 9 16 1 97 (91–100) 36 (17–55) 67 (53–80) 90 (82–99) 71 (59–82)
XECG 23 19 6 10 70 (54–85) 76 (59–93) 79 (65–94) 66 (48–83) 72 (61–84)
CCS 1–400 (n  32)
CTA 11 5 15 1 92 (76–100) 25 (6–44) 42 (23–61) 83 (69–98) 50 (33–67)
XECG 9 16 4 3 75 (51–100) 80 (63–98) 69 (44–94) 84 (64–100) 78 (64–92)
Diagnostic performance of CCS based on consecutive cut-off values, CT angiogram, and exercise electrocardiogram to identify patients with 1 vessel
with 50% diameter stenosis by quantitative catheter angiography. Patients with unavailable test results (unavailable CT angiogram, n  1; exercise
electrocardiogram, n  38; CT angiogram and exercise electrocardiogram, n  1) were excluded. Subanalysis for patients with a CCS from 1 to 400.
Sensitivity, specificity, PPV, NPV, and accuracy are presented with 95% confidence intervals.
FN  false negative; FP  false positive; NPV  negative predictive value; PPV  positive predictive value; TN  true negative; TP  true positive.
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DISCUSSION
Coronary CTA has emerged as a noninvasive angiographic alternative in patients with sus-
pected CAD. Drawbacks of CTA are the substantial radiation dose and need for potentially 
nephrotoxic contrast medium. The large diff erence in radiation dose between CTA and CCS 
is becoming smaller but unlikely to completely disappear, despite new dose-saving acquisi-
tion techniques.7 In this large prospective registry we report the clinical value of low-dose, 
nonenhanced calcium imaging by computed tomography in the diagnostic workup of 
symptomatic patients. A negative CCS makes obstructive CAD very unlikely and is associated 
with an excellent prognosis.4, 8, 9 and 10 Also in our study the prevalence of signifi cant coronary 
obstruction by CTA or QCA was very low in patients with a negative CCS. Of 175 patients only 
3 showed coronary obstruction on CT angiogram, of whom only 1 case was confi rmed by 
QCA. Few cases of obstructive disease were detected in patients with a low CCS (<10), despite 
undeniable evidence of atherosclerotic disease presenting in these patients. In a retrospec-
tive analysis of 554 patients (64% symptomatic), Cheng et al11 showed that the prevalence of 
obstructive CAD in patients with a low calcium score is low (8.7% stenosis prevalence, CCS 1 
to 50 for men, 1 to 10 for women), but signifi cantly higher compared to those with a negative 
CCS (0.5%), which is in line with our fi ndings.
In patients with a low–intermediate CCS (10 to 400), CTA could be performed with inter-
pretable results in more patients compared to XECG and ruled out obstructive CAD in 56% 
of these patients. Our study confi rmed the very modest agreement between functional tests 
and CTA.12, 13, 14, 15 and 16 Patients with a positive CT angiogram (42%) had signifi cant stenosis 
on quantitative angiogram more often when exercise electrocardiogram was also positive (p 
= 0.034).
As expected, obstructive CAD was more frequent in patients with a high CCS. CTA is less ac-
curate and tends to overestimate stenosis severity in patients with extensive calcifi cations.17 
and 18 Indeed, CTA excluded obstructive CAD in no more than 4 patients (6%).
In patients with diagnostic test results CTA and CCS with a low threshold showed the high-
est sensitivity, although specifi city was signifi cantly better for XECG or CCS with a higher 
threshold.
The debate as to whether functional or anatomical tests are preferred for the workup of 
suspected CAD is ongoing. Although XECG is considered more cost eff ective, it has poor 
diagnostic performance.19 Similar to a negative stress test result, a negative CCS also has an 
excellent prognosis.7, 8, 9, 19 and 20 This suggests that a negative CCS could suffi  ce to rule out 
obstructive CAD without the need for further testing. Whether this includes patients with a 
very low CCS (<10) is debatable.11 Those with a low–moderate CCS (<400) could undergo CTA 
to rule out obstructive CAD. Stress testing would be reserved for patients with obstructive 
CAD on CT angiogram or a CCS >400. When prognostically important left main coronary 
artery, proximal left anterior descending coronary artery, or 3-vessel disease was absent on 
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CT angiogram, we found this increased our confi dence to initiate and maintain medical treat-
ment before referral to invasive angiography. Prospective trials will need to establish whether 
this or other implementations of cardiac computed tomography are eff ective and effi  cient in 
the workup of patients with chest pain.
Because cardiac catheterization was not performed in all patients, it is not possible to 
completely exclude angiographic CAD in all patients. Based on the reported good negative 
predictive value of CTA and the assumption that patients with borderline lesions and com-
pelling, nonresolving symptoms would eventually be catheterized, we expect the number of 
missed lesions to be very small.21 A low disease prevalence, verifi cation bias, and selective use 
of invasive angiography likely contributed to the low specifi city of CTA compared to previous 
studies.22 and 23 Our fi ndings should not yet be extrapolated to patients with unstable symp-
toms, in whom signifi cant obstructive CAD without calcifi cation may be more prevalent.24
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ABSTRACT
Objective: To compare the diagnostic performance of CT angiography (CTA) and exercise 
electrocardiography (XECG) in a symptomatic population with a low–intermediate preva-
lence of coronary artery disease (CAD).
Design: Prospective registry.
Setting: Tertiary university hospital.
Patients: 471 consecutive ambulatory patients with stable chest pain complaints, mean (SD) 
age 56 (10), female 227 (48%), pre-test probability for signifi cant CAD >5%.
Intervention: All patients were intended to undergo both 64-slice, dual-source CTA and an 
XECG. Clinically driven quantitative catheter angiography was performed in 98 patients.
Main outcome measures: Feasibility and interpretability of, and association between, CTA and 
XECG, and their diagnostic performance with invasive coronary angiography as reference.
Results: CTA and XECG could not be performed in 16 (3.4%) vs 48 (10.2%, p<0.001), and 
produced non-diagnostic results in 3 (0.7%) vs 140 (33%, p<0.001). CTA showed ≥1 coronary 
stenosis (≥50%) in 140 patients (30%), XECG was abnormal in 93 patients (33%). Results by 
CTA and XECG matched for 185 patients (68%, p = 0.63). Catheter angiography showed ob-
structive CAD in 57/98 patients (58%). Sensitivity, specifi city, positive and negative predictive 
value of CTA to identify patients with ≥50% stenosis was 96%, 37%, 67% and 88%, respec-
tively; compared with XECG: 71%, 76%, 80% and 66%, respectively. Quantitative CTA slightly 
overestimated diameter stenosis: 6 (21)% (R = 0.71), compared with QCA. Of the 312 patients 
(66%) with a negative CTA, 44 (14%) had a positive XECG, but only 2/17 who underwent 
catheter angiography had signifi cant CAD.
Conclusion: CTA is feasible and diagnostic in more patients than XECG. For interpretable 
studies, CTA has a higher sensitivity, but lower specifi city for detection of CAD.
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INTRODUCTION
Exercise electrocardiography (XECG) is a well-established and inexpensive procedure 
to evaluate patients with suspected angina pectoris, and has been in widespread clinical 
use for decades. While considered cost eff ective, the test is also known for its modest di-
agnostic accuracy,1 which in practice often leads to multiple testing. Multislice computed 
tomography allows non-invasive angiography of the coronary arteries, and has emerged as 
a diagnostic alternative in patients with suspected coronary artery disease (CAD).2 However, 
recommendations for the use of CT angiography (CTA) are based on studies in populations 
often with high disease prevalence.3, 4, 5 Considering the Bayes’ theorem, performance of CTA 
may not be comparable in low-risk populations—the group of patients in whom the test is 
most commonly used. In this study we explored the value of 64-slice, dual-source CTA in a 
large, real-world, symptomatic population with a low–intermediate disease prevalence, and 
compared it with XECG.
METHODS
Study population
Between September 2006 and December 2008, 471 consecutive patients with stable chest 
pain and no history of CAD were evaluated at our 1-day chest pain clinic. All patients with a 
pre-test probability >5%6 were intended to undergo XECG and contrast-enhanced cardiac 
CT, in addition to a clinical examination, blood analysis and echocardiography. Angina was 
categorised as typical: retrosternal discomfort, precipitated by exercise or emotion, relieved 
within 10 min after rest or nitroglycerin; atypical: with only two of the previous characteristics; 
or non-anginal: with none or only a single characteristic (Table 1). The study was approved 
by the institutional ethical committee and informed consent was obtained from all patients.
Computed tomography
Contraindications to CTA were pregnancy, known allergy to iodine contrast media, impaired 
kidney function. Contrast-enhanced, 64-slice dual-source CT (Siemens Defi nition, Forchheim, 
Germany) was performed with the following parameters: spiral mode, collimation 32×0.6 
mm, 64-channel acquisition using Z-axis alternation of the focal spot, rotation time 330 ms, 
temporal resolution 83 ms, tube voltage 120 kV, tube current 380–412 mA depending on 
the patient size, variable pitch depending on the heart rate. Prospectively ECG-triggered 
tube modulation was used in all patients with a regular heart rate. A 70–100 ml bolus was 
injected at 5.0–5.5 ml/s through a peripheral vein in the arm, followed by 40 ml of saline 
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at the same injection rate. A bolus tracking technique was used to synchronise the data 
acquisition with contrast enhancement. Patients received a sublingual dose of nitroglycerin 
just before the scan. No additional β blockers were administered. Retrospective ECG-gated 
image reconstruction was performed using a slice thickness of 0.75 mm, with an overlap of 
0.4 mm. End-systolic and/or diastolic datasets were created depending on the heart rate and 
the ECG-triggered tube modulation protocol.
The coronary arteries, the right coronary artery, left main stem, left anterior descending 
coronary artery and left circumfl ex branch, were assessed using the axial images, multipla-
nar reformations and maximum intensity projections. Vessels were qualitatively scored as 
signifi cantly stenosed (>50% diameter narrowing), less than signifi cantly stenosed (<50%) 
or normal.
Table 1 Patient characteristics (n= 471)
Characteristics Value
Age (years), mean (SD) 56 (10)
Female: male 227: 244 (0.48:0.52)
Risk profile
Nicotine abuse 138 (0.29)
Hypertension 233 (0.49)
Diabetes 68 (0.14)
Dyslipidaemia 280 (0.59)
Family history of CVD 214 (0.45)
History of vascular disease 31 (0.07)
Chest pain
Typical angina 146 (0.31)
Atypical angina 251 (0.53)
Non-anginal chest pain 74 (0.16)
Pre-test probability (%), mean
(SD)6
52 (28)
Heart rate (min21), mean (SD) 68 (13)
Catheter angiography 98 (0.21)
.50% Stenosis, any vessel 57/98 (0.58)
Single-vessel disease 26/98 (0.27)
Two-vessel disease 19/98 (0.19)
Three-vessel disease 12/98 (0.12)
.70% Stenosis, any vessel 29/98 (0.30)
Percutaneous or surgical
management
59 (0.13)
Percutaneous intervention 46 (0.10)
Bypass graft surgery 13 (0.03)
Results are shown as number (proportion of the total) unless stated
otherwise.
CVD, cardiovascular disease.
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Exercise ECG
XECG on a bicycle ergometer was performed by standardised protocol. XECG was not per-
formed if the patient was technically or physically unable to perform the test, or in patients 
with a signifi cantly abnormal resting ECG. During continuous ECG registration and 12-lead 
prints at 1 min intervals, the workload was increased from 40 W by 20 W increments at 2 
min intervals. Blood pressure was measured every 2 min. Criteria for discontinuation were 
systolic blood pressure >230 mm Hg, diastolic blood pressure >130 mm Hg, a >10 mm Hg 
systolic blood pressure drop, ST depression >0.3 mV, ST elevation >0.1 mV, sustained ven-
tricular tachycardia, increasing frequency of polymorphic ventricular complexes, altered 
atrioventricular or intraventricular conduction, exhaustion, severe dyspnoea, angina or other 
discomfort. Criteria for myocardial ischaemia included horizontal or downsloping ST depres-
sion or elevation >0.1 mSv measured at 80 ms from the J point during or after exercise, or 
typical, increasing angina during exercise. The XECG was considered non-diagnostic if the 
test was discontinued without evidence of myocardial ischaemia before the 85% target heart 
rate was reached.
Invasive angiography
Clinically indicated cardiac catheterisation was performed in 98 patients using standard 
techniques. Semiautomatic quantifi cation angiography (QCA) of luminal obstruction was 
performed by an independent, blinded observer. Maximum lumen diameter stenosis ≥50% 
was considered moderate, ≥70% was considered severely stenosed.
Quantitative coronary angiography
For patients who underwent invasive coronary angiography, coronary obstructions were 
also quantitatively assessed on CTA, using validated semiautomatic quantifi cation software 
(Circulation; Siemens, Forchheim, Germany).7 8 After vessel segmentation and centre-lumen 
line reconstruction, short-axis images of the vessel at submillimetre increments were recon-
structed. The lumen area was automatically quantifi ed based on attenuation thresholds, with 
the option for manual adjustments. The diameter stenosis was calculated from the minimal 
lumen area and the average of the proximal and distal reference area, with the assumption of 
a circular shape of the respective lumen areas.
For the quantitative comparison of CTA and QCA all vessels were included, and the most 
severe lesion for each vessel was used in the analysis. Both for CTA and QCA normal vessels 
and vessels with minor wall irregularities or mildly obstructive plaque were visually scored as 
0% and 20% stenosis, respectively. Severely calcifi ed obstructions that could not be processed 
automatically, required qualitative assessment, classifi ed as moderately stenosed (50–70%), 
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severely stenosed (>70–99%), or completely obstructed (100%), and were recorded as 60%, 
80% and 100%, respectively, in comparison with quantitative invasive angiography. Quanti-
tative analysis was possible for CTA in 150, and for QCA in 143 vessels.
Statistical analysis
Summary data are presented as numbers (proportions) or means (SD), unless otherwise 
indicated. Diagnostic performance is expressed as sensitivity, specifi city, positive predictive 
value and negative predictive value, with 95% confi dence intervals. Association between 
quantitative CT and catheter angiography measurements were analysed using the Pearson 
coeffi  cient. Diff erences between groups were compared using a two-sided unpaired t test, 
a χ2 test or analysis of variance test. p Values <0.05 were considered signifi cant. For lesions 
where quantitative CT analysis could not be applied (inferior image quality, extensive 
calcifi cation) visually moderate and severe stenosis were classifi ed as 60% or 80% diameter 
stenosis. Segments with wall irregularities on QCA or non-obstructive plaque on CT were 
semiquantifi ed as 20% stenosis. Statistical analysis was performed using SPSS, version 15.0 
(SPSS, Chicago, USA).
RESULTS
CTA could not be performed in 16 patients (3.4%), for reasons of renal failure, known contrast 
allergies, patient preferences, Parkinson’s disease, patient non-cooperation, lack of venous 
access and severe obesity. Three scans (0.7%) failed because of patient movement (two) 
and premature scan initiation (one). Interpretable CT scans were available in 452/471 (96%) 
patients (Table 2). Three patients (0.7%) had mild to moderate allergic reactions.
XECG could not be performed in 48 (10.2%) patients because of orthopaedic restraints 
(13), neurological restraints (four), severe obesity (two), resting ECG abnormalities (six), 
pulmonary disease (two), combination/unspecifi ed (21). For the 423 XECGs performed the 
mean (SD) maximum workload was 143 (47) W (1.00 (24)% of the predicted workload), and 
the maximum heart rate was 87 (13)% of the target heart rate. Results were considered in-
conclusive in 140/423 (33%) patients, mostly because the target heart rate was not reached. 
CTA and XECG test agreement
The percentage of CT angiograms with >50% stenosis in at least one vessel: 30% (140/452), 
was comparable to the proportion of abnormal X-ECGs: 33% (93/283, P=0.63)(Table 2). CTA 
and XECG results matched in 185/274 (68%) patients with interpretable results (Figure 1).
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Diagnostic performance compared with quantitative coronary angiography
Clinically driven invasive angiography was performed in 98 patients (21%), which showed 
signifi cant CAD in 57 (58%). Including patients with both positive XECG and CTA, without in-
vasive angiography for confi rmation, the total number of patients with signifi cant CAD was 89 
(19%). Only 59 (13%) patients underwent percutaneous (46) or surgical revascularisation (13).
The sensitivity of CTA to identify patients with any >50% CAD was signifi cantly better than 
XECG (Table 3): 96% (95% CI 86% to 99%) compared with 71% (52% to 84%), respectively. 
After exclusion of non-diagnostic cases specifi city was signifi cantly better for XECG than 
for CTA: 76% (54% to 90%) versus 37% (23% to 53%), respectively. When an intention-to-
Table 2 CT angiography (CTA) and exercise electrocardiography (XECG) agreement (n= 452)
XECG not
performed
(n=178)
Negative
agreement
(n= 138)
Disagreement
(n= 89)
Positive
agreement
(n= 47) p Value*
Gender (female) 91 (0.51) 79 (0.57) 40 (0.45) 7 (0.15) ,0.001
Age (years), mean (SD) 57 (10) 52 (9) 56 (10) 59 (9) ,0.001
Heart rate (min21), mean (SD) 68 (12) 70 (13) 68 (10) 64 (12) 0.02
Pre-test probability (%), mean (SD) 57 (27) 45 (25) 52 (28) 68 (32) ,0.001
Risk profile
Nicotine abuse 59 (0.33) 40 (0.29) 23 (0.26) 14 (0.30) 0.65
Hypertension 98 (0.55) 52 (0.38) 43 (0.48) 27 (0.57) 0.01
Dyslipidaemia 102 (0.57) 78 (0.57) 55 (0.62) 36 (0.77) 0.08
Diabetes 27 (0.15) 12 (0.09) 16 (0.18) 8 (0.17) 0.18
Family history of CVD 72 (0.40) 75 (0.54) 39 (0.44) 20 (0.43) 0.09
History of vascular disease 20 (0.11) 4 (0.03) 3 (0.03) 5 (0.11) 0.01
Chest pain symptoms 0.003
Typical 60 (0.34) 26 (0.19) 28 (0.31) 27 (0.57)
Atypical 97 (0.54) 90 (0.65) 43 (0.48) 12 (0.26)
Non-anginal 21 (0.12) 22 (0.16) 18 (0.20) 8 (0.17)
CT angiography
.50% Stenosis, any vessel 48 (0.27) 0 45 (0.51) 47 (1.0) ,0.001
Single-vessel disease 19 (0.11) 0 26 (0.29) 16 (0.34) ,0.001
Two-vessel disease 16 (0.09) 0 10 (0.11) 13 (0.28) ,0.001
Three-vessel disease 13 (0.07) 0 9 (0.10) 18 (0.38) ,0.001
Catheter angiography 38 (0.21) 6 (0.04) 27 (0.30) 25 (0.53) ,0.001
.50% Stenosis, any vessel 22 (0.12) 0 11 (0.12) 22 (0.47)
Single-vessel disease 8 (0.04) 0 7 (0.08) 8 (0.17)
Two-vessel disease 9 (0.05) 0 3 (0.03) 8 (0.17)
Three-vessel disease 5 (0.03) 0 1 (0.01) 6 (0.13) ,0.001
Revascularisation 25 (0.14) 0 11 (0.12) 22 (0.47) ,0.001
Bypass graft surgery 5 (0.03) 0 1 (0.01) 7 (0.15) 0.05
Percutaneous intervention 20 (0.11) 0 10 (0.11) 15 (0.32) 0.03
Results are shown as number (proportion of the total) unless stated otherwise.
*Analysis of variance test. Excluding 19 patients with unavailable CT angiography results.
CVD, cardiovascular disease.
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diagnose approach was used, which includes non-diagnostic tests as positive results, the 
specifi city of XECG decreased to the same level as CTA. Combined CTA and XECG (positive 
results for both) improved specifi city, at a loss of sensitivity. CTA was not signifi cantly more 
sensitive in patients with a diagnostic exercise test than in those who could not perform 
XECG or had an inconclusive result.
Quantitatively CTA correlated fairly with QCA, with a slight overestimation of diameter 
stenosis severity (per vessel): 6 (21)% (R = 0.71). Quantitative measurements between CT and 
QCA correlated best for the right coronary artery (R = 0.79) and least for the left main coronary 
artery (R = 0.22).
Potential value of complementary imaging
CTA did not show signifi cant stenosis in 312 patients (66%), of whom 44 (14%) had a posi-
tive XECG. Seventeen patients (5%) had a clinical need for invasive angiography, which was 
positive in two patients (0.6%), of whom only one had a positive XECG. XECG was negative in 
Figure 1: CT angiography (CTA; three-dimensional volume rendered and curved reconstructions), invasive coronary angiography (QCA), and 
maximum ST depression on exercise ECG (XECG, insert) of four patients: (1) A 54-year old woman with a symptomatic exercise test, though 
modest ST depression (insert), and severe obstructive disease in the left anterior descending coronary artery (LAD) on both CTA and QCA. (2) A 
62-year-old man with atypical complaints, a negative XECG, a moderate stenosis with calcifi cation on CTA, but less than signifi cant QCA. (3) A 
55-year-old man with atypical angina, a negative XECG, but three-vessel disease on CTA and QCA, including the LAD, the intermediate branch, 
a marginal branch and the left circumfl ex branch (CX). (4) A 47-year-old man with atypical angina and a positive XECG, but without signifi cant 
obstruction on CTA or QCA.
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190 patients (40%), of whom 45 (24%) had a positive CTA. Of the 29 patients who underwent 
QCA, 10 had signifi cantly obstructive coronary disease, all with positive CTAs (fi gure 2).
Among patients with a positive CTA (140), for those with a positive XECG (47, 34%) QCA 
showed more, and more severe CAD: 22/25 signifi cant, 15/25 severe stenosis; compared with 
those with a negative XECG (45, 32%): 10/23 signifi cant (p = 0.001), 4/23 severe CAD (p<0.003).
Within the group of patients without interpretable XECGs, CAD was rules out by CTA in 
30/188 (69%) patients, contradicted by QCA in only a single patient out of seven catheterised.
Most patients with a non-diagnostic XECG and positive CTA underwent QCA (31/48, 65%), 
which confi rmed signifi cant disease in 21 (68%).
DISCUSSION
Diagnostic evaluation of chest pain of recent onset
Chest pain is a common symptom, and a potential manifestation of coronary heart disease. 
Despite a modest diagnostic accuracy of merely 70%, combined with a thorough clinical 
assessment, XECG remains the most widely used test to assess the presence of ischaemic 
heart disease.1 Rapid-access chest pain clinics, which have emerged over the past decade, 
appear eff ective to assess patients early after the onset of symptoms and to identify patients 
at increased risk for adverse cardiac events.8 9 In patients diagnosed with angina, based on 
Table 3 Diagnostic performance of CT angiography (CTA) and exercise electrocardiography (XECG) for detection of (invasive) angiographic significant
coronary artery disease, per patient (n= 98)
Analysis Excl TP TN FP FN
Sensitivity (%)
Mean (95% CI)
Specificity (%)
Mean (95% CI)
Positive PV (%)
Mean (95% CI)
Negative PV (%)
Mean (95% CI)
Per patient analysis, >50% QCA stenosis
CTA (>50% stenosis) 2 53 15 26 2 96 (86 to 99) 37 (23 to 53) 67 (55 to 77) 88 (62 to 98)
XECG 39 24 19 6 10 71 (52 to 84) 76 (54 to 90) 80 (61 to 92) 66 (46 to 81)
CTA + XECG 40 22 22 3 11 67 (51 to 83) 88 (75 to 100) 88 (75 to 100) 67 (48 to 85)
Per patient analysis, >50% QCA stenosis, intention to diagnose
CTA (>50% stenosis) – 55 15 26 2 96 (87 to 99) 37 (23 to 53) 68 (56 to 78) 88 (62 to 98)
XECG – 47 19 22 10 82 (70 to 91) 46 (31 to 62) 68 (56 to 79) 66 (46 to 81)
Per patient analysis, >70% QCA stenosis
CTA (>50% stenosis) 2 27 16 52 1 96 (80 to 100) 24 (14 to 36) 34 (24 to 46) 94 (69 to 100)
XECG 39 16 25 14 4 80 (56 to 93) 64 (47 to 78) 53 (35 to 71) 86 (67 to 95)
CTA + XECG 40 15 29 10 4 79 (61 to 97) 74 (61 to 88) 60 (41 to 79) 88 (75 to 100)
Per patient analysis, >70% QCA stenosis, intention to diagnose
CTA (>50% stenosis) – 28 17 52 1 97 (80 to 100) 25 (15 to 37) 35 (25 to 47) 94 (71 to 100)
XECG – 25 25 44 4 86 (67 to 95) 36 (25 to 49) 36 (25 to 49) 86 (67 to 95)
Per vessel analysis, CT angiography (>50% stenosis)
.50% QCA stenosis 8 83 218 68 15 85 (78 to 92) 76 (71 to 81) 55 (47 to 63) 94 (90 to 98)
Diagnostic XECG 4 52 133 41 6 90 (82 to 98) 76 (70 to 83) 56 (46 to 66) 96 (92 to 100)
Non-diagnostic XECG 4 31 85 27 9 78 (65 to 90) 76 (68 to 84) 53 (41 to 66) 90 (83 to 98)
.70% QCA stenosis 8 27 229 124 4 87 (75 to 99) 65 (60 to 70) 18 (12 to 24) 98 (96 to 100)
Diagnostic performance of (CTA), exercise ECG (XECG), or combined (with both tests required positive), by per patient or per vessel analysis, using either a .50% or .70%
quantitative catheter angiography (QCA) threshold as reference. Unavailable data were excluded, or assumed positive in the intention-to-diagnose analysis. Subanalysis in patients
with diagnostic or non-diagnostic XECG results (including XECGs not performed).
FN, false negative; FP, false positive; PV, predictive value; TN, true negative; TP, true positive.
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clinical assessment, resting ECG and XECG, death to coronary heart disease or acute coro-
nary syndrome was reported in 16.5% at 3 years’ follow-up, compared with 2.7% in patients 
with non-cardiac complaints.10 Nevertheless, nearly one-third of all major adverse coronary 
events occurred in the (larger) group of patients thought not to have coronary related 
complaints, which is explained by the fact that luminal obstruction is not required before 
these acute events. Furthermore, Sekhri, et al, demonstrated that after clinical evaluation, the 
XECG contributed only modestly to the prediction of outcome.11 Taylor et al, reported that 
patients who were unable to perform an exercise test, or produced uninterpretable results, 
experienced major adverse events at a rate similar to that of patients classifi ed as having 
stable angina pectoris.9 Considering these observations, XECG may be insuffi  cient to stratify 
patients with undiff erentiated chest pain according to risk. Stress imaging, which may be 
more accurate for myocardial ischaemia detection, shares the limitation of XECG with respect 
to the detection of less obstructive atherosclerotic disease.
Coronary CTA can be used to rule out (obstructive) coronary artery disease, particularly in 
patients at intermediate risk with non-conclusive stress test results.2 Additional prognostic 
value may be found in the detection of coronary atherosclerosis by CT, whether obstructive 
or not.12 13
Performance of CTA versus XECG
In this prospective registry of real-world, symptomatic patients with a low–intermediate 
prevalence of ischaemic heart disease, CT could be performed in more patients (p<0.001), 
and interpretable results were more often achieved (p<0.001). Using strict criteria, the num-
Figure 2: Virtual fl ow chart of exercise ECG (XECG) followed by coronary CT angiography (CTA) (A), and CTA followed by XECG (B). Unavailable 
tests (N/A) include tests that could not be performed, or produced equivocal results.
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ber of non-diagnostic XECGs was 33%, which is high in comparison with previous reports 
(18–31%).14, 15 With quantitative invasive angiography as reference, the sensitivity of CTA to 
detect signifi cant CAD was higher than XECG. Only after exclusion of non-diagnostic tests did 
XECG showed better specifi city than CTA. Sensitivity and specifi city of XECG for the detection 
of signifi cant CAD on QCA was 71% and 76%, comparable to a large meta-analysis that re-
ported a sensitivity and specifi city of 68% and 77%.1 Diff erentiation between severe stenosis 
and total occlusion can be diffi  cult by CTA.16 Catheterisation showed 14 occluded vessels, 
which CTA assessed as occluded in eight, severely stenosed in three, moderately stenosed 
in two, and less than signifi cantly stenosed in one patient (CT diameter stenosis 41%). There 
were no false-positive occlusions by CTA.
To date, two studies in populations of moderate size and high disease prevalence have 
compared the diagnostic performance of 16-slice CTA and XECG. Using an intention-to-
diagnose approach Dewey et al found that CTA outperformed XECG for both sensitivity: 91% 
vs 73%, and specifi city: 83% vs 31%, and a substantial number of non-assessable XECGs, as 
well as CTAs.17 In a population with a 74% disease prevalence Mollet et al, found a sensitivity 
and specifi city of 100% and 87% for CTA, compared with 78% and 67% for XECG.18 Verifi cation 
bias is assumed at least partially responsible for the lower specifi city of CTA in our study—
that is, patients with perceived stenosis (as a result of excessive calcifi cation) were more likely 
to undergo clinically driven invasive investigation.
This study further confi rmed earlier reported discrepancies between angiographic CTA 
and myocardial perfusion imaging.19,20,21 Some authors reported better agreement between 
CTA and nuclear imaging using a 70% stenosis cut-off  point.22
Clinical use of CTA in stable angina
CT could be performed with diagnostic quality in nearly all patients and could rule out ob-
structive CAD in 66% of patients, compared with 40% by XECG. Based on these results CT may 
be considered as initial test in patients with chest pain and reason to suspect CAD. A negative 
CTA virtually rules out ischaemic heart disease, requiring no further testing. In patients with 
obstructive CAD on CT, functional testing would be required to assess haemodynamic signifi -
cance, localise ischaemia and determine the need for revascularisation. In our study not all 
patients with an abnormal exercise test were catheterised. In the absence of severe inducible 
ischaemia and prognostically important CAD—that is, left main or three-vessel disease, the 
caring doctors were more confi dent initiating and continuing medical treatment instead of 
referral for revascularisation.
Drawbacks of cardiac CTA include the lack of prognostic information from the patient’s 
aerobic performance, the vulnerability of the technique to cardiac arrhythmia and the need 
for potentially nephrotoxic contrast media and radiation (10–15 mSv). Over the past few years 
a number of robust techniques have been (re-)introduced to decrease the radiation dose 
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associated with cardiac CT, including optimised ECG-triggered tube modulation for spiral 
acquisition protocols, variable table speed, ECG-triggered sequential acquisition protocols, 
anatomy-based dose modulation, lower tube output settings in smaller patients, tighter scan 
ranges, etc. Awareness of increased radiation dose by doctors, combined with contemporary 
technology, allows for routine cardiac CT at an eff ective dose below 5 mSv.23 24
Study limitations
Referral to cardiac catheterisation and coronary angiography was clinically driven and not 
available in the majority of patients without non-invasive evidence of (severe) CAD. Many 
patients with positive CTAs and/or XECGs were treated medically, at least initially. Selective 
referral to invasive angiography probably had a positive eff ect on sensitivity and a negative 
eff ect on the specifi city of CTA, in comparison with QCA. The results of this study have gener-
ated hypotheses for the use of CTA in patients with stable chest pain, which require testing 
in prospective, randomised trials.
CONCLUSION
Contrary to XECG, CT can nearly always be performed with diagnostic results. CTA was normal 
or showed less than signifi cantly obstructive coronary disease in the majority of patients, in 
which case an abnormal exercise test or catheter angiogram was unlikely. With invasive an-
giography as a reference, CTA is more sensitive but less specifi c than XECG for the detection 
of signifi cant CAD. Randomised trials are needed to defi ne how CTA might be used (cost-) 
eff ectively in real-world patients with stable angina.
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SUMMARY
In chapter 2 we describe our experience during a three-year period with SonoVue, a second-
generation contrast agent. SonoVue was used in 241 patients to improve endocardial border 
delineation, which in turn makes the assessment of segmental wall motion analysis, left 
ventricular ejection fraction and volumes calculations more reliable. SonoVue also improves 
the assessment of the right ventricular function, which is especially important in patients 
with congenital heart disease. In patients with non-compaction cardiomyopathy and hy-
pertrophic cardiomyopathy during septal ablation echocardiographic images with SonoVue 
added important information to standard images. Another potentially important indication 
of contrast agents is the assessment of myocardial perfusion in patients with coronary artery 
disease. Although many publications report increase in diagnostic accuracy when contrast 
agents are added to routine echocardiography this has not yet led to widespread use of 
these agents in general cardiac practice. Probably issues like costs, safety and complexity 
are reasons for many cardiologists not to use contrast agents in routine practice. In conclu-
sion we think that the use of SonoVue is helpful in providing detailed morphological and/or 
quantitative information of the heart. Although perfusion is a very attractive application of 
SonoVue we think its not yet applicable for routine practice.
In chapter 3 we studied the eff ect of second harmonic imaging (SHI) on the image quality of 
a newly developed trans esophageal transducer (TEE). Although SHI was developed for the 
use of contrast echocardiography it was already known that SHI without the use of contrast 
improved image quality in trans thoracic echocardiography (TTE). In 14 patients, who under-
went bypass surgery, images were made in 4 chamber view and the transgastric short-axis 
view. Endocardial border detection was scored in both fundamental and SHI mode in all 168 
segments. Compared to fundamental imaging endocardial border delineation improved in 
26% but worsened in 2% of 108 segments. Improvement was more evident in the short-axis 
view compared to 4-chamber view (37% vv 18%). It seems that the lower the quality of the 
fundamental image the greater the improvement when SHI is used.
In conclusion, although fundamental TEE shows good quality images, SHI further improves 
endocardial delineation.
In chapter 4 we described whether adding a second-generation contrast agent could 
decrease the intra- and inter-observer variability for assessment of left ventricular ejection 
fraction (LV-EF). The assessment of LV-EF after acute myocardial infarction (AMI) is a marker 
of prognosis and used for selecting patients who benefi t from an internal cardiac defi brilla-
tor. Although echocardiography is the most used imaging modality to assess LV-EF the high 
variability is a disadvantage of this technique. We studies 48 patients with AMI and measured 
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LV-EF in second harmonic mode with SonoVue (LVO), and in second harmonic mode without 
SonoVue (SHI). With LVO the intra-observer variability decreased from
12.5±11.5% to 7.0±7.0% (p<0.001) and inter-observer variability decreased from 
16.9±9.9% to 7.0±6.2% (p<0.001). The improvement was found in patients both with good 
and moderate-to-poor image quality.
This study shows that assessment of LV-EF is more reliable with LVO as there is better intra- 
and inter-observer variability. If clinical decision making on LV-EF is made, we recommend 
using LVO in patients with good and moderate-to-poor quality images.
In chapter 5 we studied the interobserver agreement for wall motion and wall motion score 
index (WMSI) in 100 patients who underwent both two-dimensional second harmonic (SH) 
and contrast left ventricular(LVO) echocardiography and to study the correlation between 
the LVO-imaged WMSI and left ventricular ejection fraction (LV-EF). Two independent observ-
ers’ assessed LV segmental quality and wall motion both for SH and LVO studies according 
to a 17-segment model. Wall motion was defi ned as normokinesia, hypokinesia, akinesia 
and dyskinesia. LV-EF was assessed from the LVO images according to the biplane modifi ed 
Simpson’s method. Of the 1,700 analyzed segments, 453 (26,6%) were poorly visualized with 
SH imaging, and 173 (10,2%) with LVO imaging (P<0.0001). The two observers agreed on 
segmental wall motion in 1,299 segments (76%, Kappa 0.60) in SH imaging and in 1,491 
segments (88%, Kappa 0.78) in LVO imaging. Interobserver correlation (r2) was 0.86 for the 
SH-imaged WMSI and 0.93 for the LVO-imaged WMSI. The LVO- imaged WMSI correlated well 
with LV-EF (r2=0.71). The conclusion of this study was that echo contrast improves interob-
server agreement for wall motion scoring and the WMSI. The LVO-imaged WMSI correlates 
well with LV-EF.
In chapter 7 myocardial contrast echocardiography (MCE) is used to visualize perfusion in 
30 patients 2 days after Q-wave myocardial infarction (MI). Twenty patients were treated 
with thrombolytic therapy and 10 didn’t receive reperfusion therapy. All patients underwent 
coronary angiography and 18 patients SPECT scintigraphy. MCE was performed using second 
harmonic imaging (SHI) and power Doppler imaging with an intravenous infusion of perfl uo-
rocarbon-exposed sonicated dextrose-albumin (PESDA). A 16-segment left ventricular model 
was used to relate perfusion to coronary artery territories. Sensitivity and specifi city for MCE 
detecting segments supplied by the infarct-related artery were 82% and 95% respectively. 
These results were comparable with SPECT. Concordance between MCE and SPECT for de-
tecting abnormal perfusion in a segment-by-segment analysis was 93%. A 6-week follow-up 
echocardiography was made to assess wall motion. Dysfunctional segment with hypo- or 
normal perfusion with power Doppler imaging at baseline had signifi cant more recovery of 
function after 6- weeks than dysfunctional segments without perfusion.
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Conclusion of this study is that power Doppler imaging with intravenous infusion of PESDA 
can detect reperfusion after acute MI. Also this non-invasive technique can predict late recov-
ery of ventricular function.
In chapter 8 we studied whether end-diastolic wall thickness (EDWT) can predict recovery of 
regional left ventricular contractile function after percutaneous coronary intervention (PCI).
Regional contractile function does not recover in all patients after PCI for acute myocardial 
infarction (AMI). Prediction of functional recovery after AMI may help in clinical decision 
making. Forty consecutive patients with AMI were studied with left ventricular contrast 
echocardiography for accurate wall thickness and function measurement and myocardial 
perfusion immediately after and two months following PCI.
Out of 640 segments, 175 (27%) dysfunctional segments in the infarct territory were ana-
lyzed for EDWT, wall function, and perfusion. One hundred and three (59%) dysfunctional 
segments presented with an EDWT <11 mm and 72 (41%) presented with an EDWT ≥11 mm. 
Perfusion (partial or complete) was present in 63 segments with an EDWT <11 mm (61%) and 
71 segments with an EDWT ≥11 mm (99%) (p < 0.001). At two months’ follow-up, 66 of 72 seg-
ments with an EDWT ≥11 mm (92%) improved, whereas only 35 of 103 of the dysfunctional 
segments with an EDWT <11 mm (34%) improved (p< 0.0001).
Wall thickness is an easy parameter to predict recovery of function after revascularization. 
Moreover, combining EDWT and perfusion, segments with an EDWT ≥11 mm, and presence 
of perfusion have the highest chance of recovery; segments with an EDWT <11 mm and 
perfusion have an intermediate chance of recovery. In segments with an EDWT <11 mm and 
no perfusion, chances of recovery are very low.
In chapter 9 29 patients with symptomatic severe aortic stenosis (AS) were studied and 
compared to control subjects with respect to left ventricular (LV) function. LV function is 
most commonly assessed as LV ejection fraction (LV-EF) by the modifi ed Simpson’s biplane 
disc method. Doppler tissue imaging (DTI) has shown to be more sensitive to identify subtle 
changes in both systolic and diastolic function in several conditions. We performed DTI 
measurements in 29 patients with severe AS and 17 age-matched control subjects with both 
normal LV-EF. AS patients had signifi cant lower systolic- and diastolic DTI values compared to 
control subjects. Also, LV fi lling pressure expressed by the E/Em ratio was signifi cantly higher 
in AS patients. DTI-derived variables were correlated with NT-proBNP levels. Conclusion of 
this study was that DTI derived variables showed systolic and diastolic dysfunction in patients 
with symptomatic severe AS while conventional echo parameters, as LV-EF, were normal.
In chapter 10 27 patients with severe aortic stenosis (AS) were followed one-year after aortic 
valve replacement (AVR). All had normal left ventricular ejection fraction (LV-EF) pre-operative 
and decreased Doppler tissue measurements (DTI) of both systolic- and diastolic function. 
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The aim of the study was to investigate if, and to which extend, the long-axis DTI depressed LV 
function was reversible after AVR. Echocardiography was performed 3 weeks, 6 month and 12 
months after AVR. Values were compared with age-matched controls without cardiac disease. 
Long-axis systolic LV function measured on the lateral mitral annulus (Sm) improved 3 weeks 
after AVR and sustained in the follow up. Post-operative improved Sm were not diff erent 
compared to the control group. Diastolic function expressed as the ratio of peak early fi lling 
mitral infl ow by pulsed Doppler and early diastolic peak velocity lateral mitral annulus (E/Em) 
also improved but did not reach normal values compared to the control group. Conclusion 
of this observational study was that long-axis DTI systolic LV dysfunction was reversible in 
patients with severe AS and normal LV-EF after AVR. Diastolic DTI dysfunction improved but 
still remained abnormal one-year after AVR.
In chapter 11 we studied the value of performing echocardiography in 500 consecutive 
patients evaluated for chronic chest pain (CCP). Cardiac investigations in patients CCP are fo-
cused on the detection of ischemia. In addition to stress tests, current guidelines recommend 
rest echocardiography in patients referred for the evaluation of CCP with an abnormal ECG, 
suspicion of heart failure and in the presence of murmurs. However, there are no prospective 
studies supporting this strategy. In 500 consecutive patients with intermediate and high risk 
for coronary artery disease (CAD) we performed a diagnostic protocol that consists of physi-
cal examination, ECG, bicycle exercise test and CT angiography. Also we performed handheld 
echocardiography (HHE) in all patients and compared these results with the fi nal diagnosis 
made by the other exams. Abnormal HHE results were found in 15,6% of all patients. In 346 
patients with normal blood pressure, no murmurs or signs of heart failure and a normal ECC 
only 10,4% had abnormal HHE. The majority of the fi ndings by HHE had no implications for 
patient management. In contrast, abnormal fi ndings were detected in 49 out of 154 patients 
(32%) with a guideline indication for HHE. Although systematic echocardiography in patients 
with chronic chest pain yields unexpected abnormalities in 10,4% of patients without abnor-
mal fi ndings by other investigations, the clinical relevance of these fi ndings is limited. Our 
fi nding supports the current guideline to perform echocardiography in selected cases only.
In chapter 12 we investigated the value of coronary calcium detection by computed to-
mography, in comparison with CT angiography and exercise testing, to detect obstructive 
coronary artery disease (CAD) in patients with stable chest pain. A total of 471 consecutive, 
patients with new stable chest complaints were scheduled to undergo both dual-source 
multislice CT (Siemens, Germany): coronary calcium score (CCS) and CT coronary angiogra-
phy (CTA), and exercise electrocardiography (XECG). Clinically driven invasive quantitative 
angiography (QCA) was performed in 98 patients. Only 3/175 (2%) of patients with a negative 
CCS had signifi cant CAD on CTA, with only one confi rmed by QCA. In patients with a high 
calcium score (Agatston score >400), CTA could exclude signifi cant
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CAD in no more than 4/65 patients (6%). Patients with a low-intermediate CCS, CTA more 
often yielded diagnostic results compared to XECG, and could rule out obstructive CAD in 
56% of patients. For patients with CAD on CTA, those with abnormal XECG results more often 
showed severe CAD (P<0.034). In patients with diagnostic results for all tests the sensitivity 
and specifi city to detect >50% QCA diameter stenosis was 100% and 15% for CCS>0, 82% 
and 64% for CCS>100, 97% and 36% for CTA, and 70% and 76% for XECG, respectively. In 
conclusion, non-enhanced CT for calcium detection is a reliably means to exclude obstruc-
tive CAD in stable, symptomatic patients. Contrast-enhanced CTA can exclude signifi cant 
CAD in patients with a low-intermediate CCS, but is of limited value in patients with high CCS.
In chapter 13 we compared the diagnostic performance of CT coronary angiography (CTCA) 
and exercise electrocardiography (X-ECG) in a symptomatic population with a low-interme-
diate prevalence of coronary artery disease (CAD). In this prospective registry we studied 471 
ambulatory patients with complaints of stable chest pain, age 56 (SD 10), female 227 (48%) 
and pre-test probability for signifi cant CAD >5%. All patients had to undergo both 64-slice 
dual-source CTCA and an X-ECG. Clinically driven quantitative catheter angiography (QCA) 
was performed in 98 patients. The main outcome measures were the feasibility and interpret-
ability of, and the association between CTCA and X-ECG, and their diagnostic performance 
using invasive coronary angiography as reference. CTCA and X-ECG could not be performed 
in 16 (3.4%) vs. 48 (10%, P<0.001), and produced non- diagnostic results in 3 (0.7%) vs. 140 
(33%, P<0.001). CTCA showed ≥1 coronary stenosis (≥50%) in 140 patients (30%), X-ECG was 
abnormal in 93 patients (33%). Results by CTCA and X-ECG matched for 185 patients (68%, 
P=0.63). Catheter angiography showed obstructive CAD in 57/98 patients (58%). Sensitivity, 
specifi city, positive and negative predictive value of CTCA to identify patients with ≥50% 
stenosis: 96%, 37%, 67% and 88%; compared to X-ECG: 71%, 76%, 80% and 66%. Quantitative 
CTCA slightly overestimated diameter stenosis: 6±21% (R=0.71), compared to QCA. Of the 
312 patients (66%) with a negative CTCA, 44 (14%) had a positive X-ECG, but only 2/17 that 
underwent catheter angiography had signifi cant CAD.
The conclusion of the study was that CTCA is feasible and diagnostic in more patients com-
pared to X-ECG. For interpretable studies, CTCA has a higher sensitivity, but lower specifi city 
for detection of CAD.
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Conclusions
In the majority of patients referred to a cardiologist for diagnostic or therapeutic reasons 
cardiac imaging is needed. Several imaging techniques are available and each has it’s own 
advantages and disadvantages. In this thesis the value of some new modalities of echo-
cardiography and computer tomographic angiography (CT-angiography) are evaluated in 
patients assessed by cardiologists at the Thoraxcenter.
Echocardiography is by far the most widely used imaging modality in clinical practice to 
obtain information about the structure and function of the heart and heart valves. Several 
patient characteristics, as obesity and chronic obstructive pulmonary disease, may decrease 
image quality and make reliable judgement of the cardiac structures sometimes diffi  cult. In 
chapter 2 we describe how the use of echo contrast improves the image quality. For many 
years qualitative description of left ventricular function as either severely, moderately or 
mildly impaired was suffi  cient for clinical purposes. Subsequently quantitative assessment of 
left ventricular ejection fraction was introduced for example to start medication after myo-
cardial infarction and to decide which patients would benefi t by implanting a cardioverter-
defi brillator (ICD) to prevent sudden cardiac death. In most studies echocardiography was 
the imaging technique used to measure ejection fraction despite its high intra- and inter-
observer variability. In chapter 3, 4 and 5 we used second harmonic imaging and echo con-
trast to assess wall motion, wall motion score index and left ventricular ejection fraction. We 
showed improvement of endocardial border alignment resulting in reduced intra-observer 
variability and inter-observer variability for assessment of left ventricular ejection fraction. 
Also, more segments could be analysed with echo contrast. The wall motion score index, as-
sessed with contrast, correlated well with ejection fraction. Therefore, we recommend using 
echo contrast agents when quantitative measurement of left ventricular wall motion, wall 
motion score index or ejection fraction is important.
Myocardial contrast echocardiography is also used to detect myocardial ischemia caused 
by coronary artery disease and to predict recovery of function after myocardial infarction. 
In chapter 7 and 8 we showed that myocardial perfusion and wall thickness as assessed by 
contrast echocardiography predict recovery of left ventricular function several weeks after 
myocardial infarction. Thus defi nite assessment of left ventricular function after a myocardial 
infarction has to take place at least several weeks after the acute event.
In many experimental and clinical studies including patients with hypertension, diabetes, 
valve disease and cardiomyopathy, Doppler tissue imaging is able to detect impaired longi-
tudinal left ventricular function while ejection fraction is normal. Ejection fraction is relatively 
insensitive to detect these subtle changes in left ventricular systolic function. Patients with 
cardiac disease and impaired left ventricular ejection fraction have a worse outcome than 
those with normal ejection fraction. Therefore we studied the longitudinal systolic function 
assessed by Doppler tissue imaging as a possible early marker of left ventricular dysfunction in 
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patients with severe aortic stenosis and normal left ventricular ejection fraction (chapter 9). 
Longitudinal function was reduced compared to controls and appeared to be related to NT-
ProBNP levels as independent sign of abnormal cardiac function. Interestingly, these Doppler 
tissue parameters improved after aortic valve replacement as shown in chapter 10. Because 
patients with severe aortic stenosis and abnormal ejection fraction have worse outcome after 
valve replacement compared to patients with normal ejection fraction earlier surgery might 
be considered. We propose that patients with reduced longitudinal systolic function, as an 
early sign of left ventricular impairment, should be considered for valve surgery to improve 
prognosis, even though left ventricular ejection fraction is still within the normal range. 
Further prospective and observational studies are needed to determine whether these 
measurements can be used indeed to select the optimal moment for valve replacement in 
asymptomatic patients with severe aortic stenosis and normal ejection fraction.
Chest pain can be caused by coronary artery disease and also by other cardiac and non-
cardiac causes. In the study presented in chapter 11 we investigated the clinical value of 
echocardiography when performed in all patients with chest pain. The yield of chest pain 
related cardiac diseases was very low. Although substantial other, not related to chest pain, 
cardiac abnormalities were found, these had no implications for the treatment or prognosis 
of the patients. Therefore we recommend performing echocardiography only in selected 
patients with chronic chest pain in the presence of heart murmurs, ECG abnormalities or 
signs of heart failure.
Another cardiovascular imaging technique that has been introduced in the last decade 
is CT-angiography. CT-angiography evaluated very rapidly and can now be used in the out-
patient clinic. In chapter 12 and 13 we studied the value of coronary calcium detection, 
CT-angiography and exercise testing. Patients without calcium had a 2% incidence, while 
patients with very high calcium-score had a 94% incidence of signifi cant coronary artery 
disease. Exercise testing could not be performed or showed inconclusive results in 40% 
of patients. CT-angiography was superior to diagnose signifi cant coronary artery disease 
compared to exercise testing. Further technical improvement and decreased radiation dose 
below 1 mSv allows a more liberal use of this technique in patients evaluated for chest pain. 
Implementation of CT-angiography will change our diagnostic protocol in these patients 
from an ischemia, to an anatomically approach. The following fi gure illustrates a possible 
future approach in patients with chronic chest pain:
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Abbreviations: PT-T, pre-test probability; 3 VD, 3 vessel disease; LM, left main; CAD, coronary artery disease.
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Cardiovascular imaging in the future
At this moment not only echocardiography is becoming more complex with 3-dimensional 
echocardiography, speckle tracking, Doppler tissue imaging and strain imaging, which re-
quires special expertise for recording and interpretation of the images, but also magnetic 
resonance imaging, positron emission tomography and multi-slice computer tomography 
evolve rapidly. The imaging modality chosen to answer a specifi c clinical question is currently 
based on limited individual experience as well as on availability and on the experience with 
the diff erent techniques in each hospital. To optimize the use of these modalities in clinical 
practice we need to develop non-invasive cardiovascular imaging departments with access 
to all imaging modalities and cardiologists with extensive knowledge of all these techniques. 
They should decide which technique will be used for answering specifi c questions in pa-
tients. The studies presented in this thesis provide new information for positioning contrast 
echocardiography, Doppler tissue imaging and cardiac CT.
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SAMENV ATTING
In hoofdstuk 2 beschrijven we onze ervaring opgedaan met het gebruik van SonoVue, 
een tweede generatie contrast middel, gedurende een periode van 3 jaar. SonoVue werd 
gebruikt bij 241 patiënten waarbij een verbetering werd gevonden van de afscheiding 
tussen myocard en bloed; de endocardial afscheiding. Dit vertaalde zich in een betere en 
nauwkeurige beoordeling van de ejectie fractie, volumina en analyse van wandbewegingen. 
Tevens werd een betere beoordeling van de rechter ventrikel gevonden wat vooral bij 
patiënten met een congenitale hartaandoening van grote waarde is. SonoVue werd verder 
gebruikt in cardiale aandoeningen als non-compaction cardiomyopathie en hypertrofi sche 
cardiomyopathie tijdens een alcoholablatie van het septum. Een potentieel belangrijke indi-
catie voor het gebruik van echocontrast middelen is het beoordelen van myocardperfusie, 
en dus ischeamie, in patiënten met coronair lijden. Hoewel vele publicaties aantonen dat het 
goed mogelijk is met echocontrast middelen myocard ischeamie aan te tonen heeft dit niet 
geleid tot grootschalig gebruik hiervan in de algemene cardiologisch praktijk. Waarschijnlijk 
spelen kosten van het contrastmiddel, veiligheids issues en complexiteit van het gebruik en 
techniek hierin een rol. Wij concluderen dat het gebruik van SonoVue additionele waarde 
heeft t.o.v. conventionele echocardiografi e als gedetailleerde morfologisch en/of kwantita-
tieve informatie van het hart gevraagd wordt. Voor routine gebruik van echocontrast voor 
het aantonen van myocardperfusie defecten als uiting van coronair lijden in de algemene 
cardiologisch praktijk is deze techniek nog niet geschikt.
In hoofdstuk 3 bestuderen we de invloed van second harmonic imaging (SHI) op de kwaliteit 
van de beelden verkregen met een nieuw ontwikkelde trans oesophageale transducer (TEE). 
Aanvankelijk was SHI ontwikkeld voor het gebruik van echocontrast maar gebruik bij trans 
thoracale echocardiografi e (TTE) liet zien dat SHI ook zonder contrast de beeldkwaliteit be-
langrijk verbeterde. In 14 patiënten die een coronaire bypass operatie ondergingen werden 
vanuit de 4-kamer en de trans gastrische korte as opname beelden gemaakt. Door middel 
van een visuele score werd de endocardiale afscheiding beschreven in zowel de fundamen-
tele als de SHI modus in 168 segmenten. Met SHI was de gescoorde kwaliteit in 26% van de 
segmenten beter en in 2% slechter dan in de fundamentele modus. De verbetering was het 
meest uitgesproken in de transgastrische korte as opname (37% vs. 18%). Anderen studies
lieten zien dat SHI t.o.v. fundamentele mode bij TTE beelden de verbetering nog sterker 
was. Waarschijnlijk is dat hoe lager de kwaliteit van de verkregen fundamentele beelden is 
hoe groter de verbetering wanneer SHI wordt gebruikt. Deze studie laat zien dat ondanks het 
feit dat de kwaliteit van beelden verkregen met TEE van goede kwaliteit zijn, het gebruik van 
SHI de endocardiale afscheiding verder verbetert.
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In hoofdstuk 4 beschrijven we een studie waarbij wordt onderzocht of toevoeging van een 
tweede generatie echocontrast middel de intra- en inter-observer variabiliteit van bepaling 
van de linker ventrikel ejectiefractie (LV-EF) kan verbeteren. De LV-EF na een acuut myocard-
infarct (AMI) geeft een indruk over de prognose van de patiënt en wordt gebruikt als een 
selectiecriterium voor patiënten die in aanmerking komen voor een interne defi brillator.
Hoewel echocardiografi e de meest gebruikte imaging methode is weten we dat de grote 
variatie in metingen een nadeel is van deze techniek. In deze studie werden 48 patiënten 
bestudeerd die een AMI doormaakte. LV-EF werd in de second harmonic mode zowel zon-
der (SHI) als met contrast (LVO) bepaald. LVO verbeterde de intra-observer variabiliteit van 
12.5±11.5% naar 7.0±7.0% (p<0.001) en de inter-observer variabiliteit van 16.9±9.9% naar 
7.0±6.2% (p<0.001). Deze verbetering werd zowel in de goede als in de matige tot slechte 
kwaliteit echo’s gezien. Conclusie van deze studie was dat wanneer LV-EF nodig is om klini-
sche beslissingen te nemen bij patiënten na een AMI een echocontrast middel moet worden 
gebruikt. Dit geldt zowel bij goede als matig tot slechte kwaliteit echocardiografi een.
In hoofdstuk 5 onderzoeken we de interobserver overeenstemming bij de beoordeling 
van wandbewegingen en de wandbewegingscore index (WBSI) bij 100 patiënten die een 
echocardiogram met zowel 2-dimensionale ‘second harmonic’ (SH) als linker ventrikel con-
trast (LVO ) ondergingen. Tevens werd de correlatie bestudeerd tussen de met LVO verkregen 
WBSI en de linker ventrikel ejectie fractie (LVEF). Twee onafhankelijk beoordelaars bepaalden 
wandbewegingen en WBSI zowel in SH als in LVO beelden in het 17-segmenten model. 
Wandbeweging werd beoordeeld als normokinetisch, hypokinetisch, akinetisch en diski-
netisch. LVEF werd berekend d.m.v. de biplane, gemodifi ceerde Simpson’s methode. Van de 
1700 beoordeelde segmenten waren de wandbewegingen van 453 (26,6%) slecht te beoor-
delen in de met SH verkregen beelden tegen 173 (10,2%) in de met LVO verkregen beelden 
(p<0.0001). Beide beoordelaars hadden overeenstemming over wandbewegingen in 1299 
segmenten (76%, Kappa 0.60) in de met SH verkregen beelden en in 1491 segmenten (88%, 
Kappa 0.78) in de met LVO verkregen beelden. De interobserver correlatie (r2) van de WBSI 
was 0.86 met de door SH verkregen beelden en 0.93 met de door LVO verkregen beelden. De 
WBSI verkregen door de LVO beelden correleerde goed met LVEF (r2=0.71). Conclusie van dit 
onderzoek was dat het gebruik van echo contrast de interobserver overeenstemming voor 
wandbewegingen en WBSI verbeterde en dat de LVO WBSI goed correleerde met LVEF.
In hoofdstuk 7 wordt myocard contrast echocardiografi e (MCE) gebruikt om naar myocard 
perfusie te kijken bij 30 patiënten 2 dagen na een acuut Q-wave myocardinfarct (AMI). 20 
patiënten kregen thrombolyse en 10 geen reperfusie therapie. Alle patiënten ondergingen 
na 2 dagen coronair angiografi e en 18 kregen voor ontslag een SPECT scintigrafi e. MCE werd 
verricht met second harmonic imaging (SHI) en power Doppler waarbij perfl uorocarbon-
exposed sonicated dextrose-albumin (PESDA) als contrast middel werd gebruikt. Sensitiviteit 
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en specifi citeit voor het vaststellen welke segmenten door het infarct gerelateerde vat van 
bloed werden voorzien waren respectievelijk 82% en 95%. Overeenkomst tussen SPECT en 
MCE in het vaststellen van abnormale perfusie op segment basis was 93%. Na 6 weken werd 
een follow-up echocardiogram gemaakt om een segmentale wandbeweging score te maken. 
Disfunctionele segmenten met hypo- of normoperfusie bij MCE tijdens baseline vertoonden 
signifi cant meer herstel in functie dan disfunctionele segmenten zonder perfusie met MCE.
Concluderend toont deze studie aan dat Power Doppler imaging met intraveneus toege-
diend PESDA in staat is om reperfusie na AMI aan te tonen. Tevens kan met deze non-invasieve 
techniek voorspeld worden bij welke segmenten herstel van functie optreedt.
In hoofdstuk 8 bestuderen we of de einddiastolische wanddikte (EDWD) verbetering van de 
segmentale contractiele functie voorspelt na primaire percutane coronaire interventie (PCI). 
Hiervoor werd de EDWD gemeten in 175 disfunctionele uit een totaal van 640 segmenten 
(27%) bij 40 patiënten met een acuut myocardinfarct (AMI) die behandeld waren met een PCI. 
Om de EDWD beter te bepalen werd een echocontrast middel gebruikt tijdens het echocar-
diogram. Tevens werd met behulp van power Doppler methode gekeken naar myocardiale 
perfusie (MCE) en werden deze op een semi-kwantitatieve methode gescoord.
Na 2 maanden werd opnieuw een echocardiogram gemaakt om EDWD, perfusie en functie 
te beoordelen. De 175 disfunctionele segmenten werden onderverdeeld in segmenten met 
een EDWD <11mm (103) en een EDWD≥11mm (72). MCE liet in 11 van de 103 segmenten met 
EDWD<11mm normale, in 52 gedeeltelijke en in 40 geen perfusie zien. In de 72 disfunctio-
nele segmenten met EDWD≥11mm hadden 33 normale, 38 gedeeltelijke en 1 geen perfusie. 
Bij de follow-up echo vertoonden 66 van de 72 segmenten met EDWD≥11mm verbetering 
in functie terwijl slechts 35 van de 103 segmenten met EDWD<11mm verbeterden (p<0001). 
De segmenten met de combinatie van EDWD≥11mm en aanwezigheid van perfusie hadden 
de grootste kans om in functie te verbeteren terwijl segmenten met EDWD<11mmzonder 
perfusie zelden verbetering in functie gaven na 2 maanden.
In hoofdstuk 9 wordt de linker ventrikel (LV) functie bij patiënten met een symptomatische 
ernstige aorta stenose (AS) onderzocht en vergeleken met die van een controle groep. De LV 
functie wordt in het algemeen weergegeven als de LV ejectie fractie (LV-EF) en bepaald met 
echocardiografi e en de Simpson’s biplane disc methode. Doppler tissue imaging (DTI) heeft 
bij verschillende cardiale ziekten aangetoond dat ze meer subtiele veranderingen in zowel 
systolische als diastolische LV functie kan aantonen. Metingen werden verricht met DTI in 29 
patiënten met AS en vergeleken met waarden bij 17, voor leeftijd gecorrigeerde, personen 
zonder AS. AS patiënten bleken signifi cant lagere DTI waarden te hebben vergeleken met 
de controles. Ook was de LV vullingsdruk gemeten door de E/Em ratio signifi cant hoger in 
AS patiënten. DTI variabelen waren gecorreleerd met NT-proBNP waarden. Geconcludeerd 
werd uit deze studie dat DTI variabelen LV systolische en diastolische disfunctie aantonen in 
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patiënten met symptomatische ernstige AS terwijl conventionele echo parameters als LV-EF 
normaal waren.
In hoofdstuk 10 worden 27 patiënten met een ernstige aorta stenose (AS) vervolgd tot één 
jaar na aortaklep vervanging (AVR). Alle patiënten hadden een normale linker ventrikel ejectie 
fractie (LV-EF) en abnormale systolische en diastolische linker ventrikel functie gemeten met 
Doppler tissue imaging (DTI). Het doel van deze studie was om de eventuele reversibiliteit, 
en de mate waarin, te onderzoeken van deze abnormale lange-as DTI LV functie. Drie weken, 
6 en 12 maanden na AVR werd een echocardiogram gemaakt en de gemeten waarden wer-
den ook vergeleken met een voor leeftijd gecorrigeerde controle groep zonder hartziekte. 
Lange-as systolische LV functie van de laterale mitralis annulus verbeterde al 3 weken na 
de klepvervanging en persisteerde na 1jaar. Deze verschilde niet van de controle groep. De 
diastolische functie uitgedrukt als ratio van de piek vroege diastolische mitralis fl ow gemeten 
met pulsed Doppler en de vroege diastolische piek snelheid van de laterale mitralis annulus 
verbeterde weliswaar na AVR maar bereikte niet de waarden van de controle groep en bleef 
dus verminderd. De conclusie van deze studie is dat lange-as systolische LV disfunctie bij 
patiënten met ernstige AS en normale LV-EF reversibel is maar dat diastolische LV disfunctie 
wel verbeterd maar niet normaliseert 1 jaar na de aortaklep vervanging.
In hoofdstuk 11 bestuderen we de waarde van het maken van een echocardiogram bij 
500 patiënten met thoracale pijn klachten. Bij deze patiënten richt het onderzoek zich met 
name op het diagnosticeren van eventueel aanwezig signifi cant coronair lijden. De huidige 
richtlijnen adviseren een echocardiogram als er sprake is van een abnormaal ECG, hoge 
bloeddruk, verdenking op hartfalen of de aanwezigheid van een hartgeruis. Prospectieve 
data om deze werkwijze te ondersteunen ontbreken grotendeels. Bij 500 patiënten met een 
intermediair tot hoog risico op het hebben van coronair lijden verrichten we een diagnostisch 
protocol bestaande uit lichamelijk onderzoek, ECG, fi ets ergometrie en een CT angiografi e. 
Daarnaast werd bij iedereen een handheld echocardiogram (HHE) verricht en we vergeleken 
de bevindingen hiervan met de uiteindelijke diagnose die d.m.v. de andere onderzoeken 
werd gesteld. Abnormale HHE bevindingen werden gevonden in 15,6% van alle patiënten. 
Bij 346 patiënten met normale bloeddruk, zonder hartgeruis, geen tekenen van hartfalen 
en een normaal ECG 10,4% hadden een abnormale bevinding bij HHE. Het merendeel van 
deze bevindingen had geen implicaties voor de behandeling van de patiënten. Bij 49 van 
de 154 (32%) patiënten met een, volgend de richtlijnen, indicatie voor een HHE werden 
abnormale HHE diagnoses gevonden. De conclusie van deze prospectieve analyse is dat 
met het verrichten van een echocardiogram bij alle patiënten met thoracale pijn klachten in 
10,4% een onverwachte diagnose werd gevonden the relevantie hiervan zeer beperkt is. Dit 
ondersteunt de richtlijnen om een echocardiogram alleen te verrichten in een selecte groep 
van patiënten.
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In hoofdstuk 12 wordt de waarde van de d.m.v. computer tomografi e bepaalde calcium-
score vergeleken met de CT coronaire angiografi e (CTA) en inspanningstest (XECG) om signi-
fi cant coronairlijden (CAD) te diagnosticeren bij patiënten met pijn op de borst klachten. In 
totaal ondergingen 471 patiënten met thoracale pijn klachten een dual-source multislice CT 
coronaire calcium score (CCS) en CTA en een XECG. Invasieve kwantitatieve angiografi e (QCA) 
werd op klinische gronden verricht bij 98 patiënten. Slechts 3/175 (2%) van alle patiënten 
met een negatieve CCS hadden signifi cant CAD bij de CTA, waarvan er een werd bevestigd 
bij QCA. Bij patiënten met een hoge calcium score (Agatston score >400) werd slechts bij 
4/65 patiënten (6%) CAD uitgesloten door QCA . Bij patiënten met een laag tot intermediaire 
CCS van had een CTA meer diagnostische waarde dan de XECG voor het aantonen van CAD. 
Patiënten met CAD bij CTA en abnormale XECG hadden vaker ernstig CAD (P<0.034). Bij 
patiënten die alle diagnostische testen ondergingen de sensitiviteit en specifi citeit voor het 
diagnosticeren van >50% QCA diameter stenose was 100% en 15% voor een CCS>0, 82% en 
64% voor een CCS>100, 97% en 36% voor CTA, en 70% en 76% voor XECG. Conclusie van 
deze studie is dat calciumscore detectie door CT een betrouwbare techniek is om signifi cant 
coronairlijden uit te sluiten bij patiënten met pijn op de borst klachten. CT-angiografi e is in 
staat om signifi cant coronairlijden uit te sluiten bij patiënten met een laag tot intermediair 
risico maar heeft beperkte waarde bij een hoge calciumscore.
In hoofdstuk 13 vergelijken we de diagnostisch waarde van CT angiografi e (CTA) en inspan-
ning elektrocardiografi e (X-ECG) bij symptomatisch patiënten met een laag tot intermediaire 
vooraf kans op het hebben van coronaire hartziekte (CAD). In deze prospectieve registratie 
warden 471 poliklinische patiënten bestudeerd met stabiele pijn op de borst klachten met 
een gemiddelde leeftijd van 56 jaar, 48% vrouwen en een pre-test probability op het hebben 
van CAD van >5%. Alle patiënten ondergingen i.p. een 64-slice dual-source CTA en een X-ECG. 
Invasieve kwantitatieve coronair angiografi e (QCA) werd verricht in 98 patiënten wanneer 
daar een klinische indicatie voor was. Belangrijkste eindpunten waren de uitvoerbaarheid, 
betrouwbaarheid en de relatie tussen CTA en X-ECG van beide onderzoeken waarbij de 
referentie methode de QCA was.
CTA en X-ECG konden niet worden verricht in 16 (3.4%) resp. 48 (10%, P<0.001), en waren 
niet diagnostisch in 3 (0.7%) resp. 140 (33%, P<0.001). CTA ≥1 coronair stenose (≥50%) in 140 
patiënten (30%), X-ECG was abnormaal in 93 patiënten (33%). Resultaten van CTA en X-ECG 
kwamen overeen in 185 patiënten (68%, P=0.63). Met QCA werd in 57/98 (58%) obstructief 
CAD gevonden. Sensitiviteit, specifi citeit, positief en negatief voorspellende waarde van CTA 
om patiënten te identifi ceren met ≥50% stenose waren respectievelijk: 96%, 37%, 67% and 
88%; vergeleken met X-ECG: 71%, 76%, 80% en 66%. Kwantitatieve CTA overschatte de 
diameter stenose: 6±21% (R=0.71), vergeleken met QCA. Van de 312 patiënten (66%) met 
een negatieve CTA hadden er 44 (14%) een positieve X-ECG, maar slechts 2/17 die een CAG 
ondergingen hadden signifi cant CAD.
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De conclusie van dit onderzoek is dat CTA uitvoerbaar en diagnostisch is in een groter 
aantal patiënten dan een X-ECG. In goed interpreteerbare studies heeft CTA een hogere 
sensitiviteit maar een lagere specifi citeit voor de detectie van CAD.
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Conclusies
Bij de meeste patiënten die naar een cardioloog worden verwezen is een vorm van cardiale 
beeldvorming noodzakelijk om een diagnose te stellen en/of om de juiste therapie in te stel-
len. Verschillende technieken zijn hiervoor beschikbaar en iedere techniek heeft voor- en 
nadelen. In dit proefschrift worden verschillende nieuwe modaliteiten van echocardiografi e 
en coronair angiografi e door middel van computer tomografi e (CT) geëvalueerd in patiënten 
die verwezen zijn naar de cardiologen van het Thoraxcentrum.
Echocardiografi e is zonder twijfel de meest gebruikte beeldvormende techniek in de 
klinische praktijk om informatie te verkrijgen over de structuur en functie van het hart en 
de hartkleppen. Echter de kwaliteit van de beelden kan negatief worden beïnvloed door 
verschillende patiënten kenmerken zoals obesitas en chronisch obstructief longlijden. In 
hoofdstuk 2 beschrijven wij hoe met behulp van echocontrast de beeldkwaliteit verbetert.
Gedurende lange tijd was kwalitatieve beoordeling van de linker ventrikel functie als 
“normaal”, “licht verminderd”, “matig verminderd” of “ernstig verminderd” voldoende voor 
de klinische praktijk. De laatste jaren wordt kwantitatieve beoordeling van de linker ven-
trikel ejectiefractie steeds meer gebruikt om te beslissen of patiënten behandeld moeten 
worden met bepaalde medicamenten en of zij in aanmerking komen voor een implanteer-
bare cardioverter-defi brillator (ICD). In veel studies werd echocardiografi e gebruikt om deze 
ejectiefractie te bepalen hoewel er een grote intra- en inter-observer variabiliteit bestaat bij 
deze methode. In hoofdstuk 3, 4 en 5 maken wij gebruik van ‘second harmonic imaging’ 
en echocontrast voor bepaling van wandbewegingen, de wandbeweging score index en 
de linker ventrikel ejectiefractie. Wij laten zien dat verbeterde endocard afgrenzing leidt tot 
verminderde intra- en inter-observer variabiliteit voor de bepaling van de linker ventrikel 
ejectiefractie. Tevens konden wij meer segmenten beoordelen met behulp van echocontrast. 
De wandbeweging score index correleerde goed met de ejectiefractie. Wij concluderen dan 
ook dat echocontrast gebruikt zou moeten worden als kwantitatieve beoordeling van wand-
bewegingen, wandbeweging score index of ejectiefractie essentieel is.
Myocard contrast echocardiografi e wordt gebruikt voor het aantonen van ischemie als 
gevolg van signifi cant coronairlijden en om verbetering van de linker ventrikel functie te 
voorspellen in de herstelfase na een myocardinfarct. In hoofdstuk 7 en 8 tonen we aan dat 
myocard perfusie en wanddikte gemeten met behulp van echocontrast een voorspellende 
waarde heeft voor verbetering van linker ventrikel functie een aantal weken na een acute 
cardiale gebeurtenis.
In vele experimentele en klinisch studies bij patiënten met hypertensie, diabetes mellitus, 
kleplijden en cardiomyopathie kan met Doppler tissue imaging (DTI) discrete vermindering 
van de longitudinale linker ventrikel functie worden gedetecteerd terwijl de ejectiefractie 
normaal is. De ejectiefractie is een relatief ongevoelige maat om een subtiele achteruitgang 
van de linker ventrikel functie te diagnosticeren. Patiënten met een hartziekte en een ver-
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minderde ejectiefractie hebben een slechtere prognose dan patiënten waarbij deze normaal 
is. Wij bestudeerden de longitudinale systolische functie met Doppler tissue imaging bij 
patiënten met een ernstige aortastenose en een normale ejectiefractie (hoofdstuk 9). In ver-
gelijking met een controlegroep was de longitudinale functie verminderd bij deze patiënten 
en bleek deze gerelateerd aan NT-ProBNP gehalte als een onafhankelijke maat voor een ver-
minderde hart functie. In hoofdstuk 10 beschrijven wij dat deze functie herstelt na aortaklep 
vervanging. Omdat patiënten met een ernstige aortastenose en een abnormale ejectiefractie 
een slechtere prognose hebben dan diegenen met een normale ejectiefractie moet chirurgie 
plaatsvinden voor die achteruitgang. Wij stellen voor om klepvervanging te overwegen bij 
patiënten met een verminderde longitudinale linker ventrikel functie, als teken van vroege 
linker ventrikel disfunctie, en een normale ejectiefractie om hun prognose te verbeteren. 
Toekomstige prospectieve en observationele studies zijn nodig om vast te stellen of dit soort 
metingen gebruikt kunnen worden om het optimale moment voor klepvervanging vast te 
stellen bij patiënten met een ernstige aortastenose en een normale ejectiefractie.
Pijn op de borst kan veroorzaakt worden door signifi cant coronairlijden maar ook door 
andere cardiale en niet cardiale oorzaken. In hoofdstuk 11 beschrijven wij de waarde van 
het maken van een echocardiogram bij alle patiënten die zich presenteren met pijn op de 
borst klachten. Het percentage andere cardiale oorzaken van pijn op de borst wat wordt 
gevonden door middel van een echocardiogram bleek laag te zijn. Wel werden soms andere, 
niet aan de klachten gerelateerde cardiale afwijkingen gevonden maar deze hadden weinig 
of geen invloed op de behandeling of prognose van de patiënten. Wij concluderen dan ook 
dat een echocardiogram bij patiënten met pijn op de borst klachten alleen geïndiceerd is bij 
patiënten met hart geruisen, ECG afwijkingen of tekenen van hartfalen.
Een andere cardiovasculaire beeldvormende techniek die de laatste jaren is geïntrodu-
ceerd is de CT-coronair angiografi e. Deze techniek is snel geëvalueerd en nu toepasbaar in de 
poliklinische situatie. In hoofdstuk 12 en 13 bestuderen wij de waarde van de calciumscore, 
CT-coronair angiografi e en de fi etsergeometrie bij patiënten met pijn op de borst klachten. 
Patiënten zonder calcium in de coronairvaten hadden een kans van 2% en patiënten met 
een hoge calcium score een kans van 94% op het hebben van signifi cant coronairlijden. In 
40% van de patiënten kon fi etsergeometrie niet worden verricht of gaf dit onderzoek geen 
duidelijke diagnostische resultaten. CT-coronair angiografi e was beter om signifi cant coro-
nairlijden te diagnosticeren dan fi etsergeometrie. Toekomstige technische verbeteringen en 
verlaging van de stralingbelasting tot minder dan 1 mSv maakt een meer liberale toepassing 
van deze techniek mogelijk bij patiënten met pijn op de borst klachten. Implementatie van 
CT-coronair angiografi e zal het diagnostisch protocol in deze patiënten categorie van een 
op ischemie gerichte naar een meer anatomische benadering veranderen. Wij stellen het 
onderstaande schema voor als benadering voor patiënten met pijn op de borst klachten:
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Afkortingen: PT-P = pre-test probability; 3 VD = 3 vessel disease; LM = left main; CAD = coronary artery disease.
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Cardiovasculaire beeldvorming in de toekomst
Echocardiografi e wordt steeds meer complex met 3-dimensionele echocardiografi e, speckle 
tracking, Doppler tissue en strain imaging. Daarnaast zijn nu ook magnetic resonantie ima-
ging, positron emissie tomografi e en multi-slice computer tomografi e beschikbaar in vele 
ziekenhuizen. De beeldvormende techniek die wordt gekozen om een specifi eke vraag te 
beantwoorden is veelal gebaseerd op beperkte individuele ervaring maar ook op de be-
schikbaarheid van en ervaring met deze technieken in het betreff ende ziekenhuis. Om het 
gebruik van al deze technieken te optimaliseren zijn niet-invasieve, cardiovasculaire imaging 
afdelingen nodig met cardiologen die uitgebreide ervaring hebben met al deze technieken. 
Zij bepalen welke techniek wordt gebruikt om een specifi eke vraag te beantwoorden. De 
in dit proefschrift beschreven studies geven informatie over het positioneren van contrast 
echocardiografi e, Doppler tissue imaging en CT-coronair angiografi e bij verschillende groe-
pen patiënten.
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door jouw aanwezigheid.
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Dr. K. Nieman, beste Koen, met de komst van jou hebben we de kennis in huis om de weten-
schappelijke kant van de CT-coronaire angiografi e te versterken en deze techniek verder te 
implementeren in de dagelijkse praktijk. Hoe langer we de beslissing uitstellen om bij een cal-
cium score van 0 te stoppen met de CT-coronaire angiografi e hoe meer voorbeelden er komen 
van patiënten mét signifi cant coronairlijden en een calcium score van 0. Misschien toch maar 
het hele onderzoek doen bij alle patiënten? Ook dank voor jouw bijdrage aan dit proefschrift.
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Dr. S. C. Yap, beste Sing, jouw hulp bij de statistiek en bewerking van de resultaten bij 
meerdere hoofdstukken was belangrijk. En ondertussen je eigen proefschrift in recordtempo 
afgemaakt. Word nu ook maar een goede cardioloog.
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toekomst: wel in Nederland cardioloog worden, toch maar Nederlands leren? Soms is een ver-
keerde keuze beter dan geen keuze. Dat je keuzes kunt maken laat je zien bij Loek Hollander 
waar je activiteiten indrukwekkende morfologische veranderingen hebben bewerkstelligd.
Mijn collega cardiologen van de polikliniek: Michelle Michels, Jolien Roos-Hesselink, Jaap 
Deckers, Martijn Akkerhuis, Judith Cuypers, Maarten Witsenburg, Robert-Jan van Geuns en 
Folkert Meijboom (nu in Utrecht). Mede dankzij jullie hebben we op de polikliniek een goede 
basis voor kwalitatief uitstekende patiëntenzorg én wetenschappelijk onderzoek.
De leidinggevenden op de polikliniek cardiologie in het Thoraxcentrum te weten unithoofd, 
Hans van Schendel en coördinatoren Corrie Scheepers, Lenne Stok, Angela Peterse† en 
Ellen Wiegers. Ik denk dat we met zijn allen een goed team vormen en hard werken om de 
polikliniek verder te verbeteren. Ook jullie dank voor de prettige samenwerking.
Sinds enige tijd werkzaam op de polikliniek Paul Musters, verpleegkundig specialist. Bedankt 
voor je bijdrage aan de Fast Track poli’s en aan dit proefschrift. Soms is het moeilijk om je 
plaatst te vinden tussen al die onmogelijke dokters maar het gaat je goed af. Binnenkort zelf 
artikelen schrijven is de volgende stap. De omslag van het boekje heb ik aan jou te danken.
Ook dank aan de verschillende binnen en buitenlandse cardiologen en arts-assistenten die in 
een of andere vorm meegewerkt hebben aan dit proefschrift: Eleni Vourvouri, Elena Biagini, 
Vittoria Rizzello, Guido Rocchi, Laura van Vark, Heleen van der Zwaan, Attila Nemes en Lotte 
de Groot-de Laat.
De echolaboranten die uiteindelijk de beelden maakten: Wim Vletter, Jacky Vletter-Mcghie, 
Marianne Blum, Debbie van Dongen, Anne-Marie Schets, Linda de Jonge, Lourus van Have-
ren, Anja Seton en natuurlijk Hans Brandenburg die nu in Groningen zijn kunsten vertoont. 
Rene Frowijn bedankt voor het maken van plaatjes van de echobeelden.
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Mijn dank gaat ook naar de medewerkers van de afdeling Radiologie te weten Berend 
Koudstaal, Marcel Dijkshoorn en de radiologen die de meeste CT-angiografi een hebben 
bekeken Adriaan Moelker en Mohammed Ouhlous
En uiteraard ben ik Maria de Jong veel dank verschuldigd voor haar werk om het boekje in 
zijn huidige vorm te gieten. Ook in moeilijke tijden bleef jij de nuchterheid zelve en ging 
gestaag door met je werkzaamheden. Ik moest even wennen dat niet alleen de promotor 
vroeg of iets af was maar ook mijn secretaresse.
Mijn goede vrienden, buren, collega cardiologen en paranimfen Marcel Koffl  ard en Micon Bijl 
wil ik bedanken voor hun wijze lessen betreff ende allerlei zaken in het leven en ik ben blij dat 
zij deze dag naast mij zullen staan. Hun morele steun was op zijn tijd zeer gewenst. Misschien 
maar weer eens een fi etsweekje op Mallorca of Rimini en een biertje in Stobbe?
En dan het thuisfront: lieve Annette, als je tekort gekomen bent de laatste jaren dan komt het 
niet door dit boekje. Bedankt voor je steun toen ik naar Rotterdam wilde. Ons heerlijke leven 
met alles erop en eraan is voor een groot deel aan jou te danken waarvoor mijn grote dank. 
En als laatste dank ik mijn grote trots, onze drie zonen: lieve Hidde, Jouke en Geert de scriptie 
is af, nu de spreekbeurt nog.
Tjebbe BW 19-5b.indd   191 20-05-10   10:48
Curriculu m Vitae
Tjebbe BW 19-5b.indd   192 20-05-10   10:48
193
Curriculum Vitae
Pa
rt
 V
I
CURRICULU M VITAE
Tjebbe Wilhelmus Galema werd op 28 november 1960 geboren te Roermond. Na het 
eindexamen te hebben afgelegd in 1978 aan het Triniteitlyceum te Haarlem, studeerde hij 
geneeskunde aan de VU Medisch Centrum Amsterdam van 1978-1987. In 1989 begon hij 
in het Isala kliniek te Zwolle met de vooropleiding Interne Geneeskunde (opleider: J.A. ten 
Bokkel Huinink). In 1991 startte hij met de opleiding Cardiologie in de VU Medisch Centrum 
Amsterdam (opleiders: Prof.dr. F.W.A. Verheugt en Prof.dr. C.A. Visser †). Op 01 maart 1995 werd 
hij geregistreerd als Cardioloog.
Van 1995-1997 werkte hij in de Isala ziekenhuis te Zwolle. Na zijn verhuizing naar Rotter-
dam heeft hij van 1997-1998 gewerkt in het Maasstad ziekenhuis, waarna hij stafl id werd in 
het Erasmus Medisch Centrum waar hij vanaf 2005 Medisch Coördinator van de Polikliniek 
Cardiologie is. Specifi eke aandachtsgebieden zijn: non-invasieve cardiale imaging en in het 
bijzonder echocardiografi e en MSCT van de coronairen.
Hij is getrouwd met Annette Galema-Boers en zij hebben drie zonen: Hidde (1994), Jouke 
(1996) en Geert (1998).
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PHD PORTFOL IO SUMMARY
Name PhD student: T.W. Galema
Erasmus MC: Cardiology
Research School: COEUR
Year Workload
(Hours)
1. PhD TRAINING
General academic skills
- Medische Statistiek 2006, 2007 26
- Teach-the-Teacher 2007 26
Research skills
- Cardiac CT course Level A, Maastricht 2009 25
- Masterclass: fi nanciering binnen de gezondheidszorg 2009 4
- Cardiologie & sport: van sport-ECG naar pathologie 2009 6
In-depth COEUR courses
- COEUR Research seminars (Friday afternoon) 2005-2009 17.5
Other courses
-  Cardiology and Vascular Medicine update and perspective, 
Rotterdam
2005-2009 75
- Voorjaarscongres Nederlandse Vereniging voor Cardiologie 2005-2009 62
- Najaarscongres Nederlandse Vereniging voor Cardiologie 2005-2009 22
- CV risico begrijpen 2009 6
- Symposium: Cardiale CT en MRI in de praktijk 2008 4
- Symposium: Academie & Periferie: “best of both worlds” 2008 2
- First Cardiovascular Imaging Symposium, Rotterdam 2008 5
- Post ACC symposium 2008, ASS in perspective 2008 2
- Leiden Cardiology Course 2007, 2008 19
- Cardiovasculair Risicomanagement 2007 5
- POST ASS symposium 2006 4
- Haagse cursus Echocardiografi e 2005 12
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International Conferences
- Euro Echo 2007, 2008 39
- Cardiovascular exchange summit, Madrid 2008 14
- European Society of Cardiology 2008 24
- Cardiovascular exchange summit, Montreal 2006, 2007 23
- Cardiac MRI en CT 2007 16
- ACC (Fuster), New York 2006 8
2. TEACHING ACTIVITIES
Lecturing
- Keuzeonderwijs begeleiding voor studenten 2005-2009 1
- Journal Club 2005-2009 4
- Assistentenonderwijs 2005-2009 5
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